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Summary
Neutrophil spreading is an essential process in neutrophil extravasation and is 
a key step in the process of inflammation. Inhibition of neutrophil spreading is 
therefore a potential therapeutic target for the treatment of inflammatory 
diseases. Resting neutrophils have wrinkles in their plasma membrane which 
are held in place by cytoskeletal elements which act as a ‘molecular velcro’. 
These proteins may be cleaved by cytosolic proteases such as the Ca2+- 
activated protease p calpain which contains a C2 like’ domain. Calpain 
activation is also implicated in the expansion of the membrane during 
phagocytosis.
The primary challenge over the course of this project was expressing of 
fluorescent proteins in myeloid cells. In this thesis I show that lentiviral 
transduction was the most efficient method for the stable transfection of myeloid 
cell lines. Fluorescent-C2 domain translocates to the plasma membrane during 
experimental Ca2+ influx and during phagocytosis. A similar mechanism may 
occur in human neutrophils as p-calpain is located at the plasma membrane in 
activated human neutrophils. I also found that neutrophils may have a 
mechanism of retrieving excess membrane from the phagosome after 
phagocytosis.
The work presented here has shown that by virtue of its ‘C2 like’ domain p- 
calpain could translocate to the plasma membrane during the calcium influx 
which accompanies neutrophil spreading, p calpain was shown to be present in 
the right place and at the right time in primary human neutrophils during 
neutrophil shape change and thus may play a key role in allowing the 
unwrinkling of the neutrophil membrane. Inhibition of calpain activity inhibits 
neutrophil spreading and therefore calpain poses a potential target for the 
treatment of inflammatory diseases.
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CHAPTER 1
Introduction
1.1 The Immune System
1.1.1 Introduction
The human immune system has evolved a complex system of processes in 
order to protect the body from disease. Most infections with invading 
pathogens do not result in disease as the immune system deals with the 
infection efficiently. Disease normally only occurs when there are unusually 
high levels of pathogens, the pathogen is highly virulent or the host is in some 
way immuno-compromised. The body has several ‘barriers to infection’ in order 
to prevent invading pathogens from entering the body. These are anatomical, 
chemical and biological barriers. The anatomical barriers include skin, tears, 
saliva and mucus which act to prevent pathogens from entering the body. 
Chemical barriers such as lysozyme found in tears and the low pH conditions of 
sweat create a harsh environment for pathogens to live in. Finally the biological 
barrier is the body’s own normal flora which colonise the skin and the digestive 
tract and compete with invading pathogens for space and nutrients. If a 
pathogen manages to pass the initial ‘barriers to infection’ then the next 
fundamental role of the immune system is the ability to distinguish these 
invading pathogens from the body’s own cells in order to be able to specifically 
kill the pathogen without damaging any of the body’s own tissue. This is known 
as self/non-self discrimination.
1.1.2 Innate and Acquired Immunity
There are 2 specific subdivisions of the immune system; innate and acquired 
(or adaptive) immunity. These subdivisions are made up of a diverse variety of 
cells which all perform specific functions (table 1.1.2.1). Innate immunity refers 
to the subset of cells, which an individual is born with, that are constitutively 
present in the blood and are able to act immediately upon infection. They are 
non specific and can react to any invading pathogen.
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Acquired or adaptive immunity takes longer to respond to an infection but the 
response is much stronger than the innate response. It uses ‘immunological 
memory’ which is triggered when antibodies are produced after the initial 
infection with a specific pathogen which produces immunity to that pathogen. 
Immunological memory means that the next time the body comes into contact 
with that particular pathogen the immune system can respond immediately.
C ell type Prim ary Role
Leukocytes 
-Neutrophils 
-Basophils 
-Eosinophils 
-Monocytes 
-Lymphocytes 
-B cells 
-T  cells 
-Cytotoxic T  cells 
-Helper T  cells 
-Supressor T  cells 
-N K  cells 
Plasma cells 
Macrophages 
Mast cells
Phagocytosis and microbial killing
Release histamine and other chemicals involved in inflammation 
Destroy multicellular parasites
Move to site of infection and differentiate into macrophages
Make antibodies against antigens and develop into memory cells
Bind antigens on target cells/pathogens and destroy them 
Release cytokines (to attract macrophages)
Suppress immune responses 
Kill virus infected and tumour cells 
Produce large quantities of antibodies 
Phagocytosis and antigen presentation
Degranulate upon activation and release inflammatory mediators
Table  1.1.2.1 The roles of the different cells of the immune system (Widmaier, 2006)
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1.1.3 The Inflammatory Response
When a tissue is damaged either by an injury or an invading pathogen the cells 
release chemical signals which trigger the first response of the immune system; 
the inflammatory response. Invading microbes, damaged cells and the cells 
surrounding them release a variety of inflammatory mediators which act to 
trigger the inflammatory response. Inflammatory mediators include: bradykinin; 
complement components including C3 and C5a; plasmin; thrombin; lysozyme 
granules; histamine; a variety of cytokines including Interferon y (IFNy), Tumour 
Necrosis Factor a (TNFa), Interleukin 1 (IL1) and Interleukin 8 (IL8); as well as 
the eicosanoids, leukotriene B4 and prostaglandins (Griffin eta!., 2003).
These chemicals act together to produce the series of events known as the 
inflammatory response. They:
• Act on the smooth muscle in the blood vessels in the area of damage to 
cause vasodilation which leads to an increase in blood flow to that area. 
This is responsible for the reddening of the area seen in cases of 
inflammation.
• Cause an increase in vascular permeability in the immediate area which 
causes plasma to leak into the surrounding tissue leading to swelling and 
oedema.
• Cause an increase in expression of adhesion molecules on blood 
vessels that they act on. This results in the rolling and adhesion of 
phagocytes.
• Trigger extravasation of phagocytes which have slowed sufficiently on 
the blood vessel wall, whereby the phagocyte moves through the blood 
vessel wall into the surrounding tissue.
• Create a chemotactic gradient to attract the phagocytes to the area of 
damage/infection (Widmaier; 2006).
The main phagocytic cell involved in the inflammatory response is the 
neutrophil. Its main role is to remove damaged cells or microbes through 
phagocytosis. If the inflammatory response does not eliminate the infection 
then macrophages present antibodies which stimulate the acquired immune
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response. If the body has already encountered the invading pathogen before 
then the acquired immune response will be triggered earlier on in the immune 
response and the infections will be more quickly eradicated.
1.2 Neutrophils
1.2.1 The Neutrophil
Neutrophils are the most predominant type of white blood cell in the body with 
about 7x109 neutrophils being found in every litre of blood (Lewis et al., 2006). 
They are small (approx 10pm diameter) terminally differentiated phagocytic 
cells with a lifespan of only 3-4 days. Neutrophils are the first leukocytes to 
enter an area of inflammation, where their primary purpose is to internalise 
microorganisms and kill them by generating toxic free radicals. Neutrophils are 
essential for survival. For example the genetic defect chronic granulomatous 
disease (CGD) which affects one neutrophil specific protein and therefore 
impairs their function is fatal {Segal, 1987, Segal, 1996). However 
inappropriate activation of neutrophils in inflammatory diseases such as chronic 
obstructive pulmonary disease (COPD) can also be damaging to the body.
The different types of white blood cells were first described by Paul Ehrlich in 
1898 (Ehrlich P et al, 1898) when he noted that there were cells which 
appeared to have more than one nuclei but in fact had one nucleus with many 
lobes (figure 1.2.1.1). He termed these cells ‘cells with polymorphous nuclei’. 
Later they were renamed polymorphonuclear leukocytes {Metchnikoff, 1905), a 
term which is still used today. Metchnikoff also further classified the three types 
of polymorphonuclear leukocytes based on the staining properties of their 
granules. Basophils are stained with a basic stain, eosinophils stain with an 
eosin stain and neutrophils stain best with neutral dyes.
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Erythrocytes Leukocytes Platelets
A
Figure 1.2.1.1: Cellular constituents of blood. Blood is made up of three main classes of cells; red blood cells (erythrocytes), white blood cells 
(leukocytes) and platelets. Leukocytes can be further divided into two groups; the polymorphonuclear granulocytes whose nuclei are made up of many 
lobes (neutrophils, eosinophils and basophils) and the mononuclear leukocytes (monocytes and lymphocytes). Figure produced using Servier Medical 
Art.
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Establishing the role of the neutrophil proved controversial initially. As they 
were present in large numbers in pus and at the sites of infection it was first 
believed that they were generated at the infection site. However Waller was the 
first to show in 1846 that neutrophils in fact originated from the blood stream 
and that they left the blood vessels through a process known as diapedesis 
(Cohnheim, 1867, Cohnheim, 1967, Waller, 1846). It was also thought that 
they acted as agents of infection and ingested the bacteria in order to ferry 
them to the infection site and around the body. It was the ‘thorn in starfish’ 
experiments carried out by Metchnikoff in 1893 which first proposed the role of 
the neutrophil that we know today. He was able to show that when a 
transparent starfish embryo was pierced with a thorn that neutrophils moved 
towards the damaged area. This experiment he believed confirmed his theory 
that neutrophils were in fact beneficial to the body and that upon infection they 
moved towards the damaged area to phagocytose and kill the invading 
microbes (Metchnikoff, 1905, Metchnikoff, 1893, Metchnikoff, 1901).
1.2.2 Production -  Myelopoiesis
As neutrophils circulating in the blood stream have a short half life of only 4-10 
hours it is necessary for neutrophils to be constantly produced throughout a 
person’s life. This production is called myelopoiesis and occurs in the bone 
marrow. Pluripotent stem cells in the bone marrow undergo a series of mitotic 
cell divisions to give rise to the stem cells responsible for all of the different 
blood cell lineages (figure 1.2.2.1). Neutrophils as well as all other 
granulocytes, monocytes, platelets and erythrocytes are derived from the 
myeloid stem cell lineage. Within the myeloid progenitor pool there are several 
subtypes of proliferative pools all containing cells that are at different stages of 
maturation, some cells are already committed to a certain fate whereas others 
are not. As the cells mature they become more committed to their fate.
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Neutrophil production starts with the myeloid stem cell. The myeloid stem cell, 
the CFU-GEMM (colony forming unit -  granulocyte, erythroid, monocyte, 
megakaryocyte) no longer has the ability to self replicate and differentiates into 
the CFU-GM (colony forming unit -  granulocyte, macrophage) which then 
differentiates into the CFU-G (colony forming unit -  granulocyte). These cells 
make up the neutrophil progenitor pool (NPP). As they differentiate these cells 
become progressively more committed (figure 1.2.2.2). However, the CFU-G is 
still not a fully committed cell and still has the potential to become any type of 
granulocyte. The first stages of committed neutrophil differentiation are the 
myeloblast, promyelocyte and the neutrophilic myelocyte. These cells are 
formed by mitotic divisions which take approximately one week and they make 
up the neutrophil proliferative pool (NPP). Following this stage of differentiation 
post mitotic maturation takes place. This leads to the formation of 
metakaryocytes, band cells and finally neutrophils. These constitute the 
neutrophil storage pool (NSP). There are several factors regulating the 
maturation of neutrophils including Granulocyte Macrophage -  Colony 
Stimulating Factor (GM-CSF), Colony Stimulating Factor (CSF) and Interleukin 
3 (IL-3) (O k u d a e ta l1992).
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Figure 1.2.2.1: Production of the cellular constituents of blood. All blood cells are formed 
from a single pluripotent stem cell which undergoes a series of mitotic divisions to produce the 
myeloid and the lymphoid stem cells which are committed to that cell type. Neutrophils are 
derived from the myeloid lineage. Figure produced using Sen/ier Medical Art.
As the neutrophils mature they become more deformable, they gain new 
receptors on their plasma membrane and finally they become mobile. This 
enables them to migrate through the endothelial pores in the bone marrow and 
into the blood stream. Here they become the circulating neutrophil pool (CNP), 
There are two pools of neutrophils in the peripheral blood stream. These are 
the circulating neutrophil pool (CNP) which are circulating freely in the blood 
stream and the marginated neutrophil pool (MNP) which are adhered to blood 
vessel walls via selectins on the endothelial cells. They roll along the blood 
vessel walls until receptors (p2 integrin) on the neutrophil surface encounters 
their corresponding ligands (Intercellular Adhesion Molecule 1 (ICAM1)) on the 
blood vessel endothelium. ICAM1 expression on blood vessel endothelium is 
enhanced on activated endothelial cells. This occurs at sites of infection or 
damage and this is the trigger for the neutrophil to extravasate from the blood 
vessel into the surrounding tissue.
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Figure 1.2.2.2: Neutrophil production. Neutrophils are derived from the myeloid lineage, 
starting with the myeloid stem cell, CFU-GEMM. The CFU-GEMM has the potential to become 
several different cell types. As it divides it becomes gradually more committed to a certain fate. 
The myeloblast is the first cell type committed to become a neutrophil. Several more mitotic 
divisions occur in the bone marrow before final maturation takes place. Figure produced using 
Servier Medical Art.
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1.2.3 Neutrophil Structure
Neutrophils are small round cells, only approximately 10pm in diameter. They 
have a large multilobed nucleus which takes up 20% of the space in the cytosol 
of the cell (Schmid-Schonbein et at., 1980). The rest of the cytosol contains 
mostly granules which neutrophils have in very large numbers. Their function is 
to store pre-synthesised inflammatory mediators, enzymes and chemicals 
which would be harmful to the cell if allowed to diffuse freely in the cytosol. 
There are three primary types of granules which differ based on their contents. 
These are azurophilic granules, specific or small storage granules and 
gelatinase granules. The targeting of proteins to these granules is determined 
by the timing of protein synthesis during maturation and not by granule specific 
sorting and so not all granules are completely distinct; some have a mixture of 
contents. The contents of these granules can be harmful to the cell and so they 
are only secreted upon neutrophil activation. There is also a fourth form of 
granule known as secretory vesicles which are formed from endocytosis. There 
are very few mitochondria in neutrophils compared to other cells. Mitochondria 
only make up 0 .2% of the organelle volume of a neutrophil compared with 22% 
of the volume in liver cells (Hallett and Lloyds, 1997). This is because 
neutrophils are not very metabolically active cells. Once mature, very little, if 
any protein synthesis occurs as they are terminally differentiated cells and once 
activated they are removed via apoptosis. Neutrophils have 84% more plasma 
membrane than is needed to enclose the contents of the cell (Hogg, 1987).
This is specific to neutrophils as it contributes to their motility and ability to 
spread and phagocytose. This will be further discussed in section 1.5. Another 
factor that contributes to a neutrophils ability to be motile is the protein actin. 
Polymerised globular g-actin forms a layer of filamentous f-actin underneath the 
plasma membrane known as the cortical cytoskeleton. Actin polymerisation is 
continuous in a neutrophil but upon neutrophil activation there is a 4 fold 
increase in the proportion of f-actin in the cell (Stossel', 1989). There are many 
different receptors on the neutrophil which sense the environment around them 
and bind receptors enabling neutrophils to sense a chemotactic gradient as low 
as 0.1% over the cells length. Internal signalling molecules then allow for signal
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transduction from the receptors on the cells plasma membrane throughout the 
cell.
1.2.4 Neutrophil Function
The neutrophils primary function is to kill microbes that could potentially cause 
damage to the body. However to do this they must be able to move from the 
blood stream into the tissues.
Neutrophils circulating in the blood are able to move freely between the 
circulating neutrophil pool (CNP) and the marginated neutrophil pool (MNP). 
Ligands on the surface of circulating neutrophils can bind selectins on the blood 
vessel endothelium. This causes the neutrophils to become loosely attached to 
the blood vessel endothelium so that they can roll along the blood vessel wall at 
a slower rate than those that are freely circulating in the blood. They can 
however still be washed off by the shear stress of the blood flowing past them. 
Microbes and damaged tissues stimulate tissue macrophages to release 
inflammatory mediators such as TNFa, which stimulates increased expression 
of ICAM-1 and other molecules such as Platelet Activating Factor (PAF) on the 
blood vessel endothelium (Lorant et al., 1991). Neutrophils constitutively 
express integrins on their surface. Neutrophils that are in the MNP and are 
loosely bound to the blood vessel endothelium via selectins are moving slowly 
enough for the integrins on the neutrophil to bind the ICAM-1 that is expressed 
on the blood vessel endothelium (Lawrence and Springer, 1991). This causes 
a firm adhesion of the neutrophil to the blood vessel wall and signals the 
neutrophil to flatten and pass through the endothelium into the tissue through a 
process known as diapesis or extravasation, (figure 1.2.4.1). The high levels of 
TNFa in the local environment around the area where the neutrophil 
extravasates “primes” the neutrophil for an increased oxidative response when 
it is finally activated at the site of infection (Hallett and Lloyds, 1995, Lloyds et 
al., 1995).
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Figure 1.2.4.1: Neutrophil Function. Invading bacteria release inflammatory mediators which 
cause an increase in the expression of ICAM1 on the blood vessel endothelium. Neutrophils 
constitutively express integrins on their surface which enables them to bind to the ICAM1 on the 
endothelium and adhere and spread out before passing through the endothelium into the 
surrounding tissues in a process called diapedesis. Neutrophils then move along a chemotactic 
gradient created by chemicals released by invading bacteria and the damaged cells to the 
source of the infection where they phagocytose and kill any invading bacteria.
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Formylated peptides released by the invading bacteria, the damaged cells and 
complement components and chemokines (IL-8 , C5a and leukotrine B4) act as 
chemoattractants and attract the neutrophils that have left the blood stream to 
the area of damage. It is also thought that they can increase the lifespan of a 
neutrophil to up to 1-2 days, compared to 4-10 hours for a neutrophil circulating 
in the blood stream.
When a neutrophil encounters an invading microorganism opsonised with either 
immunoglobulin or complement (C3bi) it phagocytoses and destroys the 
microbe. Fc receptors on the neutrophil surface recognise and bind to 
immunoglobulins on foreign particles and (32 integrins (CD11b/CD18) recognise 
and bind complement (C3bi) opsonised particles (Lee et al., 2003). Activation 
of these receptors initiates a complex signalling cascade, discussed in section 
1.3.5 which culminates in a global calcium signal, actin polymerisation and 
extensive membrane remodelling. The cell extends pseudopodia around the 
particle and encloses it within the phagosome taking it inside the cell where the 
phagosome fuses with the neutrophil granules containing degradative enzymes 
which destroy the microorganism. The global calcium signal is the trigger for 
granule fusion (Jaconi et al., 1990) and oxidase activation (Dewitt et al., 2003) 
with different granules having different calcium thresholds (Sengelov et al.,
1993). Many of the enzymes are activated only after degranulation occurs 
when the pH of the granule which has fused with the phagosome activates the 
enzymes to destroy the microbe (Hirsch and Cohn, 1960, Pryzwansky et al., 
1979). Respiratory/oxidase mediated killing occurs when a nicotinamide 
adenine dinucleotide phosphate (NADPH) enzyme on the membrane of the 
granules is activated releasing toxic oxygen species into the granule which 
destroy the microorganism. The degranulation and oxidation responses act 
together to ensure an extremely powerful and efficient method for the removal 
and killing of bacteria.
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Once the neutrophil has destroyed as many of the invading microbes as 
possible it undergoes programmed cell death (apoptosis). It is then ingested by 
macrophages or other phagocytic cells which ensures that the harmful contents 
of the neutrophil granules are disposed of safely without any damage to 
surrounding tissues.
1.3 Calcium Signalling
1.3.1 Cytosolic free calcium measurement and visualisation.
The most common method of measuring cytosolic free calcium in neutrophils is 
using fluorescent calcium chelator indicators bound to acetoxymethyl esters 
(AM). Binding of the probe to an AM confers lipid solubility and masks the 
calcium binding site of the probe. When the probe is added to the cells it either 
precipitates in the medium or dissolves in the cell membrane. Once the probe 
has diffused across the cell membrane it comes into contact with non-specific 
esterases in the cytosol of the neutrophil which cleave the acetotoxymethyl 
ester, unmasking the calcium binding site of the probe and creating a 
hydrophilic molecule which is then trapped in the cytoplasm of the cell (Hallett 
and Lloyds, 1997). The most commonly used of these probes is Fura-2-AM: it 
has an affinity for Ca2+ of about 200nM which is in the mid-range of 
physiological cytosolic Ca2+ and thus sensitive to change in Ca2+ in this range; a 
high quantum yield which confers a high level of fluorescence in both the bound 
and unbound form of the probe so that less of the probe needs to be used to 
get a signal (less potential for calcium buffering from the probe); and the 
excitation wavelength is different for the calcium bound and calcium free form of 
the probe enabling the use of ratiometric imaging so that changes in 
fluorescence can be confidently interpreted as a consequence of a change in 
calcium concentration (Tsein and Poenie, 1986). However one of the excitation 
wavelengths is in the UV spectrum which is not ideal as many molecules found 
in neutrophils are excited by UV light. Therefore probes which are excited by 
longer wavelengths of light can sometimes be more useful. One such probe is
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fiuo4. It is highly fluorescent when excited at 488nm. At this longer wavelength 
the levels of auto fluorescence are generally much lower. It also has a high 
(100 fold) increase in fluorescence when bound to calcium, and a Kd near 
345nM (Gee et al., 2000) making it sensitive to changes in cytosolic Ca2+. 
However as there is no shift in excitation or emission wavelength, Ca2+ changes 
cannot be measured ratiometrically and confocal techniques must be employed 
for optical slicing (Hallett and Lloyds, 1997).
1.3.2 Cytosolic free calcium homeostasis
The calcium ion is a ubiquitous intracellular messenger that controls a wide 
range of processes in many different types of cells. Cytosolic Ca2+ levels are 
important for the control of most neutrophil behaviour including phagocytosis, 
spreading and possibly chemotaxis. Intracellular Ca2+ in neutrophils is actively 
buffered or sequestered into calcium storage organelles. This, along with 
calcium pumps in the plasma membrane and the low permeability of the plasma 
membrane in resting neutrophils, maintains a low resting free cytosolic calcium 
concentration. The free cytosolic calcium concentration ([Ca2+]) in a resting 
neutrophil is 100nM (Hallett and Lloyds, 1997). Since the extracellular calcium 
concentration is up to 1mM, this creates a gradient of 1:10000 across the 
plasma membrane.
During neutrophil activation, intracellular calcium concentrations can reach up 
to 1pM due to the release of calcium from stores and the opening of calcium 
channels in the plasma membrane (Demaurex et al., 1992). More recently, it 
has been suggested that Ca2+ concentrations can even reach concentrations of 
up to 30pM in the membrane wrinkles when the neutrophil is activated (Brasen 
et al., 2010)
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1.3.3 Calcium stores in neutrophils
Neutrophils have a high capacity to buffer calcium. In order to do this the 
neutrophil has many intracellular calcium stores. Calcium can be taken up from 
the cytoplasm into these stores when calcium concentration in the cytoplasm is 
too high, and calcium that has been sequestered into these stores can be 
released into the cytoplasm when cytosolic calcium concentration is too low. 
There are two distinct calcium stores in neutrophils: a sub plasma membrane 
site and a juxtanuclear site. Stimulation of the neutrophil with N- 
Formylmethionyl-leucyl-phenylalanine (fMLP) triggers calcium release from the 
juxtanuclear site and CD11b/CD18 (integrin) cross linking stimulates calcium 
release from the sub plasma membrane site (Pettit and Hallett, 1998b). The 
juxtanuclear calcium storage site is likely to be either the Endoplasmic 
Reticulum (ER) or golgi (Davies et al., 1991). There is also evidence to suggest 
that there is a further inositol 1,4,5-trisphosphate (IP3) sensitive calcium 
storage site known as the ‘calciosome’. The calcium sequestering protein 
calsequestin has been shown to co purify with the discrete IP3 sensitive 
organelle known as the ‘calciosome’ (Krause et al., 1989, Volpe et al., 1988). 
These calcium storage organelles have been shown to become redistributed 
around the phagosome during phagocytosis (Favre et al., 1996, Stendahl et al., 
1994). Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA)2b calcium 
ATPase pumps are also found on these IP3 sensitive calcium storage sites and 
act to pump calcium into the stores. These can be inhibited by a number of 
different inhibitors to prevent calcium being pumped into the calcium stores 
(Favre et al., 1996)
1.3.4 Calcium signalling by seven transmembrane receptors (G protein 
coupled receptors)
Chemoattractants such as fMLP act on seven transmembrane (7TM) receptors 
in the neutrophils plasma membrane to cause a cytosolic calcium signal in the 
neutrophil. Upon stimulation the cytosolic calcium concentration in the
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neutrophil can rise from 0.1 pM to 1pM. This signal is required for most 
neutrophil responses (Hallett and Campbell, 1984). The calcium signal caused 
by activation of 7TM receptors results from the release of calcium from 
intracellular stores such as the juxtanuclear calcium storage site (Davies et al., 
1991) followed by an influx of calcium from channels in the plasma membrane 
(Pettit and Hallett, 1995). Activation of the 7TM receptor activates a G protein 
on the inner surface of the plasma membrane which leads to activation of 
Phospholipase C (5 (PLCP) (Cockcroft and Gomperts, 1985), this cleaves 
Phosphatidylinositol 4,5-bisphosphate (PIP2) to liberate IP3. This results in the 
release of calcium from IP3 sensitive calcium stores. The release of calcium 
from IP3 sensitive intracellular stores is sufficient to activate Melastatin-related 
Transient Receptor Potential cation channels 2 (TRPM2) channels in the 
plasma membrane (Du et al., 2009) and may account for the Ca2+ influx phase 
which follows store release in neutrophils (figure 1.3.5.1). There is a delay 
between activation of the 7TM receptors and the increase in cytosolic calcium 
(Hallett et al., 1990). This delay can be explained by the time it takes for the 
signalling molecules to diffuse from the plasma membrane to the intracellular 
calcium stores (Hallett and Lloyds, 1997).
1.3.5 Calcium signalling via cross-linking of receptors (Integrin 
engagement)
A calcium signal can also be caused in neutrophils by cross-linking of IgG 
receptors (Fc (CD16/CD32) receptors) (Roberts et al., 1997) or integrin 
(CD11b/CD18) receptors on the neutrophils surface (Hellberg et al., 1996).
This calcium signal is generated via a different mechanism to that generated by 
the activation of 7TM receptors.
Cross-linking of stimuli still generates release of calcium from intracellular 
stores followed by a global calcium signal due to calcium influx through 
channels in the plasma membrane (Davies and Hallett, 1995). However the
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release of calcium from the intracellular stores is not sufficient to trigger the 
calcium influx (Pettit and Hallett, 1997). The site of calcium store release is 
also different to that triggered by 7TM receptors, being peripheral rather than 
central (Davies and Hallett, 1995), localised to the site of receptor cross linking 
(Pettit and Hallett, 1996). There is evidence from electron microscope studies 
supporting the presence of motile calcium storage sites close to the plasma 
membrane (Hoffstein, 1979). As with calcium signalling via 7TM receptors 
there is a delay between activation of the receptor and generation of the 
calcium signal. This can be explained by the time taken for the lateral diffusion 
of the receptors in the cell membrane to form aggregates capable of generating 
a calcium signal (Roberts et al., 1997). The signal can be inhibited by tyrosine 
phosphorylation inhibitors (Morgan et al., 1993) and inhibitors of the actin 
bundling protein L-plastin (Rosales et al., 1994), suggesting that the actin 
cytoskeleton is essential for transduction of the signal from the plasma 
membrane. Integrin engagement triggers tyrosine kinase dependent calcium 
mobilisation, Phospholipase C y2 (PLCy2) phosphorylation and an increase in 
levels of IP3 generation (Hellberg et al., 1996) which may suggest that the 
mechanism of calcium signalling via cross linking of stimuli is more similar to 
calcium signalling via 7TM receptors than was first thought. A possible 
mechanism is illustrated in figure 1.3.5.1. The exact mechanism however is yet 
to be resolved.
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Figure 1.3.5.1: Schematic diagram of some of the possible routes for calcium signalling in the neutrophil. When a 7TM receptor is activated by 
a chemoattractant such as fMLP, its G protein activates PLCp which converts PIP2 into IP3 and Diacylglycerol (DAG) and IP3 goes on to activate IP3 
receptors on the intracellular calcium stores to trigger the release of calcium into the cytosol. Cross linking of integrins in the neutrophil plasma 
membrane results in the phosphorylation and activation of PLCy2 and consequently the production of IP3 and DAG, leading to release of calcium from 
intracellular stores. Calcium release from stores is followed by calcium influx into the cytosol through plasma membrane calcium channels. Several 
possible mechanisms for this exist which are shown in the diagram, direct activation of calcium channels by DAG, activation of calcium channels by 
calcium released from the intracellular stores or a diffusible second messenger known as calcium influx factor (CIF). However, the exact mechanism by 
which calcium influx through the plasma membrane calcium channels is so far unknown.
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1.3.6 Calcium influx
Calcium signalling via both 7TM receptors and via cross-linking of receptors 
involves calcium influx through channels in the plasma membrane. In both 
cases the calcium influx occurs after the release of calcium from intracellular 
stores, although the exact mechanism that triggers calcium influx remains 
unclear. Blocking this calcium influx inhibits most neutrophil responses (Hallett 
and Campbell, 1984, Marks and Maxfield, 1990). There is a delay between the 
addition of the stimulus to the neutrophil and the global calcium influx 
suggesting a series of stochastic events such as diffusion of small molecules 
must take place in order to trigger calcium influx (Hallett and Pettit, 1997, Pettit 
and Hallett, 1995). Although the sequence of events is similar for the 
generation of the calcium signal through the two different types of receptors the 
mechanisms appear to be quite distinct.
Inhibiting release of calcium from intracellular stores in neutrophils stimulated 
with the 7TM receptor agonist fMLP is difficult but micro-injection of the IP3- 
receptor blocker heparin, prevents the calcium influx from the plasma 
membrane channels (Davies-Cox et al., 2001). Also anucleated cytoplasts, 
where the juxtanuclear calcium store is removed along with the nucleus, are 
unable to produce a calcium signal when stimulated with C5a, a neutrophil 
chemoattractant (Gennaro et al., 1984). However inhibition of IP3 independent 
calcium stores in neutrophils stimulated with IgG immune complex had no effect 
on the calcium influx (Davies and Hallett, 1995). The timing of the calcium 
signal differs in both cases also. In neutrophils stimulated with fMLP calcium 
influx is seen at approximately 500ms after calcium is released from the 
intracellular stores (Pettit and Hallett, 1995). The delay is longer when the 
signal is triggered by integrin cross linking, with channel opening occurring 
between 10s and 100s after store release (Pettit and Hallett, 1996). It was 
suggested that the two distinct mechanisms of calcium signalling may be due to 
the initial release of calcium being from two separate intracellular calcium 
stores.
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The mechanism of calcium influx in both cases though is yet to be fully defined. 
Inhibition of SERCa pumps on the endoplasmic reticulum using agents such as 
thapsigargin causes calcium to leak from the calcium stores into the cytoplasm, 
this is followed by the opening of plasma membrane channels. It has been 
suggested that the channels open in response to a ‘need’ to replenish the 
calcium stores (Smyth et al., 2006). This is discussed further in relation to 
calcium channel activation in section 1.3.7. It has recently been shown that an 
increase in cytosolic calcium is sufficient to open TRPM2 channels in the 
plasma membrane and that IP3 receptor activation induced calcium release can 
activate these channels potentially causing calcium influx (Du et al., 2009). It 
may therefore be possible that in the case of 7TM stimulated calcium signalling, 
the release of calcium from the IP3 sensitive juxtanuclear calcium store is 
sufficient to trigger the calcium influx.
1.3.7 Calcium channels in the plasma membrane
Influx of calcium into the cytoplasm through calcium channels in the plasma 
membrane is a key step in the neutrophils cytosolic calcium signal. However 
the exact channels through which this influx occurs and how they are activated 
is still unknown. The calcium influx still occurs even in the presence of 
inhibitors of voltage sensitive calcium channels (Demaurex et al., 1994) 
suggesting that the channels in this case are not voltage gated channels. The 
channels are not directly activated by receptor occupancy but channel activity is 
linked to the emptying of the intracellular calcium stores (von Tscharner et al., 
1986).
Three mechanisms have been proposed linking calcium being released from 
intracellular stores and the activation of calcium channels in the plasma 
membrane. Firstly is has been proposed that the IP3 receptor on the calcium 
store dynamically interacts with the calcium channel in the plasma membrane in 
order to activate it (Irvine, 1990). Secondly it has been suggested that there is
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a requirement for a thus far unidentified diffusible second messenger known as 
the calcium influx factor (CIF) which acts to activate the calcium channels in the 
plasma membrane upon calcium release from internal stores. Stromal 
interaction molecule 1 (STIM1) is a 1 transmembrane calcium binding protein 
found in the plasma membrane which has been proposed to function as a 
calcium sensor and provide a trigger for the activation of calcium channels in 
the plasma membrane (Spassova et al., 2006). Finally, a secretory like 
mechanism involving close but reversible interactions between the plasma 
membrane and the endoplasmic reticulum has been proposed (Patterson et al., 
1999).
The most studied candidates for potential calcium channels involved in the 
neutrophil calcium signal are the human homologues of the drosophila 
Transient Receptor Potential Cation (TRP) channels. Human neutrophils 
express TRPC1, TRPC3, TRPC4 and TRPC6 (Brechard and Tschirhart, 2008) 
although the activity of each channel is still uncertain. It has been shown that 
the TRPC channels are essential for the calcium influx phase of the calcium 
signal as cytoskeletal reorganisation that results in the internalisation of the 
TRPC channels inhibits calcium entry into the neutrophil (Itagaki et al., 2004). 
TRPC1 has been shown to be involved in calcium entry into platelets with the 
proposed mechanism involving coupling of the IP3 receptor with the TRPC1 
channel (Rosado et al., 2002). TRPC3 and TRPC6 are both activated by 
diacylglycerol (DAG) (Hofmann et al., 1999). Activation of 7TM receptors 
results in the breakdown of PIP2 into IP3 and DAG, the DAG can then go on to 
activate TRPC6 calcium channels and cause calcium influx. TRPC6 is also 
activated by membrane phosphatidylinositol (3,4,5)-triphosphate (PIP3). 
Another well studied calcium channel in the neutrophil is the TRPM2 channel, 
which is activated adenosine diphosphate (ADP) ribose (Perraud et al., 2001).
It has been reported that higher cytosolic calcium concentrations lower the ADP 
ribose concentration required to activate the channel but that ADP ribose is still 
essential for the channels activation (Heiner et al., 2005). However more
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recently it has been shown that TRPM2 channels can be activated by an 
increase in cytosolic calcium alone (Du et al., 2009) making them the perfect 
candidate for the store operated calcium channel responsible for the calcium 
influx stage of the neutrophil cytosolic calcium signal.
1.3.8 Role of calcium signalling in neutrophil adhesion.
Neutrophil spreading is directly linked to an increase in cytosolic calcium. 
Multiple cytosolic Ca2+signals have been observed during neutrophil spreading 
(Jaconi et al., 1991), in particular during CD11b/CD18 mediated adhesion 
(Pettit and Hallett, 1997). It has been shown that the neutrophil initially 
attaches to the substrate with no change in cytosolic calcium, this is followed by 
the global cytosolic calcium signal and finally neutrophil spreading (Kruskal et 
al., 1986), suggesting that the cytosolic calcium signal is the trigger for 
neutrophil spreading. This suggestion is further backed up by evidence that the 
release of caged cytosolic calcium in human neutrophils provides a calcium 
signal large enough to trigger neutrophil spreading when neutrophils are in 
contact with an integrin engaging surface (Pettit and Hallett, 1998a).
The calcium increase and, as a result, neutrophil spreading can be inhibited by 
incubating neutrophils with antibodies to CD11b/CD18 (Jaconi et al., 1991,
Pettit and Hallett, 1998a). This illustrates that integrin engagement is the 
trigger for the calcium signal that causes neutrophil spreading. Cross linking 
antibodies bound to CD11b/CD18 integrins can trigger a local calcium signal 
(Petersen et al., 1993) as a result of calcium release from the sub plasma 
membrane storage site (Pettit and Hallett, 1998b). The exact mechanism by 
which integrin engagement may lead to a cytosolic calcium signal was 
discussed in section 1.3.5 but briefly, it has been shown that integrin 
engagement in neutrophils triggers the phosphorylation of PLCy2 and the 
formation of IP3 (Hellberg et al., 1996). The calcium concentration has been 
shown to increase locally at the integrin engagement sites as the neutrophil
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initially adheres, followed by a global cytosolic calcium signal which 
accompanies neutrophil spreading (Pettit and Hallett, 1996).
The cytosolic calcium signal is also required for the rapid shape change 
observed during integrin-mediated phagocytosis (Dewitt and Hallett, 2002).
The mobilisation of intracellular calcium promotes (32 integrin mediated 
adhesion in neutrophils (Leitinger et al., 2000) and increases the amount of 
Lymphocyte function-associated antigen 1 (LFA1) integrin clustering in 
lymphocytes (Stewart et al., 1998). This all confirms that the global cytosolic 
calcium signal is the key signal for triggering neutrophil spreading and 
neutrophil shape change.
1.4 Neutrophil extravasation
1.4.1 Triggers and chemoattractants
Neutrophil extravasation is triggered by the inflammatory response, discussed 
in section 1.1.3. Invading microbes, damaged cells and the cells surrounding 
them release a variety of inflammatory mediators which act to trigger the 
inflammatory response. Inflammatory mediators involved in neutrophil 
extravasation include: TNFa C5a; fMLP; IL1, IL8 and leukotriene B4 (Griffin et 
al., 2003). These have different effects on neutrophils and the blood vessel 
endothelium which act to trigger neutrophil extravasation. TNFa is a cytokine 
released by monocytes and macrophages in response to lipopolysacharides 
and IL-1 (other molecules involved in the inflammatory process) (Gallin and 
Snyderman, 1999). Similar to IL-1 it acts to increase the expression of 
adhesion molecules on the blood vessel endothelium. It also acts to ‘prime’ the 
neutrophils ready for transmigration and activation. Complement component 
C5a acts as a chemoattractant and fMLP is a formylated tripeptide produced by 
bacteria. Both act as neutrophil chemoattractants and lead to an accumulation 
of neutrophils at the site of inflammation once the neutrophils have migrated
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across the endothelium. IL-1 is a cytokine produced by monocytes and 
macrophages at the site of inflammation and acts on nearly all cell types (Gallin 
and Snyderman, 1999). It acts to increase the expression of adhesion 
molecules on the blood vessel endothelium in order to increase the slow rolling 
of neutrophils in the blood vessel (Dinarello, 1996). IL-8 is a chemokine 
produced by macrophages and neutrophils in areas of inflammation. It acts as 
a chemoattractant, triggering a calcium signal in the neutrophils by binding the 
G-protein coupled receptors CXC chemokine receptor 1 (CXCR1) and CXC 
chemokine receptor 2 (CXCR2) (Gallin and Snyderman, 1999). The 
mechanism behind the generation of the calcium signal from G protein coupled 
receptor activation is discussed in section 1.3.4. Leukotriene B4 is another 
chemokine produced by macrophages which acts as a potent neutrophil 
chemoattractant (Gorska et al., 2010).
1.4.2 Rolling and adhesion
Before neutrophils leave the blood stream they first roll along the blood vessel 
endothelium binding transiently via selectins to facilitate rolling and then 
integrins on the neutrophil bind ICAM-1 on the blood vessel endothelium where 
they adhere and spread out before they extravasate from the blood vessel into 
the tissue
- P selectin glycoprotein ligand 1 (PSGL1)
P selectin glycoprotein ligand 1 (PSGL1) is found on the microvilli of neutrophils 
and other leukocytes (McEver and Cummings, 1997). It binds P-selectin on 
endothelial cells. This binding is strong enough to slow the neutrophils to a 
slow roll along the endothelium so that they do not get washed away by shear 
force but is not strong enough to cause firm adhesion to the endothelium 
(McEver and Cummings, 1997). This rolling is inhibited by antibody blockade of 
PSGL1 (Norman et al., 1995) and PSGL1 knock out cells derived from mouse 
bone marrow show no L-selectin dependent rolling (Sperandio et al., 2003). 
PSGL1 interacts with the cytoskeleton via Ezrin Radoxin Moesin (ERM) domain
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proteins (Zarbock and Ley, 2008) and the binding of PSGL1 initiates signalling 
events which induce the activation of the neutrophils and the (32 integrins which 
initiate firm adhesion (Simon et al., 2000).
- L selectin
L-selectin is expressed by all neutrophils and is a type 1 transmembrane 
glycoprotein which interacts with sialylated ligands expressed on the endothelial 
surface of blood vessels (Zarbock and Ley, 2008). It is involved in the rolling 
and activation of neutrophils. The cytoplasmic domain of L-selectin interacts 
with a actinin and forms complexes with other cytoskeletal proteins such as 
viniculin (Pavalko et al., 1995) and the ERM proteins ezrin and moesin (Ivetic et 
al., 2002). Disruption of this interaction by deletion or mutation of the 
cytoplasmic tail of L-selectin impaired or eliminated neutrophil rolling in vitro 
and in vivo (Dwir et al., 2001, Kansas et al., 1993). This suggests that the 
cytoskeletal interaction of L-selectin is important for stabilising the neutrophil 
tether. Cross linking of the L-selectins leads to (32 integrin activation which is 
the trigger for the firm adhesion of the neutrophil to the endothelium (Simon et 
al., 1995).
- Integrins
Integrins are type 1 transmembrane cell adhesion molecules consisting of two 
non covalently associated subunits, a and (3 (Zarbock and Ley, 2008).
Uniquely, p2 integrins are only expressed in immune cells. The predominant 
integrins expressed on neutrophils are aLP2 (LFA1) and OMp2(Mac1) but they 
also express axP2 and CX4P2 at lower levels (Zarbock and Ley, 2008). Integrins 
are involved in slow rolling, adhesion, post adhesion strengthening, migration, 
respiratory burst, phagocytosis and polarisation of neutrophils. Binding of 
integrins results in a signalling cascade leading to a cytosolic calcium signal 
(discussed in section 1.3.5), which triggers neutrophil shape change. Once 
neutrophils are bound to selectins and rolling slowly along the endothelium they 
are moving slow enough for integrins to bind their ligand ICAM1 which triggers 
firm adhesion and spreading before extravasation (Lawrence and Springer,
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1991). |52 integrins can regulate adhesion by altering their conformation and 
clustering in the plasma membrane in response to external stimuli. Knocking 
out of LFA1 integrins in mice abolished rolling and decreased adhesion 
efficiency posing a role for LFA1 in controlling the rolling velocity of neutrophils 
(Dunne et al., 2002) LFA1 knockout mice also display a decrease in the firm 
attachment of neutrophils and a decrease in neutrophil influx to areas of 
infection which also suggests a role for LFA1 in adhesion and migration of 
neutrophils (Ding et al., 1999). Further evidence for the role of LFA1 in 
neutrophil migration comes from experiments showing that LFA1 is evenly 
distributed on the membrane at neutrophil arrest but redistributes to the 
neutrophil - endothelial cell junction and co localises with its ligand ICAM1 
during transmigration and is further redistributed to the uropod as 
transmigration is completed (Shaw et al., 2004). Mac1 integrins are stored in 
granules in the cytoplasm in resting neutrophils which are incorporated into the 
plasma membrane upon neutrophil activation (Borregaard et al., 1994). Once 
incorporated into the membrane they play a role in regulating rolling velocity 
and migration (Dunne et al., 2002). Once integrins have been activated and the 
neutrophil is adhered to the endothelium and spread then extravasation into the 
surrounding tissue can occur.
1.4.3 Transmigration
After selectin mediated slow rolling has lead to integrin engagement, firm 
adhesion and neutrophil spreading, the next step in neutrophil extravasation is 
transmigration through the endothelial cell wall of the blood vessel into the 
surrounding tissue. This is a multistep and complex process and the exact 
mechanism by which this occurs, and even the route that the neutrophil takes is 
still not fully understood. The paracellular route of transmigration, during which 
the neutrophil migrates through the junctions between the endothelial cells, is 
generally agreed to be the most likely route of neutrophil transmigration through 
the endothelium (figure 1.4.3.1). There is however some evidence that 
neutrophils may also migrate through the endothelial cell itself, this is known as
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the transcellular route (figure 1.4.3.2). Both of these mechanisms will be 
discussed in this section.
- Paracellular route
The paracellular route of neutrophil transmigration involves the migration of the 
neutrophil through the junctions between the endothelial cells without disturbing 
the integrity of the cells of the blood vessel wall. This route is thought to be 
regulated in part by several key molecules found in the intercellular junctions of 
the endothelium. A schematic view of this mechanism of this is shown in figure 
1.4.3.1.
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Figure 1.4.3.1: The paracellular route of neutrophil transm igration. Neutrophils roll along 
the endothelium via selectins and integrins before transmigrating between the endothelial cells. 
(Garrido-Urbani et al., 2008)
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Platelet-endothelial cell adhesion molecule 1 (PECAM1) is a member of the 
immunoglobulin super family and is expressed on endothelial cells, leukocytes 
and platelets (Garrido-Urbani et al., 2008). Antibody blockade of this molecule 
blocks the migration of neutrophils into the inflamed peritoneal cavity of mice in 
vivo which suggests that it plays a role in neutrophil extravasation (Bogen et al.,
1994). It later became apparent that PECAM1 may in fact play two distinct 
roles in leukocyte transmigration as two different antibodies to different parts of 
the molecule led to arrest of neutrophils at different stages of the transmigration 
process, one before the cells had moved through the endothelial cell junctions 
and one after the cells had moved through the cell junctions but before they 
passed through the basement membrane (Nakada et al., 2000, Wakelin et al., 
1996). PECAM1 is involved but is not essential for neutrophil transmigration. 
Knocking out ICAM2 in mice led to a decrease in neutrophil accumulation at 
sites of inflammation suggesting that ICAM2 may play a role in PECAM1 
independent transmigration (Huang et al., 2006).
Vascular endothelial cadherin (VE-cadherin) is expressed in the plasma 
membrane of endothelial cells at the adherens junctions of the endothelium and 
is linked to the actin cytoskeleton via catenin complexes (Garrido-Urbani et al.,
2008). It is displaced from the plasma membrane of the endothelial cells during 
neutrophil transmigration but is replaced after the neutrophil has passed 
through the endothelial layer (Shaw et al., 2001). Antibody mediated inhibition 
of VE-cadherin increases vascular permeability and enhances the entry of 
neutrophils into inflamed peritoneum in mice. This suggests that VE-cadherin is 
essential for the maintenance of the endothelial barrier and that the opening of 
this barrier is essential for neutrophil transmigration (Gotsch et al., 1997). 
Engagement of ICAM1 leads to phosphorylation of VE-cadherin, inhibition of 
which decreases neutrophil transmigration suggesting that this is an essential 
step (Allingham et al., 2007).
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The junctional adhesion molecule super family consists of 3 classical members; 
JAM A, JAM B and JAM C. JAM A is expressed by endothelial cells (Bradfield 
et al., 2007) and leukocytes but there have been contradictory reports as to its 
role in transmigration (Garrido-Urbani et al., 2008). JAM B is expressed at the 
intercellular junctions of high endothelial venules (Palmeri et al., 2000). JAM C 
is expressed by endothelial cells (Bradfield et al., 2007), inhibition of JAM C 
decreases neutrophil migration (Aurrand-Lions et al., 2005, Chavakis et al., 
2004) whereas over expression increases recruitment of leukocytes to areas of 
inflammation in mice (Aurrand-Lions et al., 2005) suggesting this JAM plays the 
most important role in neutrophil transmigration.
- Transcellular route
Some experiments have also shown evidence for a transcellular route of 
neutrophil transmigration where neutrophils transmigrate through the 
endothelial cell itself. A schematic diagram of how this may work is shown in 
figure 1.4.3.2.
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Figure 1.4.3.2: The transcellular route of neutrophil transm igration. After neutrophils 
firmly adhere to the endothelium via integrins and ICAM1, the ICAM1 is internalised into the 
endothelial cell creating a channel for the neutrophil to travel through. (Garrido-Urbani et al., 
2008)
Electron microscopy studies provide evidence of neutrophil transmigration 
through endothelial cells in response to fMLP stimulation (Feng et al., 1998). 
The proposed mechanism for this involves clustering of ICAM1 on the 
endothelial cell. As it has been shown that ICAM1 translocates to caveolin rich 
domains in the plasma membrane at the end of actin stress fibres (Millan et al., 
2006), the proposed mechanism of neutrophil migration involved the 
internalisation of the ICAM1 which is then trancytosed to the basal plasma 
membrane through caveolae. This creates a route through which the neutrophil 
can follow (Millan et al., 2006). Despite evidence for both the transcellular and 
the paracellular route of neutrophil transmigration the exact mechanism by 
which this takes place is yet to be conclusively identified.
1.5 Neutrophil spreading
1.5.1 The surface area problem
When a neutrophil spreads on the blood vessel endothelium the surface area of 
the cell increases by more than two fold (Dewitt and Hallett, 2007). It is not 
possible for the plasma membrane to simply stretch to accommodate this 
increase in surface area as the biochemical nature of the lipid bilayer that 
makes up the plasma membrane means that it can only stretch approximately 
4% before rupturing (Hamill and Martinac, 2001). It is also unlikely that the 
neutrophil gains this extra membrane through exocytosis of intracellular 
granules. Neutrophils have approximately 1300 primary granules and 
approximately 4600 secondary granules. If all these granules were to fuse with 
the plasma membrane, it would increase the surface area of the plasma 
membrane by 540pm2 (Nusse and Lindau, 1988). Although this would be 
sufficient to increase in surface area for the neutrophil to spread, fusion of all of 
the neutrophil granules to the plasma membrane would release all of the 
degradative enzymes contained in neutrophil granules into the surrounding 
tissue causing massive damage. Not to mention that these calculations are
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only theoretical and that it is difficult to release more than a third of neutrophil 
granules experimentally (Dewitt and Hallett, 2007). Cytoskeletal expansion or 
swelling has also been ruled out as a mechanism of membrane expansion as a 
computer simulation showed that the object to be internalised would be initially 
pushed out before being pulled back into the cell, whereas this is not seen 
experimentally. Also the measurements of the forces involved in phagocytosis 
experimentally differ to those predicted by the computer model suggesting that 
membrane expansion is an active rather than a passive process (Herant et al., 
2006)
1.5.2 Plasma membrane wrinkles
The final possibility is that the reservoir of extra membrane required for 
neutrophil spreading comes from the ‘un-wrinkling’ of the neutrophil membrane 
as it spreads out (figure 1.5.2). Surface folds on macrophages have been 
shown to disappear rapidly after phagocytosis (Petty et al., 1981) suggesting a 
similar mechanism in other phagocytic cells. Neutrophil membrane wrinkles are 
approximately 300nm in length (Bruehl et al., 1996, Shao et al., 1998), cover 
approximately 30-40% of the neutrophil plasma membrane (Bruehl et al., 1996) 
and can be stretched when enough force is applied (Shao et al., 1998).
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Un-activated ‘spherical’ neutrophil 
with membrane wrinkles still in 
place.
Activated adherant neutrophil with no 
membrane wrinkles
Figure 1.5.2: Scanning electron m icroscope images o f a resting ‘spherica l’ neutrophil 
and an activated adherent neutrophil. Image adapted from (Bessis, 1973).
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Biophysical experiments comparing membrane expansion during phagocytosis 
to forcibly stretched areas of membrane using a micropipette have shown that 
tension remained low during phagocytosis until 80% of the membrane had 
expanded compared to only 30% expansion when the membrane was forcibly 
expanded, suggesting that there is only a limited amount of slack in the wrinkles 
in the neutrophil membrane (Herant et al., 2005). It is known that neutrophil 
spreading is directly linked to an increase in cytosolic calcium concentration as 
a large rise in cytosolic calcium accompanies neutrophil spreading and un­
caging cytosolic Ca2+ or IP3 provides an increase in Ca2+ large enough to 
trigger neutrophil spreading (Pettit and Hallett, 1998a). This raises the 
possibility that an enzyme or second messenger activated by the cytosolic 
calcium signal which triggers neutrophil spreading and phagocytosis is actively 
increasing the amount of membrane available. L-selectin is found on the apical 
surface of neutrophil membrane wrinkles (Bruehl et al., 1996, Erlandsen et al.,
1993) and (52 integrins are found on the cell body between the membrane 
wrinkles (Erlandsen et al., 1993). This would be a logical position if the 
neutrophil did unwrinkle its membrane during spreading as during extravasation 
neutrophils first roll along the blood vessel endothelium binding transiently via 
selectins before they spread and make firm adhesions via (32 integrins. L- 
selectin is bound to the actin cytoskeleton by the linker molecule ezrin (Ivetic et 
al., 2002) and (32 integrin is anchored between the plasma membrane and the 
cytoskeleton via talin (Sampath et al., 1998), both members of the ERM family 
of proteins. It is possible that these molecules hold the membrane wrinkles in 
place in resting neutrophils like a ‘molecular velcro’. Cleavage of these 
molecules would release the membrane when the neutrophil is activated.
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1.6 Talin
1.6.1 Structure
Talin is a member of the ERM family of proteins. It is a 270kD protein 
consisting of a 47kD head at the N terminal and a 220kD flexible rod domain at 
the C terminal. The head domain is made up of a FERM (4.1 ezrin, radixin, 
moesin) domain which consists of three sub domains, F1-3 (Moser et al.,
2009). The F3 domain is responsible for binding the NPxY domain in the 
cytoplasmic tail of integrin, one of talins main functions (Cheung et al., 2009). 
There is an additional F0 domain which bears no homology to any known 
protein domains (Moser et al., 2009). The rod domain comprises a series of 
helical bundles with several binding sites for the actin binding protein viniculin 
(Moser et al., 2009). Talin, as a whole contains 3 actin binding sites each of 
which is adjacent to one of the viniculin binding sites (Hemmings et al., 1996). 
The rod domain also contains a second integrin binding domain. Both integrin 
binding sites are required for high affinity binding of talin to integrin (Gingras et 
al., 2009). At the C terminus talin contains a THATCH (talin/H1P1 R/Sla2P actin 
tethering C terminal homology) domain. This domain is crucial for the primary 
linkage between talin and f-actin (Moser et al., 2009). The key structural 
elements of talin are shown in figure 1.6.1.1.
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Figure 1.6.1.1: Structure of talin. Talin is made up of a head domain and a rod domain. The head domain contains the FERM domain where integrin 
and actin bind talin. The rod domain contains further integrin and actin binding sites as well as multiple viniculin binding sites. The calpain cleavage 
site is between the head domain and the rod domain
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1.6.2 Function
The primary role of talin is to connect integrin to the cytoskeleton. Talin has 
been shown to bind (31,2 and 3 integrins (Gingras et al., 2009, Sampath et al., 
1998). There has also been some evidence to show that talin plays a role in the 
activation of integrins. Mice deficient for talin show integrin mediated cell 
adhesion defects. However, talin alone is not sufficient to activate integrins.
The protease calpain cleaves talin between the FERM domain in the head and 
the rod domain (Critchley and Gingras, 2008) and this is thought to be a key 
step in focal adhesion complex turnover and control of the actin cytoskeleton. 
Talin co localises with calpain in focal adhesion complexes (Lebart and 
Benyamin, 2006), where it can be cleaved by calpain. A decrease in talin 
proteolysis due to a down regulation of m-calpain has been shown to make 
focal adhesion complexes last longer in the cell due to a decrease in focal 
adhesion complex turnover, suggesting that talin proteolysis is a key 
mechanism in the disassembly of focal adhesion complexes (Franco et al., 
2004). The binding of talin to integrin may explain this. It has been reported 
that the head domain of talin has a higher affinity for the cytoplasmic domain of 
(32 (Ivetic and Ridley, 2004) and (33 integrins (Yan et al., 2001) than intact talin 
within focal adhesion complexes. It was shown that calpain cleavage of the 
talin head group from the whole molecule increases the affinity of the head 
group for integrins (Yan et al., 2001) and as a result increases integrin 
clustering (Ivetic and Ridley, 2004). This would lead to a more stable focal 
adhesion which may contribute to the effect observed when talin proteolysis 
was decreased (Franco et al., 2004). Talin has also been shown to be involved 
in the final stages of cell spreading. When talin is knocked out completely there 
is no (3 integrin activation and the final stages of cell spreading do not occur, re- 
expression of the head group leads to spreading only at the cell edges and re- 
expression of the whole molecule rescues the defect and the cells are able to 
spread (Zhang et al., 2008). However, talin deletion had no effect on the early 
integrin independent stages of cell spreading (Zhang et al., 2008). Talin’s exact 
role in neutrophils is still unknown. However, it has been shown that intact talin 
co localises with the (32 integrin subunit in un-activated neutrophils (Sampath et
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al., 1998). A cleaved 190kD talin subunit is found in activated neutrophils and 
this subunit no longer associates with p2 integrin (Sampath et al., 1998). This 
shows that talin is cleaved in activated neutrophils although the reason for this 
cleavage is as yet unknown, as discussed in section 1.5.2 talin may provide the 
tether between p2 integrins and the actin cytoskeleton which holds the 
neutrophils plasma membrane wrinkles in place in the un-activated cell.
1.7 p-Calpain
1.7.1 The calpain family
The calpains are cytosolic calcium activated proteases found in all vertebrate 
cells. The family consists of two main members m-calpain (calpain 2) and p- 
calpain (calpain 1) as well as other less well characterised “calpains” and 
calpain- like molecules (Goll et al., 2003). However, p-calpain is the 
predominant calpain found in neutrophils and other blood components such as 
platelets and erythrocytes. Both p-calpain and m-calpain are made up of a 
large subunit and small subunit which together form a heterodimer. The small 
subunit is common to both calpains and is encoded on a single gene on 
chromosome 19 in humans (Goll et al., 2003). The large subunit of m and p 
calpain are different gene products and are encoded on chromosome 1 and 
chromosome 2 respectively (Goll et al., 2003). m-calpain is made up of an 
80kD large subunit (Aoki et al., 1986, Imajoh et al., 1988) and the 28kD 
common small subunit. The calcium requirement for half maximal activation of 
m-calpain is very high, 400-800pM calcium and the optimum pH for activation is 
7.2-8.2 (Goll et al., 2003). p-calpain is made up of an 80kD large subunit, 
slightly larger than the m-calpain large subunit (Aoki et al., 1986, Imajoh et al., 
1988), and the 28kD common small subunit. The calcium requirement for half 
maximal activation of p-calpain is considerably lower, 3-50pM calcium and the 
optimum pH for activation is 7.2-8.2 (Goll et al., 2003). There is only one 
known endogenous protein inhibitor specific for calpain, calpastatin. Binding of
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calpastatin to calpain requires calcium to also be bound to calpain and the 
inhibition is reversible (Otsuka and Goll, 1987)
1.7.2 iJ-calpain structure
Calpain 1 or p-calpain is the predominant calpain found in neutrophils (Goll et 
al., 2003) and as previously stated, is made up of a large proteolytic subunit 
(80kDa) and the small regulatory subunit (28kDa). Each subunit is then made 
up of several different domains. The large subunit has a clear 4 domain 
structure made up of domains I -  IV (Aoki et al., 1986). Domains V and VI 
make up the small subunit (Goll et al., 2003). Figure 1.7.2.1 shows the 
important features and the domains of p-calpain.
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protease domain ‘C2 like’ domain
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Domain I Domain II
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Domain
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Large subunit 
(calpain 1)
EF hand sequences
Small subunitDomain V Domain VI
(calpain 4)
calmodulin like domain
Figure 1.7.2.1 Structure of p-calpain. p-calpain is made up of a large 80kD subunit (also known as calpain 1) and a small 28kD subunit (also known 
calpain 4) which come together to form a heterodimer. The large subunit is made up of four domains and contains the protease domain and the C2 like 
domain. There are also several EF hand calcium binding domains found in domain IV and domain VI. The small subunit is made up of 2 domains with 
domains VI forming the calmodulin like domain.
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Domain VI in the small subunit contains a calmodulin like domain which 
contains 4 EF hand calcium binding sequences (Ohno et al., 1986). X ray 
crystallography studies on common small subunit have shown that there is also 
potentially a 5th EF hand domain (Blanchard et al., 1997). Crystallographic 
structures are not yet available for the large subunit of p-calpain.
Domain I at the N terminal of the large subunit of p-calpain bears no amino acid 
sequence homology to any other proteins. Domain II of the large subunit is 
also known as the protease domain as it contains amino acid residues which 
form a catalytic triad similar to that found in cysteine proteinases (Goll et al., 
2003). Domain III contains a C2 like domain which could enable the protein to 
translocate to the plasma membrane and bind phosphatidylserine in areas of 
high calcium (Tompa et al., 2001). This domain may also have a regulatory 
function. Domain IV is marginally homologous to calmodulin and contains 4 
potential EF hand sequences which enable calcium binding (Goll et al., 2003).
1.7.3 v-calpain activation
The catalytic triad is not fully assembled in unactivated calpain, suggesting that 
calcium binding must induce a conformational change and reorientate the 
protease domain into an active state (Hosfield et al., 1999). p Calpain (calpain 
1) requires unusually high cytosolic calcium concentrations to be activated, 
around 30 pM (Michetti et al., 1997). This is much higher than the physiological 
calcium concentration found in the bulk cytoplasm where p-calpain is located in 
resting cells. There has been much debate as to whether autolysis of the 
calpains occurs in order to decrease the calcium concentration required for their 
activation. Both m and p calpain can undergo autolysis when incubated with 
calcium (Cong et al., 1993), however the calcium concentrations required to 
induce autolysis are around the levels required for calpain activation therefore 
they would be higher than encountered in living cells and p-calpain which had 
not undergone autolysis is still active as a proteinase (Cong et al., 1993). Also
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oxidation of p-calpain inhibits its proteolytic activity but not autolysis (Guttmann 
et al., 1997). This suggests that proteolysis and autolysis are two separate 
events and that autolysis of calpain is not required for its activity. This leaves 
the question of how calpain activity is regulated in the cell. There have been 
suggestions of the existence of a calpain activator protein in human 
erythrocytes which associates with the plasma membrane and activates calpain 
at physiological levels (Salamino et al., 1993) but there is yet to be any 
evidence of this in other cell types. During calcium influx in human neutrophils 
there are areas of calcium concentrations high enough to activate calpain just 
below the plasma membrane, especially within the membrane wrinkles (Davies 
and Hallett, 1998, Brasen et al., 2010). p-calpain has been shown to 
translocate from the cytosol to the plasma membrane (Gil-Parrado et al., 2003). 
Calpain’s C2 like domain may enable it to translocate from the cytoplasm and 
bind to the phosphatidylserine on the membrane where calcium is highest. This 
may be a potential mechanism by which calpain would encounter calcium 
concentrations high enough for proteolysis to occur.
1.7.4 p-calpain substrates
Calpain cleaves the ERM proteins talin and ezrin but not moesin (Ivetic and 
Ridley, 2004, Shcherbina et al., 1999). These proteins associate with the 
cytoskeleton and are found at the plasma membrane. It is therefore probable 
that calpain is involved in cytoskeletal regulation in processes such as cell 
spreading and focal adhesion formation. There have been several reports of 
calpains involvement in focal adhesion formation and maintenance (Franco et 
al., 2004, Lebart and Benyamin, 2006, Undyala et al., 2008). Cleavage of talin 
by calpain appears to be the crucial step in calpains role in focal adhesion 
turnover, calpain co-localises with talin in focal adhesion complexes and a 
deficiency of calpain results in a decrease in focal adhesions formed (Lebart 
and Benyamin, 2006). There are also many reports of calpains involvement in 
cell spreading, motility and adhesion of other cell types which likely involves 
calpain mediated cleavage of cytoskeletal proteins (Croce et al., 1999, Dourdin
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et al., 2001, Rosenberger et al., 2005, Stewart et al., 1998, Wiemer et al.,
2009).
1.7.5 Potential role of/j-calpain in neutrophil spreading
There is evidence that inhibition of calpain can lead to a decrease in 
inflammation in animal models (Chatterjee et al., 2005, Cuzzocrea et al., 2000, 
Marzocco et al., 2004, Yoshifuji et al., 2005). The exact mechanism by which 
calpain inhibition leads to a decrease in inflammation is so far unknown. It has 
been demonstrated that inhibition of calpain impairs neutrophil spreading and 
phagocytosis (Dewitt and Hallett, 2002, Wiemer et al., 2009). This leads to the 
possibility that the mechanism by which calpain inhibition decreases 
inflammation involves the impairment of neutrophil function, namely neutrophil 
spreading. If neutrophil spreading was inhibited this would lead to a decrease 
in neutrophils leaving the bloodstream at areas of inflammation as neutrophil 
spreading is a key step in neutrophil transmigration, as discussed in section 
1.4. As discussed in section 1.5 in order to spread onto the blood vessel 
endothelium before extravasation the neutrophil needs to unwrinkle its plasma 
membrane. The wrinkles in the neutrophil plasma membrane are held in place 
by cytoskeletal proteins among which are the calpain substrates talin and ezrin 
(Ivetic et al., 2002, Sampath et al., 1998). Should calpain cleave these proteins 
this would lead to unwrinkling of the neutrophil plasma membrane allowing the 
neutrophil to spread out and transmigrate through the blood vessel 
endothelium. There are two key features of calpain that make this possible. 
Firstly, calpain is activated by high calcium concentrations of around 30pM 
(Michetti et al., 1997). Under physiological conditions calcium concentrations 
this high are found specifically in the neutrophil membrane wrinkles, but not the 
bulk cytosol, during calcium influx, which occurs before neutrophil spreading 
(Brasen et al., 2010). Secondly by virtue of its ‘C2 like’ domain, calpain would 
be able to translocate from the cytosol where it is located under resting 
conditions to the plasma membrane where the calcium concentration would be 
high enough for proteolysis to occur when the neutrophil is activated and
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calcium influx occurs. It has been observed that unactivated calpain is located 
in the cytoplasm and upon ionomycin induced calcium influx it translocates to 
the plasma membrane (Gil-Parrado et al., 2003). These two features of calpain 
would ensure that the protease is activated specifically at the cell membrane 
upon neutrophil activation where it would be able to cleave the cytoskeletal 
proteins talin and/or ezrin and release the neutrophil membrane wrinkles 
allowing neutrophil spreading to occur.
1.8 Clinical application -  Chronic Obstructive Pulmonary 
Disease
1.8.1 Causes and symptoms
Chronic obstructive pulmonary disease (COPD) is term used to describe a 
number of conditions involving the long term inflammation of the lungs including 
chronic bronchitis and emphysema. It is one of the most common forms of lung 
disease and affects more than 900,000 people in the UK. COPD primarily 
affects people over the age of 40. The primary cause of COPD is smoking 
although it can also be caused by coal dust and other work related and 
environmental pollutants and can also be caused by inherited a1 anti trypsin 
deficiency. During COPD the bronchioles become inflamed and narrowed and 
this leads to damage to the alveoli. Symptoms include a persistent cough, high 
amounts of phlegm and shortness of breath. These are usually only present 
when undertaking physical activity in patients with mild forms of COPD but in 
severe cases these symptoms can persist throughout everyday life.
1.8.2 Current treatment
There is currently no cure for COPD. Current NICE guidelines for the treatment 
of COPD include the cessation of smoking and management of diet as well as
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the use of bronchodilators such as p2 agonists and anticholinergics, and 
nebulisers to treat the everyday symptoms. Antibiotics are used to treat further 
lung infections and oxygen therapy can be used when not enough oxygen is 
getting into the blood stream. In cases where the disease is exacerbated 
temporarily for example by an infection inhaled corticosteroids are prescribed 
on a short term basis. In severe disease where exacerbations are regular 
occurrence non invasive ventilation where air is forced into the lungs through a 
sealed face mask can be used to ensure the patient receives adequate oxygen. 
Only as a last resort in very severe cases is surgery and a lung transplant 
considered.
1.8.3 Potential role of catpain inhibitors
As COPD is primarily caused by the inflammation of the bronchioles then a 
therapy that would decrease the inflammation may provide long term relief. 
Neutrophils are the most abundant white blood cells found at areas of 
inflammation and are responsible for releasing degradative enzymes into the 
tissue and causing damage. Inhibition of neutrophil trafficking to the lung by 
inhibiting a key step in the process of neutrophil spreading such as calpain 
activation would prevent the neutrophils from leaving the blood stream and 
entering the area of inflammation. Although calpain inhibition may not 
completely obliterate the number of neutrophils leaving the blood stream and 
entering the lung space, it would reduce the numbers and may therefore be of 
benefit to patients suffering from COPD.
1.9 Aims of the thesis
The aims of this thesis are to establish that calpain translocation and activation 
plays a role in neutrophil shape change and that membrane is actively 
recovered after neutrophil shape change.
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These aims will be achieved by demonstrating:
(i) The route of calcium influx during neutrophil shape change 
(phagocytosis)
(ii) The role of p-calpains ‘C2 like’ domain in calpain translocation
(iii) That calpain translocation occurs during neutrophil morphological 
change (including spreading and phagocytosis): and that calpain 
translocation and activation has a role in the control of neutrophil 
morphology change
(iv) A potential route for the retrieval of excess plasma membrane after 
neutrophil shape change
A key route to achieving these aims will be the establishment of an efficient 
method for stably expressing foreign proteins in myeloid cell lines.
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CHAPTER 2
Materials and Methods
2.1 Cell line maintenance
The HL60, PLB-985 and NB4 cell lines are myeloid cell lines isolated from 
blood or bone marrow samples from patients with myeloid leukaemia (Collins et 
al., 1977, Lanotte et al., 1991). They are immature myeloid cells that have 
been immortalised so that they may be grown continuously in culture. HL60 
and PLB-985 cells are slightly more mature than NB4 cells.
HL60, PLB-985 and NB4 cells were cultured in RPMI medium supplemented 
with 10% heat inactivated Foetal Calf Serum (FCS), 5mM glutamine, 100pg/ml 
streptomycin and 100pg/ml penicillin at 37°C in 5% CO2.
The MyPH8B6 cell line was immortalised from bone marrow cells isolated from 
the femurs of Black6 mice by J.Mcdonald according to the method described by 
Wang et al (Wang et al., 2006). They showed that enforced production of 
HoxB8 blocks the differentiation of stem cell factor (SCF) or granulocyte- 
macrophage colony stimulating factor (GM-CSF) dependent myeloid 
progenitors. Myeloid progenitors isolated from mouse bone marrow were 
therefore transfected with oestrogen dependent HoxB8 such that when the cells 
are grown in the presence of oestrogen they express HoxB8 and are held in an 
immortal state, but when the oestrogen is removed from the cell medium the 
cells cease to express HoxB8 and are able to continue their maturation.
MyPH8B6 cells were cultured in OptiMem medium (Invitrogen) supplemented 
with 10% heat inactivated FCS, 5mM glutamine, 100pg/ml streptomycin, 
100pg/ml penicillin, 30pM p-mercaptoethanol, 1pM p-estradiol and 10ng/ml 
stem cell factor at 37°C in 5% C02.
3T3 NIH cells are a mouse fibroblast cell line which is easily transfectable. 3T3 
cells were cultured in DMEM medium supplemented with 10% heat inactivated 
FCS, 5mM glutamine, 100pg/ml streptomycin and 100pg/ml penicillin at 37°C in 
5% C02.
RAW 264 cells are a mouse monocyte-macrophage cell line. They are 
relatively easy to transfect and are capable of phagocytosing opsonised
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zymosan particles. RAW cells were cultured in DMEM medium supplemented 
with 10% heat inactivated FCS, 5mM glutamine, 100pg/ml streptomycin and 
100pg/ml penicillin at 37°C in 5% CO2.
For long term storage cells were frozen in either; 10% DMSO, 90% medium 
supplemented with FCS (HL60, NB4 3T3 and RAW cells) or FCS with 10% 
DMSO (MyPH8B6 cells). 5x106 (1 confluent flask) cells were frozen per 
cryovial.
A stock solution of 20% DMSO in medium was prepared. Cells were 
centrifuged at 1600rpm for 4 minutes and re-suspended in 500pl medium and 
added to a cryovial along with 500pl stock medium+DMSO solution so that final 
concentration of DMSO was 10% and cells were exposed to DMSO for as little 
time as possible. Cryovials were then frozen down slowly (1°C per minute) in 
the -80°C freezer overnight then moved to the liquid nitrogen for long term 
storage.
To defrost, cells were thawed quickly in a water bath and transferred into 15mls 
pre-warmed RPMI/DMEM to dilute the DMSO. Cells were allowed to recover 
for approx 20 minutes in 37°/5% C02 incubator, then centrifuged at 1600rpm 
for 4 minutes and then re-suspended in 5mls warm RPMI/DMEM and put into 
flasks.
2.2 Isolation of human neutrophils from peripheral blood.
2.2.1 White blood cell isolation from human blood.
Neutrophils were isolated from blood donated by healthy volunteers as 
previously described (Davies et al., 1991). 2.5mls of 6% dextran (Mr 70,000) 
was added to 10ml heparinised blood which was allowed to sediment for 
approx 30 minutes. Once the blood had separated the middle ‘buffy coat’ layer 
(figure 2.4.1.1) which contains the white blood cells was removed and 
centrifuged at 2000rpm for 0.7 minutes.
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Figure 2.2.1.1: Sedimentation of whole blood. Whole blood is sedimented with 6% dextran 
at room temperature for 45 minutes. Red blood cells being the heaviest sediment to the bottom 
of the tube and platelets being the lightest remain in the top layer with the neutrophils being 
found in the ‘buffy coat’ layer between the red blood cells and the platelets.
After the supernatant was removed the pellet was re-suspended in 1ml water to 
lyse the red blood cells followed by 20ml BSS to restore osmolarity. Cells were 
centrifuged at 2000rpm for 0.5 minutes and the pellet was re-suspended in 5ml 
Krebs-BSA. The typical proportion of neutrophils in the preparation is high, and 
these cells are used for single cell experiments, as less preparation means less 
risk of activation, and less time taken, so cells are ‘fresher’
2.2.2 Neutrophil isolation from a white blood cell preparation
This type of preparation was used when a pure neutrophil preparation was 
required. 5ml ficoll-paque solution was added underneath the cell suspension 
and the suspension was centrifuged at 1000rpm for 25 minutes. The 
supernatant was then decanted to leave the pellet which contains the 
neutrophils (figure 2.2.2.1)
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2.2.2.1: Separation of granulocytes from other white blood cells. Granulocytes are 
separated from other white blood cells using ficoll-paque density gradient centrifugation.
2.3 Purification of plasmid DNA
Plasmids pEYFP-C1 -calpain 4 (calpain 4-YFP) (Gil-Parrado et al., 2003), pMX- 
Mu-calpain-EGFP (calpain 1-GFP) (Lokuta et al., 2003), C2-gamma-YFP and 
C2-beta-RFP (Adjobo-Hermans et al., 2008) were all kind gifts from other 
laboratories.
Plasmids were transformed into Invitrogen oneshot® top10 Eshcericia coli 
(;E.coli) cells according to the manufacturers protocol. Briefly, plasmid is 
transformed into chemically competent E.coli (OneShot® TOP10 cells) by 
adding the plasmid to the cells and then incubating the cells on ice and then 
heat shocking to permeabalise the cell membrane to allow the plasmid to enter. 
Nutrient rich SOC medium is added to increase the efficiency of the 
transformation. Bacteria were then spread onto Ampicillin selective LB agar 
plates at different concentrations in order to grow one plate containing evenly 
spaced colonies. Plates were incubated overnight at 37°C.
Plasmids were then purified using Machery-Nagel Nucleobond® Extra Maxi kit 
(Abgene) according to the manufacturer’s protocol. Briefly, the bacterial cells 
are lysed by adding SDS and NaOH which breaks the phospholipid bilayer by 
denaturing the proteins involved in holding it together. Plasmid DNA is 
separated from other nucleic acids and proteins through anion exchange. The 
solution is applied to an anion exchange column made from anion exchange 
resin which consists of hydrophilic, pourus silica beads with a methyl-amino- 
ethanol (MAE) group. This functional group has an overall positive charge 
which means that under acidic conditions the negatively charged phosphate 
backbone of the DNA binds to the resin.
Large double stranded chromosomal DNA is denatured by the addition of an 
acidic solution to neutralise the column. In its single stranded form
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chromosomal DNA will be washed from the column at a lower pH than the 
double stranded plasmid DNA. Increasing concentrations of salt buffer are 
added to the column to wash off any protein, RNA and chromosomal DNA. The 
more interactions that molecule can make with the resin the higher salt 
concentration is required to wash it off. Small nucleic acids and single stranded 
DNA make fewer interactions than the double stranded plasmid DNA and so 
are washed off at a lower pH. A high salt concentration elution buffer is then 
applied to the column finally to wash off the plasmid DNA. The plasmid DNA is 
then recovered from the supernatant by ethanol precipitation. This precipitate 
can then be re-suspended in a buffer of ddH20. Plasmids were digested to 
check plasmid integrity and cut plasmid was run on a 0.8% agarose gel at 100 
volts for approx 45 minutes. Plasmids were quantified using a 
spectrophotometer to analyse absorbance at 260nm
Where plasmid concentration was too low, plasmids were precipitated using 
sodium acetate precipitation. 10% of the sample volume 3M sodium acetate 
(pH 5.2) was added to the plasmid along with double the sample volume ice 
cold 100% ethanol. Sample was vortexed and centrifuged for 15 minutes at 
maximum speed at 4°C. Supernatant was removed carefully without disturbing 
the pellet and replaced with 1 ml ice cold 70% ethanol. Sample was centrifuged 
for 10 minutes at maximum speed at 4°C. The supernatant was removed and 
the pellet was air dried at 55°C for 5 minutes and re-suspended in 30pl PCR 
quality H20.
2.4 Plasmid Sequencing
All plasmids for which there were known primer sites before, after or within the 
insert were sequenced. The resulting sequences were then entered into a 
Basic Local Alignment Search Tool (BLAST) search to confirm that the 
plasmids contained the correct insert (Appendix IV).
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2.5 Differentiation of cell lines into phagocytosis-competent 
cells
2.5.1 Differentiation of the NB4 cell line
All trans-retinoic acid (ATRA) was purchased from Sigma-Aldrich® in powder 
form which was diluted in DMSO to desired concentration in an argon 
atmosphere under dimmed light to prevent decomposition. ATRA is a vitamin A 
derivative that acts via the retinoic acid nuclear receptor to cause differentiation 
in the NB4 cell line (Idres et al., 2001).
Sterile cover slips were placed in a 6 well plate and 2x105 NB4 cells in 2mls 
RPMI with varying concentrations of All Trans Retinoic Acid (ATRA) (1, 0.75, 
0.5, 0.25, 0.1 or 0.01 pM) was placed in each well. Controls were cells treated 
with DMSO or received no treatment. Cells were monitored daily.
To see if it was possible to achieve a high transfection frequency and a high 
level of differentiation 2x106 NB4 cells were cultured in a flask in the presence 
of 0.01 pM ATRA for 3 days prior to transfection with pmaxGFP plasmid using 
the Amaxa nucleofector device according to the manufacturer’s protocol. Cells 
were recovered in RPMI supplemented with 0.01 pM ATRA and were placed in 
2mls RPMI supplemented with 0.01 pM ATRA on cover slips in a 6 well plate 
and allowed to differentiate for a further 2 days before checking if the 
transfection had been successful.
2.5.2 Differentiation of the HL60 cell line
Treatment with DMSO causes the HL60 cell line to differentiate into neutrophil 
like cells. The exact molecular mechanism that causes this differentiation is still 
unknown.
Sterile cover slips were placed in a 6 well plate and 1x105 HL60 cells in 2mls 
RPMI with varying concentrations of DMSO (1.3%, 1.7% and 1.9%) were 
placed in each well. Control cells received no treatment. Cells were checked
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daily to determine the optimum length of time that they needed to be treated 
with DMSO for maximum levels of differentiation.
For calpain translocation experiments 2x106 HL60 cells were cultured in a flask 
in the presence of 1.3% DMSO for 5-7 days prior to transfection with the 
pEYFP-C1+30cDNA (calpain 4) plasmid using nucleoporation according to the 
manufacturer’s instructions. Cells were recovered in RPMI supplemented with 
1.3% DMSO and were placed in 1ml RPMI supplemented with 1.3% DMSO on 
cover slips in a 6 well plate and left overnight to adhere to the cover slips before 
observing them on the CLSM.
2.5.3 Differentiation of the MyPH8B6 cell line
7x105 cells were centrifuged at 350xg for 5 minutes and washed 3 times in 
PBS. Cells were seeded at 7x104 cells/ml in 10ml OptiMem medium 
(Invitrogen) supplemented with 10% heat inactivated FCS, 1% glutamine, 
100pg/ml streptomycin, 100pg/ml penicillin, 30pM p-mercaptoethanol, SCF 
(20ng/ml) and G-CSF (20ng/ml). Cells were maintained in this medium for 4 
days until differentiation was complete. Additional medium was added daily to 
renew the growth factors.
2.6 Cytosolic calcium measurement
2.6.1 Cytosolic calcium measurement using Fura Red Calcium indicator
Fura Red was loaded into the cells in an AM form using the same method 
described in section 1.3.2 for Fura2 (figure 2.6.1.1). Fura red is a non 
ratiometric calcium indicator which is excited at the same wavelength in both 
the calcium free and calcium bound forms. Calcium free fura red is excited by 
488nm light and emits light at 650nm. Calcium bound fura red is excited at 
488nm light and emits light at 650nm but at a lower intensity, (figure 2.6.1.2) 
Changes in cytosolic calcium concentration can be detected by the decrease in
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fluorescence intensity of the indicator. The calcium concentration in the cell at 
any given time can be calculated from the fluorescence intensity if the indicator 
using the following equation:
[Ca2+]j = Kd x (Fmax + F) -  1 Where, Fmax is the maximum fluorescence
intensity of the indicator and F is the 
fluorescence of the indicator at any given 
point, relative to the minimum value of zero.
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Diffusion
Calcium indicator 
molecule
Figure 2.6.1.1: AM  bound calcium indicator loading of cells. The acetotoxymethyl ester 
that is bound to the fura-red molecule makes the molecule lipid soluble. This allows the fura- 
red to pass through the plasma membrane of the cell. Once in the cytoplasm of the cell non­
specific esterases within the cytoplasm digest the ester bond linking the acetotoxymethyl ester 
to the fura-red molecule. This leaves the hydrophilic form  of fura-red trapped in the cytoplasm.
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Figure 2.6.1.2: M easurem ent of calcium concentration using fura-red. (a) Fluorescence 
excitation (excited at 488nm) and emission (detected at 650nm) spectra of Ca2+-saturated (A) 
and Ca2+-free (B) fura-red in pH 7.2 buffer, (b) Unbound fura-red is excited by the 488nm 
wavelength emits high levels of fluorescence at the 650nm wavelength and calcium bound fura- 
red is excited by the same wavelength but emits less fluorescence than the unbound 
conformation, (c) Increasing the cytosolic calcium within the cell causes an increase in the 
amount of calcium bound fura-red and d) lead to a decrease in the overall fluorescence of the 
cell detected at 650nm
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2.7 Ca2* elevating experiments
lonophore increases intracellular calcium by creating artificial calcium channels 
in the plasma membrane which allows calcium to enter the cell. Thapsigargin 
increases intracellular calcium by inhibiting the CaATPase on the sarcoplasmic 
and endoplasmic reticulum. This increases intracellular calcium by stopping the 
cell from pumping calcium from the cytoplasm into the intracellular calcium 
stores. Depletion of calcium from the intracellular stores then causes the 
plasma membrane calcium channels to open causing further calcium influx. 
fMLP causes a physiological calcium signal in neutrophils and in neutrophil like 
cells. fMLP binds to the formyl peptide receptor (FPR). This is a G protein 
coupled receptor and its fMLP binding leads to the activation of numerous 
second messenger proteins (Selvatici et al., 2006). These act to initiate the 
release of Ca2+ from intracellular stores. This produces the initial small 
increase in Ca2+ seen upon fMLP treatment. Depletion of Ca2+ from these 
stores results in the opening of Ca2+ channels in the plasma membrane, this 
leads to Ca2+ influx into the cytoplasm and results in a large increase in 
cytosolic Ca2+.
Ca2+ elevating experiments were performed on all cell lines including cord blood 
derived neutrophils. Differentiated cells were placed on cover slips on a heated 
stage on the Confocal Laser Scanning Microscope (CLSM). Adhered cells 
were treated first with 1pM fMLP to try and produce a physiological calcium 
signal. Cells were then treated with 1pM or 10pM ionophore, 1pM or 5pM 
thapsigargin and finally 26mM CaCL was added 50:50 to their medium so that 
the final concentration of the CaCL in the medium was 13mM to further 
increase the intracellular calcium.
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2.8 Confocal Microscopy
Confocal imaging of cells was carried out on a Leica SP2 or SP5 confocal 
microscope using a x64 oil immersion objective. Fura red calcium indicator and 
green and yellow fluorescent proteins were excited using the 488nm laser. Red 
fluorescent proteins were excited with the 543nm laser. Emission was detected 
at the appropriate wavelength for the fluorophore being imaged. Where more 
than one fluorophore was being imaged in the same sample sequential imaging 
techniques were employed. Sequential imaging allows for simultaneous 
imaging at two different wavelengths whilst minimising interference and 
‘crosstalk’ between the two images by recording the image for the different 
wavelengths sequentially between frames.
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CHAPTER 3
Translocation of C2 domain proteins
3.1 Introduction
Domain III of calpain contains a C2-like domain which is very important for its 
ability to act as a protease localised to the cell periphery. This C2 domain 
enables the protein to translocate to the plasma membrane where it binds 
phosphatidylserine at areas of high calcium (Tompa et al., 2001). In this 
chapter, data will be presented to show that that classical C2 domain 
constructs, as a surrogate model for translocation of C2 containing proteins 
such as calpain-1, can be used to map out Ca2+ influx sites and potential sites 
of calpain translocation during activation of myeloid cells.
3.1.1 C2 domains
C2 domains are Ca2+ dependent phospholipid binding domains found in a wide 
range of eukaryotic proteins (Nalefski and Falke, 1996). The most common C2 
domains are around 130 amino acid residues in length with a 3D structure 
made up of an 8 stranded anti parallel (3 sandwich consisting of a pair of 4 
stranded |3 pleated sheets (Nalefski and Falke, 1996). The C2 domain was 
first discovered in protein kinase C and is the 2nd of 4 conserved domains in 
that protein. C2 domains were also found in the neuronal protein 
synaptotagmin. As both protein kinase C and syntaptotagmin bind phosphatidyl 
serine upon an increase in calcium concentration it was postulated that the C2 
domain may be involved in calcium regulated phosphatidyl serine binding 
(Bazzi and Nelsestuen, 1987). Experiments showing that the C2 domain from 
phospholipase A2 translocated to membrane vesicles upon increased calcium 
concentration (Clark et al., 1991) and the C2 domain from synaptotagmin 
binding phospholipid vesicles upon calcium increase (Davletov and Sudhof, 
1993) confirmed that the C2 domain was indeed a calcium dependent 
phospholipid binding domain. A fully saturated C2 domain can bind two 
calcium ions (Shao et al., 1996). It is still not known how the binding of calcium 
to the C2 domain mediates phospholipid binding but there have been two 
models proposed. The first is a ternary complex model in which the calcium is
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bound simultaneously by the phosphatidyl serine and the C2 domain therefore 
mediating the binding of the lipid and the protein (Nalefski and Falke, 1996). 
This model is based on data from other molecules which are not homologous to 
the C2 domain but do bind phosphatidyl serine with the aid of calcium ions such 
as AnnexinV. Also the [Ca2+]i/2 of C2 domains from protein kinase C is reduced 
in the presence of membrane phospholipids suggesting that there is some sort 
of binding equilibrium taking place between the calcium and the membrane 
phospholipids (Kohout et al., 2002). The second proposed model is the 
conformational change model which suggests that a conformational change of 
the C2 domain upon binding calcium exposes necessary functional groups 
which in turn enable the C2 domain to bind to phosphatidyl serine (Davletov 
and Sudhof, 1994). This model is based upon observations that in certain C2 
domains calcium binding induces a conformational change in the protein 
(Davletov and Sudhof, 1994), however as yet no direct evidence exists to 
suggest that this conformational change leads to phosphatidyl serine binding. 
As still very little is known about the mechanism of phosphatidyl serine binding 
by C2 domains both very different theories remain plausible. The existence of 
a ternary complex method of binding phosphatidyl serine via calcium by other 
non C2 domain proteins suggests that it is not unlikely that C2 domain proteins 
employ a similar method however experimental evidence of a conformational 
change in C2 domains upon calcium binding makes the second theory just as 
feasible. Until further direct experimental evidence is achieved the mechanism 
of phosphatidyl serine binding by C2 domains will remain unknown.
3.1.2 Catpains C2 like domain
Domain III of calpain is known as the ‘C2 like’ domain (figure 3.1.2.1). X-ray 
crystallography images of m-calpain confirm that domain III of m-calpain is a 
calcium regulated phospholipid binding domain (Tompa et al., 2001). As well 
as amino acid sequence homology to the classical C2 domains the ‘C2 like’ 
domain of m-calpain folds into an anti-parallel (3 sandwich consisting of a pair of 
4 stranded p pleated sheets (Tompa et al., 2001). This is the same
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conformation as the original classical C2 domains discovered in protein kinase 
C (PKC). m-calpains ‘C2 like’ domain can also bind to phosphatidyl serine in a 
calcium dependent manner (Tompa et al., 2001) further confirming its function 
as a C2 domain. As these studies were all done on domain III from m-calpain 
further investigation is needed to confirm that domain III from p calpain is also a 
C2 domain. However the amino acid sequences of domain III from calpain 1 
and calpain 2 are 62% identical and 82% similar (figure 3.1.2.2) so it is likely 
that the two domains would act in a similar manner. It has been shown that 
domain III is required for membrane targeting of p calpain (Gil-Parrado et al., 
2003) and it had been suggested that calpain activation may be caused by its 
association with the plasma membrane (Molinari and Carafoli, 1997). In any 
case, the C2 domain is clearly important for physiological calpain activation.
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Figure 3.1.2.1 S tructure o f M-calpain. M-calpain is made up of a large 80kD subunit (also 
known as calpain 1) and a small 28kD subunit (also known calpain 4) which come together to 
form a heterodimer. Domain III is known as the ‘C2 like’ domain.
CAPN1 D3 PDALKSRTIRKWNTTLYEGTWRRGSTAGGCRNYPATFWVNPQFKIRLDETDDPDDYGDRE 
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Figure 3.1.2.2: Protein sequence alignm ent of dom ain III from calpain 1 and domain III 
from calpain 2. Sequences are 82% similar and 62% idenditcal. * denotes identical residues 
and : o r . denotes homologous residues.
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In the case of neutrophil spreading, it is hypothesised that the role of the C2 
domain in calpain is to permit calpain to translocate to the plasma membrane 
upon cytosolic Ca2+ increase therefore ensuring that calpain is activated 
specifically at the plasma membrane where it can cleave its target molecule(s).
3.1.3 Calcium influx and 02 domain translocation
Neutrophil spreading and phagocytosis are directly linked to an increase in 
cytosolic calcium concentration (Dewitt and Hallett, 2002, Jaconi et al., 1991, 
Kruskal et al., 1986, Pettit and Hallett, 1998a, Pettit and Hallett, 1997). This 
increase in cytosolic calcium concentration is caused by calcium ion influx 
across the plasma membrane and blocking this influx inhibits most neutrophil 
responses (Hallett and Campbell, 1984, Marks and Maxfield, 1990). Despite 
substantial evidence pointing to the importance of the calcium influx and the 
cytosolic calcium signal to neutrophil activity the exact channels through which 
this calcium influx occurs are still unknown. There are several potential 
candidates which are discussed in more detail in section 1.3.7.
To further investigate potential triggers of calcium influx and the potential 
calcium channels involved in calcium influx it would be useful to know if the 
plasma membrane calcium channels opened globally, all over the plasma 
membrane during calcium influx or locally i.e. just at the position on the plasma 
membrane where the neutrophil is stimulated. Observation of C2 domain 
translocation during a global stimulation such as fMLP or a local stimulation 
such as attachment of a particle during phagocytosis can help to answer this 
question. As C2 domains are calcium sensitive phosphatidyl serine binding 
domains (Clark et al., 1991, Davletov and Sudhof, 1993) they will translocate 
from the cytosol to the plasma membrane and bind phosphatidyl serine only 
where calcium concentration is high (i.e. where the plasma membrane calcium 
channels are open). This translocation would occur immediately prior to a 
global increase in cytosolic calcium concentration which must “lag” behind Ca2+ 
influx itself. Therefore where the C2 domain binds the plasma membrane in the
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first few ms after stimulation (either via fMLP or phagocytosis) will give an 
indication as to where on the plasma membrane the calcium channels are open 
when the neutrophil is activated.
C2 domains from protein kinase C are able to translocate to the plasma 
membrane in response to an increase in cytosolic calcium concentration in a 
variety of cell types (Adjobo-Hermans et al., 2008). C2 domain translocation 
has been used successfully to analyse different types of calcium signal in rat 
basophilic leukaemia cells (Teruel and Meyer, 2002) and oscillations in C2 
domain membrane binding have been used to illustrate the calcium regulation 
of PLCp (Adjobo-Hermans et al., 2008). Different types of C2 domains display 
different calcium binding properties. In the two studies highlighted above the 
C2 domain from protein kinase C y was used. This particular C2 domain has a 
[Ca2+]i/2 of 0.7pM and as such has a very high calcium affinity when compared 
to another C2 domain from the same family, protein kinase C p, which has a 
[Ca2+]i/2 of 5pM (Kohout et al., 2002). As such the C2 domain from PKCy (C2y) 
will translocate and bind to the plasma membrane at much lower calcium 
concentrations than the C2 domain from PKCp. As C2y is highly sensitive to 
changes in calcium concentration, it may be possible to utilise C2y plasma 
membrane binding to reveal the location of calcium influx during phagocytosis 
(i.e. global versus local influx)
3.1.3 Aims of the chapter.
The aims of this chapter are therefore to use classical C2 domain constructs as 
a surrogate model for translocation of C2 containing proteins such as calpain-1. 
In addition, translocation of C2 domain constructs will enable the mapping of 
Ca2+ influx sites during activation of myeloid cells.
In this chapter the specific objectives are:-
• To characterise the translocation of different C2 domains
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• To use C2 domain translocation to investigate where in the 
membrane calcium channels open to cause calcium influx during 
phagocytosis
• To investigate the role of calpains C2 like domain
These objectives will be achieved with the use of fluorescently tagged classical 
C2 domains which will be expressed by different cell types. Their translocation 
in response to calcium influx will be investigated using pharmacological and 
physiological methods of raising calcium within the cells.
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3.2 Materials and Methods
3.2.1 Transfection of cell lines
3.2. laTransfection of the 3T3 cell line using nucleofection
1x106 cells were transfected with C 2y-YFP  or C2J5-RFP using the Amaxa 
nucleofector device according to the manufacturer’s protocol. Cells were 
centrifuged at 2000rpm for 10mins and re-suspended in 100pl nucleofector 
solution (kit V). 2pg plasmid was added to the cells which were then 
transferred to a cuvette and electroporated using programme X-001 on the 
Amaxa nucleofector device. Cells were recovered in 500pl pre-warmed DMEM 
before being transferred to glass bottomed ‘confocal dishes’ containing 1ml pre­
warmed DMEM per transfection. Cells were incubated at 37 °C in 5% C02 
overnight before being used for calcium elevating experiments on the CLSM the 
next day.
3.2.1b Transfection of the RAW 264 cell line using nucleofection
2x106 cells were transfected with C2y-YFP or C2(3-RFP using the Amaxa 
nucleofector device according to the manufacturer’s protocol. Cells were 
centrifuged at 750rpm for 10mins and re-suspended in 100pl nucleofector 
solution (kit V). 2pg plasmid was added to the cells which were then 
transferred to a cuvette and electroporated using programme D-035 on the 
Amaxa nucleofector device. Cells were recovered in 500pl pre-warmed DMEM 
before being transferred to glass bottomed ‘confocal dishes’ containing 1ml pre- 
warmed DMEM per transfection. Cells were incubated at 37°C in 5% C02 for 4 
hrs before being used for calcium elevating experiments on the CLSM.
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3.2.1c Transfection of partially differentiated PLB-985 cells using nucleofection.
2x106 cells were differentiated in 1.3%v/v DMSO for 4 days. These cells were 
then transfected with C2-gamma-YFP or C2-beta-YFP using the Amaxa 
nucleofector device according to the manufacturer’s protocol. Cells were 
centrifuged at 2000rpm for 10mins and re-suspended in 100pl nucleofector 
solution (kit V). 2pg plasmid was added to the cells which were then 
transferred to a cuvette and electroporated using programme X-001 on the 
Amaxa nucleofector device. Cells were recovered in 500pl pre-warmed RPMI 
before being transferred to glass bottomed ‘confocal dishes’ containing 1ml pre­
warmed RPMI per transfection. Cells were incubated at 37°C in 5% CO2 for 3 
hours before being used for calcium elevating experiments on the CLSM the 
next day.
3.2.2 Confocal Microscopy and calcium elevating experiments
Pharmacologically stimulated cytosolic calcium increase was achieved by 
treating the cells with a cocktail containing 10pM ionophore, 5pM thapsigargin 
13mM CaCb as described in section 2.7. Physiologically stimulated cytosolic 
calcium influx was achieved by treating the cells with mouse serum. Cytosolic 
calcium concentration was monitored using fura red calcium indicator as 
described in section 2.6. All experiments were imaged using a Leica SP2 
confocal microscope as described in section 2.8.
3.2.3 Phagocytosis experiments
RAW 264 expressing C2-gamma YFP were presented with zymosan particles 
opsonised using mouse serum using a micropipette and manipulator. Cells 
were allowed to bind the particle before the micropipette was removed and 
phagocytosis was allowed the complete (see phase contrast image sequence in 
figure 3.3.2.4 for demonstration). C2 domain translocation and/or cytosolic 
calcium concentration was recorded continuously during phagocytosis.
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3.2.4 Induction ofapoptosis in RAW-264 cells
RAW 264 cells were transfected with YFP tagged C2 domain from protein 
kinase C as described in section 3.2.1b. As RAW 264 cells are immortalised 
they do not undergo spontaneous apoptosis as neutrophils do. Therefore 
Staurosporine (STS) was needed to induce apoptosis. It is thought that STS 
induces apoptosis by inhibiting various kinases in the cells (Yamaki et al., 2002) 
in a non-specific manner. To induce apoptosis, STS (4pM) was added to the 
transfected RAW 264 cells 3.5 hours before CLSM visualisation. C2 domain 
translocation was pharmacologically stimulated as described in section 3.2.2.
3.2.4.1 Visualisation of phosphatidylserine (PS) externalisation
Phosphatidylserine that had been externalised to outer leaflet of the plasma 
membrane was visualised using AnnexinV-FITC (1pl of AnV-FITC in 0.02% 
NaN3, PBS and 1% BSA to 100pl of sample), excited at488nm, with a 
maximum emission wavelength of 570nm.
3.2.1.2 Identification of necrotic cells with propidium iodide
Necrotic cells were identified by their uptake of propidium iodide nucleic acid 
stain which is excluded from viable cells.
3.2.5 Immunofluorescent staining for calpainl in apoptotic neutrophils
White blood cells, including neutrophils were isolated from human blood as 
described in section 2.2.1. Half of the sample was allowed to age for 24 hours 
in order for apoptosis to occur and half of the sample was fixed immediately. 
Before fixing and permeabilisation AnV-FITC (1pl) and CaCI2 (1pl) were added 
to lOOpI aged and non-aged neutrophil suspension and incubated for 30 
minutes at 37°C. This mixed suspension was allowed to settle onto glass slides
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pre-coated with fibronectin (5pl of 0.1% fibronectin) for 20 minutes at 37°C. 
Cells were washed twice in Krebs-BSA before being fixed in 100pl 3.7% 
formaldehyde for 10 minutes at room temperature. Cells were washed 3 times 
in PBS and then permeabilised in 0.1% triton for 4 minutes after which they 
were washed a further 2 times in PBS. Non specific binding sites were blocked 
by incubating the cells in 4% horse serum for 1 hour before the addition of the 
primary antibody. Primary antibody was monoclonal anti-calpain 1 (6C-12) 
(Santa Cruz -  sc32327). Primary antibody was diluted 1 in 100 (in 4% horse 
serum) before use and cells were incubated in primary antibody overnight at 
4°C. The following morning cells were washed thoroughly in PBS before 
secondary antibody was added. Secondary antibody was goat anti-mouse IgG 
Rhodamine (Santa Cruz santa cruz -  sc-2092). Cells were incubated in 
secondary antibody for 1 hour at room temperature in the dark. Secondary 
antibody was removed by washing thoroughly twice with PBS. Microscopic 
visualisation of the cells, once stained, was carried out using the CLSM.
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3.3 Results
3.3.1 Classical 02 domains
3.3.1.1 C2 domain translocation in response to pharmacologically stimulated 
calcium influx.
As a preliminary to using the translocation of fluorescently tagged-C2 domains, 
it was necessary to ensure that the constructs expressed biologically active 
protein in myeloid cells. Both human (PLB-985 cells) and mouse (RAW 264 
cells) myeloid cell lines were transfected, and investigated by utilising a strategy 
aimed to elevate cytosolic Ca2+ (and influx) pharmacologically. Cytosolic 
calcium levels were raised using a “cocktail” of ionomycin (10pM), thapsigargin 
(5pM) and 13mM CaCI2 which was shown to be effective in increasing Ca2+ 
concentration and inducing C2 translocation using a model cell line 3T3 cells 
(figure 3.3.1.1). Using this strategy, C2 translocation was shown to be triggered 
in both PLB-985 cells (figure 3.3.1.2) and RAW 264 cells (figures 3.3.1.3 and 
3.3.1.4). This translocation was reversed when Ca2+ influx was 
stopped/reduced by replacement of the cocktail with physiological medium 
(figures 3.3.1.3 and 3.3.1.4). Simultaneous measurement of cytosolic Ca2+ 
showed the dependency on cytosolic calcium influx being maintained at a high 
level of calcium influx (figure 3.3.1.5). It was concluded that active C2 construct 
was generated in myeloid cells and that its translocation was a monitor of Ca2+ 
influx.
3.3.1.2C2 domain translocation in response to physiologically stimulated 
calcium influx.
In order to establish whether C2 translocation was sensitive enough to detect 
Ca2+ influx triggered physiologically, rather than pharmacologically, mouse 
serum (as a source of mouse C5a) was used. This physiological stimulus 
caused a transient increase in cytosolic Ca2+ in the mouse cell line RAW 264 
which was accompanied by a clear translocation of C2 domain to the plasma
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membrane (n=3). The C2 domain was released from the plasma membrane 
before cytosolic calcium concentration decreased to resting levels (figure 
3.3.1.6)
3.3.2 C2 domain translocation during phagocytosis
The preceding results demonstrate the usefulness of C2 domain translocation 
as a surrogate measure for the translocation of C2 proteins, like calpain. Using 
RAW 264 cells transfected with C2 domain constructs, it was found that the 
Ca2+ influx accompanying phagocytosis is sufficient to stimulate C2 domain 
proteins to translocate from the cytoplasm to the plasma membrane (figure
3.3.2.1 and 3.3.2.2). This suggests that calpain may also translocate to the 
plasma membrane during phagocytosis (see chapter 4 section 4.3.2.4). 
However RAW 264 cells like neutrophils can still undergo phagocytosis without 
the accompanying Ca2+ influx (figure 3.3.2.4).
Although it is known that phagocytosis is accompanied by a physiological Ca2+ 
influx, the sites at which influx occurs are unknown. C2 translocation thus 
provides a useful means of mapping out sites of Ca2+ influx during 
phagocytosis. The duration of the Ca2+ influx and the location of the start of the 
Ca2+ influx varied between cells. Some cells exhibited a fast, short calcium 
influx where the C2 domain translocated immediately to the whole plasma 
membrane and was quickly released (figure 3.3.2.1), whereas other cells 
displayed a longer Ca2+ influx (figure 3.3.2.2). In this example C2 can be seen 
to initially translocate to the plasma membrane of the phagocytic cup in the first 
few seconds after particle binding, and before the global calcium signal (figure 
3.3.2.3). Subsequently, the cytosolic calcium concentration increases and the 
C2 domain translocates to the plasma membrane throughout the cell (figure
3.3.2.2). These results suggest that although it is possible that Ca2+ influx 
channels may be opened initially at the particle contact site they are also 
opened at sites remote from the initial particle contact site.
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3.3.3 C2 domain translocation in apoptotic RAW cells
During apoptosis around 50% of the phosphatidyl serine on the inner leaflet of 
the plasma membrane which C2 domains bind to during calcium influx is 
externalised to the outer leaflet of the plasma membrane. Cells with 
externalised phosphatidyl serine were identified by staining positive with 
AnnexinV-FITC (figure 3.3.3.1). C2 domain proteins in cells with externalised 
phosphatidyl serine did not translocate as much as C2 domain proteins in 
normal cells when cytosolic calcium was increased using pharmacological 
stimuli as described in section 3.2.2. Translocation of YFP tagged C2 domain 
was significantly decreased in PS externalised cells (figures 3.3.3.2 and
3.3.3.3). There is no significant difference in C2 domain distribution between 
AnV+ve cells and AnV-ve cells before the addition of the pharmacological 
stimulus (P=0.9 at 3.5s) but once the stimulus has been added and the C2 
domain has translocated C2 domain distribution is significantly different in 
AnV+ve and AnV-ve cells (P=0.02 at t=39s)(figure 3.3.3.2).
3.3.4 Location of calpain in apoptotic neutrophils with externalised 
phosphatidyl serine
Neutrophil adhesion and spreading has previously been shown to involve an 
increase in the cytosolic calcium concentration. Healthy human neutrophils 
fixed and stained for calpain after spreading on glass, show enriched calpain at 
the plasma membrane (figure 3.3.4.1). Stimulation of healthy (Annexin V 
negative), human neutrophils with Ca2+ elevating reagents (ionomycin and 
thapsigargin) also triggers and enrichment of calpain at the plasma membrane 
(figure 3.3.4.2). However, apoptotic neutrophils which have externalised 
phosphatidyl serine (Annexin V positive), fail to accumulate calpain at the 
plasma membrane when the cytosolic calcium concentration is increased, as 
illustrated by the difference between cytoplasmic fluorescence intensity and 
membrane fluorescence intensity (figure 3.3.4.2).
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Figure 3.3.1.1: Typical C2yYFP translocation in 3T3 cells in response to 
pharm acologically stimulated calcium influx (n-7). A typical experiment where 3T3 cells 
expressing C2yYFP were treated with 10pM ionomycin and 5|jM thapsigargin in medium 
containing 13mM calcium and C2 domain translocation was observed. YFP fluorescence was 
imaged throughout the experiment, a) When the treatment is added to the cells to increase the 
cytosolic calcium the C2 domain translocates from the cytosol to the plasma membrane, b) 
Fluorescence intensity measurements were taken for the cytosol (i) and the plasma membrane 
(ii) for the entire time of the treatment and are displayed in c) along with the ratio of these 
intensities. The decrease in intensity of fluorescence in the cytosol is evident, as the plasma 
membrane increases in intensity as the C2 domain translocates.
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Figure 3.3.1.2: Typical C2pRFP translocation in PLB-985 cells in response to 
pharm acologically stimulated calcium influx (n=2). A typ ica l experiment in which PLB-985 
cells expressing C2J3RFP were treated with 10pM ionomycin and 5pM thapsigargin in medium 
containing 13mM calcium and C2 domain translocation was observed. RFP fluorescence was 
imaged throughout the experiment, a) When the treatment is added to the cells to increase the 
cytosolic calcium the C2 domain translocates from the cytosol to the plasma membrane, b) 
Fluorescence intensity measurements were taken for the cytosol (i) and the plasma membrane 
(ii) for the entire time of the treatment and are displayed in c) along with the ratio of these 
intensities. The decrease in intensity of fluorescence in the cytosol is evident, as the plasma 
membrane increases in intensity as the C2 domain translocates.
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Figure 3.3.1.3: Typical C2pRFP translocation in RAW 264 cells in response to 
pharmacologically stimulated calcium influx (n-2). A typical experiment, where RAW 264 
cells expressing C2pRFP were treated with 10pM ionomycin and 5pM thapsigargin in medium 
containing 13mM calcium for 80 seconds to increase cytosolic calcium concentration before the 
medium was replaced with normal medium to decrease the cytosolic calcium to normal levels. 
RFP fluorescence was imaged throughout the experiment, a) When calcium is increased in the 
RAW cell expressing the C2 domain it translocates from the cytosol to the plasma membrane, 
the C2 domain is then released from the plasma membrane after the stimulus is removed and 
replaced with normal medium as the cytosolic calcium returns to resting levels, b)
Fluorescence intensity measurements were taken for the cytosol (i) and the plasma membrane 
(ii) for the entire time of the treatment and are displayed in c) along with the ratio of these 
intensities. The decrease in intensity of fluorescence in the cytosol is evident, as the plasma 
membrane increases in intensity as the C2 domain translocates with the reverse being 
apparent when the pharmacological stimulus is removed and cytosolic calcium decreases.
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Figure 3.3.1.4: Typical C2yYFP translocation in RAW 264 cells in response to 
pharm acologically stimulated calcium influx (n=3). A typical experiment, where RAW 264 
cells expressing C2yYFP were treated with 10pM ionomycin and 5pM thapsigargin in medium 
containing 13mM calcium for 80 seconds to increase cytosolic calcium concentration before the 
medium was replaced with normal medium to decrease the cytosolic calcium to normal levels. 
YFP fluorescence was imaged throughout the experiment, a) When calcium is increased in the 
RAW cell expressing the C2 domain it translocates from the cytosol to the plasma membrane, 
the C2 domain is then released from the plasma membrane after the stimulus is removed and 
replaced with normal medium as the cytosolic calcium returns to resting levels, b)
Fluorescence intensity measurements were taken for the cytosol (i) and the plasma membrane 
(ii) for the entire time of the treatment and are displayed in c) along with the ratio of these 
intensities. The decrease in intensity of fluorescence in the cytosol is evident, as the plasma 
membrane increases in intensity as the C2 domain translocates with the reverse being 
apparent when the pharmacological stimulus is removed and cytosolic calcium decreases.
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Figure 3.3.1.5: Typical C2 domain translocation in RAW 264 cells in response to 
pharmacologically stimulated calcium influx accompanied by cytosolic calcium  
m easurm ent (n=6). Typical experiment, in which RAW 264 cells expressing C2yYFP were 
loaded with fura red Ca2+ indicator before pharmacological stimulus was added. YFP and fura 
red fluorescence were imaged simultaneously throughout the experiment. Cells were treated 
with 25pM thapsigargin and 10pM ionomycin in medium containing 13mM calcium for 30 
seconds to increase the cytosolic calcium concentration before the medium was replaced with 
normal medium to decrease the cytosolic calcium to normal levels, a) Treatment of RAW cells 
expressing C2 domain proteins with ionomycin and thapsigargin increased cytosolic calcium 
concentration; this was accompanied by translocation of the C2 domain to the plasma 
membrane. Removal of the stimulus sees cytosolica calcium concentration return to resting 
levels and the C2 domain is released from the plasma membrane back into the cytosol, b) 
Fluorescence intensity measurements were taken for the cytosol (i) and the plasma membrane 
(ii) for the entire time of the treatment and are displayed in c) The decrease in intensity of 
fluorescence in the cytosol is evident, as the plasma membrane increases in intensity as the C2 
domain translocates with the reverse being apparent when the pharmacological stimulus is 
removed and the C2 domain is released back into the plasma membrane. Fura red 
fluorescence intensity was also imaged at the same time as the YFP fluorescence intensity d) 
Shows the quantification of cytosolic calcium concentration from the fura red fluorescence 
intensity along with the ratio of the YFP PM and cytosol fluorescence for the entire series. The 
C2 domain translocates as soon as the cytosolic calcium concentration increases and is 
released from the plasma membrane as soon as the stimulus is removed but the cytosolic 
calcium concentration is still high.
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Figure 3.3.1.6: Typical C2 domain translocation in RAW 264 cells in response to 
physiologically stimulated calcium influx (n=3). a) Atypical experiment in which, RAW 
264.7 cells expressing C2yYFP were loaded with the fura red Ca2+ indicator and a cytosolic 
calcium influx was stimulated with mouse serum. Fura red fluorescence and YFP were imaged 
simultaneously throughout the experiment and mouse serum was added at t=5s. a) The upper 
row (red) shows a transient decrease in fura red fluorescence intensity, corresponding to a 
transient increase in cytosolic Ca2+ (quantified in (d)) The bottom row (yellow) shows a 
corresponding translocation of C2yYFP from cytosol to plasma membrane, which is then 
released from the plasma membrane as the cytosolic calcium returns to resting levels, b) 
C2yYFP fluorescence intensity measurements were taken for the cytosol (i) and the plasma 
membrane (ii) for the entire time series and are displayed in (c). c) The decrease in intensity of 
fluorescence in the cytosol is evident, as the plasma membrane increases in intensity as the C2 
domain translocates with the reverse being apparent when the C2 domain is released back into 
the cytosol, d) Fura red fluorescence intensity was also imaged at the same time as the YFP 
fluorescence intensity. This was used to calculate to cytosolic calciu concentration shown in 
the graph e) The ratio of C2YFP fluorescence at the plasma membrane and the cytosol 
showing C2 domain translocation. When graphs (d) and (e) are compared it can be seen that 
the C2 domain is released from the plasma membrane back into the cytosol whilst the bulk 
cytosolic calcium concentration is still high.
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Figure 3.3.2.1: An example o f C2 domain translocation in RAW 264 cells to  the whole 
plasma membrane before phagosome closure (n-2). RAW 264 cells expressing C2yYFP  
and loaded with fura red calcium indicator were allowed to phagocytose mouse serum 
opsonised zymosan particles in order to induce a physiological calcium increase. Fura red and 
YFP were imaged simultaneously throughout the experiment, a) Cytosolic calcium 
concentration was calculated from the fura red fluorescence intensity (red line). There is a very 
fast cytosolic calcium signal (t=72.1s) accompanied by a brief translocation of the C2 domain 
from the cytosol to the plasma membrane (shown by the ratio of plasma membrane 
fluorescence and cytosolic fluorescence (yellow line)), b) Shows an increase in the 
fluorescence intensity at the plasma membrane and a decrease in fluorescence in the cytosol 
as the C2 domain translocates, c) Shows the entire process of phagocytosis, which completes 
over 100 seconds after the cytosolic calcium signal, d) Shows the C2 domain translocation 
and the accompanying decrease in fura red fluorescence at 72.1 seconds.
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F ig u re  3 .3 .2 .2 : A n  e x a m p le  o f C 2  d o m a in  tra n s lo c a tio n  b e fo re  p h a g o s o m e  c lo s u re  in R A W  ce lls
(n=1). RAW 264 cells expressing C2yYFP were allowed to phagocytose mouse serum opsonised 
zymosan particles in order to induce a physiological calcium increase. YFP fluorescence was imaged 
throughout the experiment, a) The decrease in cytosolic calcium concentration observed when the C2 
domain translocates was used as a measure of the rate of calcium influx, b) Shows the decrease in 
cytosolic YFP fluorescence as the C2 domain translocates to the plasma membrane, c) Fluorescence 
intensity of the YFP was measured in the cytosol throughout the experiment, d) Illustration of C2 domain 
translocation before closure of the phagocytic cup. There is a sharp increase in cytosolic calcium 
concentration after the cell has bound the particle which is illustrated by the translocation of the C2 domain 
(a,d). This influx lasts ~25 seconds and the C2 domain is released from the plasma membrane before the 
cell continues to phagocytose the particle. The fluorescence intensity of the cytosol decreases sharply at 
~95s as the cell binds the particle and the C2 domain translocates to the plasma membrane indicating the 
start of calcium influx, within ~25s the fluorescence intensity in the cytosol has returned to starting levels 
indicating the end of calcium influx (b,d)
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Figure 3.3.2.3: An example of C2 domain translocation to the plasma membrane around 
the phagosome in RAW 264 cells (n=1). RAW cells expressing C2yYFP were allowed to 
phagocytose mouse serum opsonised zymosan particles in order to induce a physiological 
calcium increase. YFP fluorescence was imaged throughout the experiment, a) Image of the 
cell upon part. When the cell initially binds the particle the C2 domain can be seen to move 
initially to the plasma membrane around the phagocytic cup in the first few seconds after 
particle binding, b) An illustration of the fluorescence intensity of the plasma membrane if it 
were taken from the middle of the phagocytic cup around the outside if the cell to the middle of 
the opposite side of the cell. The units on the graph are arbitrary units, illustrating fluorescence 
intensity on the y axis and distance from the centre of the phagocytic cup on the x axis. This 
illustrates that the fluorescence intensity is high initially at the phagocytic cup and decreases 
gradually as you move away from the cup suggesting that the C2 domain is moving first to the 
phagocytic cup and then making its way around the rest of the plasma membrane.
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Figure 3.3.2.4: An example of phagocytosis in Raw 264 cells from particle binding to 
completion w ithout an accompanying calcium influx (n=3). The upper sequence shows 
phagocytosis of a serum opsonised particle presented to a RAW 264 cell expressing C2yYFP. 
The lower sequence shows the failure of the C2 domain to translocate in the absence of a Ca2+ 
signal during the process of phagocytosis.
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Figure 3.3.3.1: Example of how phosphatidyl serine externalised RAW 264 cells were 
identified by AnnexinV staining. PS externalised cells stain positive with AnnexinV at the cell 
membrane. Dead cells were identified byPropidium Iodide (PI) nuclear staining.
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Figure3.3.3.2: C2 domain translocation in PS normal and PS externalised cells. C2
domain translocation was quantified as a ratio between the increase in plasma membrane 
fluorescence and the decrease in cytosolic fluorescence over time, this ratio is shown here. C2 
domain translocation was reduced significantly in cells which displayed externalised 
phosphatidyl serine. Data shown represents the mean translocation from 9 separate 
experiments. The shaded area indicates the standard error of the mean.
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F ig u re  3 .3 .3 .3 : T y p ic a l C 2  d o m a in  tra n s lo c a tio n  in A n V  n e g a tiv e  R A W  26 4  c e lls  w ith  no Ps e x te rn a lis a tio n  an d  in A n V  p o s itiv e  R A W  26 4  ce lls  w ith  PS  
e x te rn a lis e d . (AnV negative (n=5) and AnV positive (n=9)). Apoptosis was induced in RAW cells expressing C2YFP before 5pM ionomycin and 10pM thapsigargin 
was added to the cells to stimulate cytosolic calcium concentration increase, stimulus was then removed and replaced with fresh tissue culture medium to allow cytosolic 
calcium concentration to return to resting levels. YFP fluorescence was measured during the stimulation to monitor C2 domain translocation. After stimulation and 
removal of the stimulus AnnexinV was added to the cells and FITC fluorescence was monitored in order to identify which cells stained positive for AnnexinV at the 
membrane and where therefore AnnexinV positive apoptotic cells. Propidium Iodide was then added to the cells to identify any necrotic cells. TRITC fluorescence and 
FITC fluorescence were measured simultaneously for this part of the experiment. The top panel shows C2 domain translocation in an AnnexinV negative cell, followed 
by a still image of the AnnexinV and Propidum Iodide staining showing that the cell in which the C2 domain translocated was neither apoptotic nor nectrocic. One other 
cell in the field of view was apoptotic (although this cell was not expressing YFP) and that two of the cells in the field of view were necrotic (one of which was expressing 
YFP and the other was not). The bottom panel shows decreased C2 domaint translocation in an AnnexinV positive cell, followed by a still image of AnnexinV and 
Proidium Iodide staining showing that all cells in the field of view were indeed apoptotic and none where necrotic.
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Figure 3.3.4.1: Location of calpain in spread human neutrophils. Healthy human neutrophil 
fixed and stained for calpain location after being allowed to spread onto a glass coverslips. 
Calpain staining is localised to the plasma membrane.
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Figure 3.3.4.2: Difference in fluorescence intensity between plasma membrane and 
cytosol in apoptotic human neutrophils fixed and stained for calpain. Cells (n=30) 
staining positively and negatively for Annexin V as an indicator of phosphatidyl serine
externalisation were stimulated with 5pM ionomycin and 5pM thapsigargin to initiate Ca2+ influx 
and increase the cytosolic Ca2+ concentration. The difference in fluorescence between the 
plasma membrane and the cytosol was used as a confirmation of the membrane location of the 
calpain staining (measured in arbitrary units). Cells with a high difference between plasma 
membrane fluorescence and cytoplasmic fluorescence were deemed to have calpain located at 
the plasma membrane and cells with no difference between the plasma membrane 
fluorescence and the cytosolic fluorescence were deemed to have cytoplasmic calpain staining. 
Calpain was found to be located at the plasma membrane in AnnexinV negative cells and in the 
cytsol in AnnexinV positive cells.
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3.4 Discussion
The data here show that classical C2 domains are able to translocate in 
response to both physiological and pharmacological stimuli. Provided that 
calcium influx is triggered (monitored by a rise in Ca2+concentration) C2 domain 
translocation to the plasma membrane occurs. Monitoring C2 domain 
translocation provides an indication of when the calcium channels in the plasma 
membrane are open during calcium influx.
3.4.2 C2 domain translocation during phagocytosis
The data presented here illustrate that the calcium influx triggered by 
phagocytosis is sufficient to trigger C2 domain translocation. C2 domain 
translocation occurred before phagosome closure suggesting that calcium influx 
starts before closure of the phagosome. Not all of the cells displayed C2 
domain translocation during phagocytosis suggesting that calcium influx did not 
occur in all cells. Previous reports have shown that calcium influx is not 
necessary for particle internalisation but is for bacterial killing once the particle 
has been internalised (Dewitt et al., 2003, Jaconi et al., 1990). It is therefore 
not unusual that not all of the cells in this study displayed calcium influx during 
phagocytosis. The data presented in this chapter show some suggestion that 
C2 domain proteins translocate first to the membrane around the phagosome 
before the rest of the plasma membrane. This suggests that the initial source 
of calcium influx is from the calcium channels in the membrane around the 
phagosome. Previous studies have shown that after phagosome closure there 
is a decrease in calcium concentration within the phagosome suggesting that 
calcium is entering the cell from the phagosome through calcium channels in 
the phagosomal membrane (Lundqvist-Gustafsson et al., 2000). Local increase 
in cytosolic calcium concentrations around the phagosome have also been 
reported (Jaconi et al., 1990). The C2 domain used in these experiments has a 
very high calcium affinity (0.7pM) (Kohout et al., 2002) and as such will 
translocate readily to the membrane when calcium influx is occurring. A
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comparison of the translocation of this C2 domain during phagocytosis with 
another C2 domain with a lower calcium affinity would give a more definitive 
answer as to where in the plasma membrane calcium influx was occurring first 
and how long the calcium channels remained open.
3.4.3 Activity of C2 domains in apoptotic cells
The data presented in this chapter show that in apoptotic cells C2 domain 
translocation is diminished but not completely abolished in apoptotic 
neutrophils. During the process of apoptosis ~50% of the total phosphatidyl 
serine is externalised from the inner leaflet to the outer leaflet of the plasma 
membrane (Martin et al., 1995). Despite this, upon pharmacologically 
stimulated cytosolic calcium influx, YFP tagged C2 domain is still seen to 
translocate to the plasma membrane. However, unlike in normal healthy cells 
where all of the YFP-C2 domain translocates from the cytoplasm to the plasma 
membrane, only a small percentage of the total C2 domain in the cell 
translocates in the phosphatidyl serine externalised cells. This is most likely 
due to there simply being less phosphatidyl serine on the inner leaflet of the 
plasma membrane for the C2 domain to bind and as such the rate of 
translocation remains the same.
3.4.4 Location of calpain in apoptotic neutrophils
The data presented here show that despite translocation of classical C2 
domains being diminished but not completely abolished in apoptotic cells p- 
calpain (which contains a ‘C2 like’ domain) is completely absent from the 
membrane in apoptotic neutrophils. This suggests that calpains ‘C2 like’ 
domain does not act in the same manner as a typical C2 domain. Phosphatidyl 
serine binding and calcium ion binding by C2 domain proteins are intrinsically 
linked. Phosphatidyl serine binding cannot occur without calcium ion binding 
(Nalefski and Falke, 1996). As the Kd of phospholipid affinity of p-calpains ‘C2
98
like domain’ and its [Ca2+]i/2 is unknown this data suggests that the [Ca2+]i/2 of 
p-calpains ‘C2 like domain’ and consequently its Kd of phospholipid affinity 
must be higher than that of classical C2 domains as it does not bind 
phosphatidyl serine as readily as classical C2 domains when the phosphatidyl 
serine is decreased, suggesting that its affinity for calcium and therefore 
phosphatidyl serine must be lower than that of classical C2 domain proteins 
because, as previously stated, the affinity of a C2 domain protein for calcium 
dictates its phosphatidyl serine binding affinity. The [Ca2+]i/2 of the C2y-YFP 
used in these experiments is 0.7pM and the Kd of its phospholipid affinity is
3.1 pM (Kohout et al., 2002). Therefore the [Ca2+]i/2 of p-calpains ‘C2 like’ 
domain must be higher than 0.7pM. This is an important point as the calcium 
concentration required for the activation of p-calpain is also relatively high, 
around 30pM (Michetti et al., 1997), as discussed in section 1.7.3. If the 
[Ca2+]i/2 of calpains ‘C2 like’ domain is higher than 0.7pM it would require 
higher calcium concentrations to bind phosphatidyl serine and translocate from 
the cytoplasm to the plasma membrane than that required by classical C2 
domain proteins such as that from PKCy. As a result p-calpain would only be 
found at the plasma membrane where calcium concentration is at its highest, 
this is postulated to be within the neutrophil membrane wrinkles (Brasen et al., 
2010). If this were the case then p-calpain would be very specifically located 
and activated to cleave its substrates, talin and ezrin (Ivetic et al., 2002, 
Shcherbina et al., 1999), within the membrane wrinkles. As these calpain 
substrates act to bind the plasma membrane to the actin cytoskeleton to hold 
the membrane wrinkles in place (Ivetic et al., 2002, Sampath et al., 1998) then 
the cleavage of these calpain substrates would allow for unwrinkling of the 
neutrophil membrane and therefore allow the neutrophil to spread.
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3.4.4 General discussion
This chapter has established the usefulness of C2 domain translocation as a 
marker of calcium influx as well as a model of the activity of other putative C2 
domain containing proteins such as calpain.
The results presented here have pointed to the possibility that during 
phagocytosis, calcium influx occurs first via calcium channels around the 
phagosome followed by influx through calcium channels in the rest of the 
plasma membrane. In order to further confirm this it would be useful in the 
future to compare the translocation of different C2 domain proteins with 
different calcium affinities in order to establish at what part of the plasma 
membrane calcium concentration was the highest and therefore give a better 
idea of where in the plasma membrane the calcium influx was occurring.
It has also been illustrated in this chapter that C2 domain proteins with a high 
enough calcium affinity can still translocate to the plasma membrane upon 
cytosolic calcium increase in apoptotic cells in which half of the total 
phosphatidyl serine has been externalised. However calpain is not found to be 
located at the plasma membrane in apoptotic cells suggesting that the ‘C2 like’ 
domain in calpain has a lower calcium affinity than the classical C2 domain 
used in these experiments. In the future it would be interesting to look at the 
translocation of other C2 domains with lower calcium affinities in apoptotic cells 
to see if a lower calcium affinity decreases the translocation when phosphatidyl 
serine is decreased as has been suggested is the case for calpain.
1 0 0
CHAPTER 4
Translocation of calpain in human neutrophils
and RAW-264 cells
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4.1 Introduction
In the previous chapter, it was shown that C2 domain proteins move to the 
plasma membrane during pharmacological and physiological stimulation, 
including phagocytosis. Since calpain-1 includes a C2 like domain, it is 
possible that calpain-1 also translocates. In this chapter evidence relating to 
this will be presented both in primary human neutrophils and in the mouse 
model cell. Firstly, however, it is necessary to distinguish the roles of elevated 
Ca2+ in calpain translocation and in its activation (as a protease).
4.1.1 Cytosolic calcium as a trigger for calpain translocation
There is some amino acid sequence homology between domain III from calpain 
1 and classic C2 domains from protein kinase C gamma and beta, although 
they are not highly similar, suggesting that calpains ‘C2 like’ domain is not the 
same as a classical C2 domain. It has been shown that calpain is found at the 
plasma membrane after cytosolic calcium has been increased (Gil-Parrado et 
al., 2003) and that without phosphatidyl serine it is not possible for calpain to 
bind the plasma membrane. It is therefore likely that an increase in cytosolic 
calcium concentration is a trigger for calpain to move from the cytoplasm to the 
plasma membrane.
4.1.2 Cytosolic calcium as a trigger for calpain activation
The exact mechanism of calpain activation is not yet fully understood. Potential 
mechanisms for calpain activation including the much debated role of autolysis 
and calpain activator protein are discussed in detail in section 1.7.3. It is known 
that calpain 1 requires exceptionally high calcium concentrations of around 
30pM in order to be activated (Michetti et al., 1997). This is much higher than 
the physiological calcium concentrations found in the cytosol in a resting cell 
and even higher than the calcium concentrations found in the bulk cytosol 
during calcium influx. However calcium concentrations high enough to activate
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calpain 1 have been found near the plasma membrane in the neutrophil 
membrane wrinkles (Brasen et al., 2010, Davies and Hallett, 1998). This would 
mean that it is possible for calpain 1 to encounter calcium concentrations high 
enough to be activated in neutrophils.
4.1.3 Potential role of calpain translocation in neutrophil spreading
The calpain substrates ERM proteins talin and ezrin are proteins that are 
associated with the actin cytoskeleton and are found at the plasma membrane 
in resting cells (Ivetic et al., 2002, Shcherbina et al., 1999). It has been 
proposed that these proteins hold the wrinkles on the neutrophil membrane in 
place and that release of these wrinkles is essential for neutrophil spreading 
(Hallett and Dewitt, 2007). If calpain were able to translocate from the cytosol 
where it is found in resting cells to the plasma membrane it would be in the right 
location to be able to cleave these proteins and trigger neutrophil spreading. 
Another reason that it is necessary for calpain to translocate to the plasma 
membrane is that it is here only that it may encounter calcium concentrations 
high enough to trigger its activation (Brasen et al., 2010).
4.1.4 Aims of the chapter
The work presented in this chapter aims to extend the work presented in the 
previous chapter to the more difficult question of calpain in human neutrophils. 
The specific objectives of this work were:
- to establish the location of calpain in neutrophils during spreading and 
phagocytosis
- to establish whether calpain translocation occurs during cytosolic calcium 
influx
These aims will be achieved using immunofluorescent staining for calpain in 
primary human neutrophils and using physiological and pharmacological
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techniques to increase cytosolic calcium concentration in RAW-264 cells which 
have been transfected with YFP tagged calpain 4 in order to visualise its 
location in the cell.
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4.2 Materials and Methods
4.2.2 Immunofluorescent staining for calpain in human neutrophils.
4.2.2a Neutrophils spread on glass
Neutrophils were isolated from human blood as described in section 2.4.1.
100pl of the total cells isolated were placed in a glass bottom dish and 
incubated at 37°C for 15 minutes to allow the cells to adhere to the glass. Cells 
were washed 2 times in Krebs-BSA before being fixed in 100ul 3.7% 
formaldehyde for 10 minutes at room temperature. Cells were washed 3 times 
in PBS and then permeabilised in 0.1% triton for 4 minutes after which they 
were washed a further 2 times in PBS. Non specific binding sites were blocked 
by incubating the cells in 4% horse serum for 1 hour before the addition of the 
primary antibody. Primary antibody was monoclonal anti-calpain 1 (6C-12) 
(Santa Cruz -  sc32327). Primary antibody was diluted 1 in 100 (in 4% horse 
serum) before use and cells were incubated in primary antibody overnight at 
4°C. The following morning cells were washed thoroughly 3 times in PBS 
before secondary antibody was added. Secondary antibody was goat anti­
mouse IgG FITC (Santa Cruz santa cruz -  sc-2010). Cells were incubated in 
secondary antibody for 1 hour at room temperature in the dark. Secondary 
antibody was removed by washing thoroughly twice with PBS. Microscopic 
visualisation of the cells, once stained, was carried out using the CLSM.
4.2.2b Neutrophil phagocytosis
Neutrophils were isolated from human blood as described in section 2.4.1.
100pl of the total cells isolated were incubated for 30 minutes in 0.5mg/ml 
serum opsonised zymosan particles before being allowed to adhere to glass 
coverslips to enable fixation and viewing. Cells were then fixed and stained as 
described in the previous section.
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4.2.3 Localised Calpain-YFP Photo bleaching
RAW-264 cells were transiently transfected with calpain4-YFP as described in 
section 3.2.1b. Cells were analysed using confocal microscopy. Localised 
photo bleaching was achieved using the restricted area laser scanning mode 
(“zoom”) so that the area to be photo bleached could also be visualised. The 
laser power was increased during the localised scanning and the effect on local 
YFP fluorescence monitored as bleaching in that area proceeded. Once 
significant bleaching had been achieved, the full image acquisition was restored 
at normal laser power, and extent the calpain YFP bleaching outside the 
exposed area established. This procedure (FLAP - fluorescence loss after 
photo bleaching) gives an indication of the mobility of the fluor. A time course of 
frames was then taken at a rate of 1 frame every 2 seconds to establish the 
extent of fluorescence recovery (FRAP) as fluorescent molecules diffuse into 
the exposed zone to replace those which were bleached.
4.2.4 Calcium elevating experiments in RAW-264 cells transiently 
expressing calpain4-YFP
RAW-264 cells were transiently transfected with calpain4-YFP as described in 
section 3.2.1b. Pharmacologically stimulated cytosolic calcium increase was 
achieved by treating the cells with a cocktail containing 10pM ionophore, 5pM 
thapsigargin 13mM CaCfe as described in section 2.9. Physiologically 
stimulated cytosolic calcium influx was achieved by treating the cells with 
mouse serum. Cytosolic calcium concentration was monitored using fura red 
calcium indicator as described in section 2.8. All experiments were imaged 
using a Leica SP2 confocal microscope.
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4.3 Results
4.3.1 Calpain-YFP in living cells during phagocytosis and shape change
RAW-264 cells were initially used as a surrogate myeloid cell to investigate the 
properties of endogenous calpain in a myeloid cell line. The strategy was to 
express a fluorescent analogue subunit of calpain which does not contain a C2- 
like subunit (calpain4-YFP). Its translocation would only be by virtue of it 
partnering endogenous calpain-1. In this way, we can study the movement of 
endogenous calpian-1 without disturbing its expression levels or increasing the 
amount of C2 domain protein.
4.3.1.1 Location of calpain-YFP in cells spread on coverslips
Calpain-4 -YFP expressed in RAW 246 cells was located in the cytosol. There 
was no significant calpain4-YFP at the plasma membrane in resting RAW246 
cells. In order to establish whether a small proportion of calpain-4 was attached 
to the plasma membrane which was not possible to detect because of the 
larger amount in the cytosol, localised photo bleaching of the cytosol was 
undertaken. This showed that none of the calpain was permanently bound to 
the membrane as the total fluorescence decreased and it revealed no 
fluorescent protein at the cell edge (figure 4.3.1.1.1)
4.3.1.2 Calpain-YFP activity in response to pharmacological cytosolic calcium 
concentration increase and cell shape change
A pharmacologically stimulated cytosolic calcium increase was stimulated by 
treating the cells with 10pM ionophore, 5pM thapsigargin 13mM CaCb- Upon 
the addition of the stimulus cytosolic calcium concentration increased sharply 
and remained high (figure 4.3.1.2.1a). However no calpain4-YFP translocation 
was observed even when cytosolic calcium concentration was at its highest 
(figure 4.3.1.2.1b)
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4.3.1.3 Calpain-YFP activity in response to physiological cytosolic calcium 
concentration increase and shape change
Physiologically stimulated cytosolic calcium increase was achieved through 
treating the cells with mouse serum. Upon the addition of mouse serum the 
cytosolic calcium concentration increased sharply before quickly returning to 
resting levels (figure 4.3.1.3.1a). This cytosolic calcium concentration increase 
was not sufficient to trigger calpain4-YFP translocation (figure 4.3.1.3b).
4.3.2 Calpain in human neutrophils
In order to establish the relevance of the finding of C2 domain translocation 
shown in chapter 3 and the earlier work here, it was decided to use 
immunohistochemistry to determine the location of calpain-1 in primary human 
neutrophils.
4.3.2.1 Calpain location in spread neutrophils
Calpain in primary human neutrophils is mainly cytosolic. In order to investigate 
its location during spreading, neutrophils were allowed to spread onto glass 
coverslips before being fixed, permeablised and probed with anti-calpain. This 
procedure showed that calpain-1 was concentrated at the cell edge in cells that 
had spread (figure 4.3.2.1.1). These data are consistent with the translocation 
of calpain-1 during neutrophil spreading. In spread cells which had polarised 
and begun the process of chemotaxis, calpain was highest at the leading edge 
of the cell (figure 4.3.2.2.4), suggesting the possibility that calpain localisation 
may be important in active cell shape change.
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4.3.2.2 Calpain location during and after neutrophil phagocytosis
In order to establish whether translocation of calpain-1 occurred during 
phagocytosis, primary human neutrophils were allowed to phagocytose human 
serum opsonised zymosan particles before probing with anti-calpain antibody. 
Under these conditions, calpain-1 was concentrated around the phagocytic cup 
when cells were fixed at the start of phagocytosis (figure 4.3.2.2.1) or around 
newly internalised phagosomes when cells were fixed immediately after the 
particle had been internalised (figure 4.3.2.2.2). However when cells were fixed 
after phagocytosis was complete, older phagosomes were devoid of calpain 
(figure 4.3.2.2.3). This was consistent with translocation of calpain to a localised 
site of Ca2+ influx (i.e. the phagosomal membrane) as detected in the early 
stages of phagocytosis by RAW246 cells (chapter 3).
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Figure 4.3.1.1.1: Typical result o f photo bleaching of calpain 4-YFP in RAW264 cells
(n-3). RAW-264 cells expressing YFP tagged calpain 4 were exposed to high intensity laser 
light in order to bleach the YFP molecules in the cytoplasm of the cell, a) Shows a total loss of 
YFP fluorescence intensity of the entire cell after photo bleaching, with only a minor recovery, 
b) shows the cell before (left) and after (right) photo bleaching, showing the area of the cell that 
was bleached and that the whole of the cell had decreased in fluorescence intensity as 
molecules from the rest of the cytoplasm moved into the bleached area. Fluorescence at the 
cell membrane is also decreased indicating that none of the calpain is permanently bound to 
the plasma membrane in unstimulated cells.
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Figure 4.3.1.2.1: Typical response of RAW  264 cells expressing calpain4-YFP to 
pharmacologically stimulated calcium  influx (n=20). RAW cells expressing calpain 4-YFP 
were treated with 10pM ionophore and 5pM thapsigargin in medium containing 13mM CaCI2to 
increase cytosolic calcium concentration in an attempt to stimulated calpain translocation. Cells 
were also loaded with fura red to measure cytosolic calcium concentration. YFP and fura red 
fluorescence were monitored simultaneously throughout the experiment, a) Cytosolic calcium 
concentration was calculated from fura red fluorescence. After the addition of the stimulus 
cytosolic calcium concentration increased sharply (t~33.7) and remained high, b) Calpain4- 
YFP did not translocate to the plasma membrane upon pharmacologically induced cytosolic 
calcium increase.
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Figure 4.3.1.3.1: Typical response of RAW  264 cells expressing calpain4-YFP to 
pharmacologically stimulated calcium  influx (n=3). RAW cells expressing calpain4-YFP 
were treated with mouse serum in order to stimulate a physiological calcium influx. Cells were 
loaded with fura red in order to monitor cytosolic calcium concentration and fura red and YFP 
fluorescence were monitored simultaneously throughout the experiment, a) Cytosolic calcium 
concentration was calculated from the fura red intensity. Upon the addition of the mouse serum 
cytosolic calcium concentration increased sharply (t~18.0s) before returning to normal levels 
(t~36.0s). b) During this spike in cytosolic calcium concentration no translocation of calpain4- 
YFP was observed.
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Figure 4.3.2.1.1: Calpain sta in ing in spread neu troph ils . Neutrophils were allowed to 
spread onto glass coverslips before being fixed, permeablised and stained for calpain. Calpain 
is concentrated at the cell membrane in neutrophils which have spread onto the coverslips 
(images representative of >200 cells imaged over 4 separate experiments, taken at different 
magnifications)
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Figure 4.3.2.2.1: Calpain staining in neutrophils during phagocytosis. Neutrophils were 
allowed to phagocytose human serum opsonised zymosan particles (red arrowhead) before 
being fixed, permeablised and stained for calpain. The coverslip was then searched for cells 
which had been fixed at the particle binding stage of phagocytosis. They indicate that calpain is 
concentrated around the phagocytic cup (white arrows) in neutrophils which are just beginning 
phagocytosis. (Images are representative of 8 cells caught during the particle binding stage of 
phagocytosis over 3 separate experiments).
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Figure 4.3.2.2.2: Calpain staining in neutrophils im m ediately after phagosome closure.
Neutrophils were allowed to phagocytose human serum opsonised zymosan particles before 
being fixed, permeablised and stained for calpain. The coverslip was then searched for any 
cells that still retained calpain staining after phagosome closure. Calpain is concentrated 
around the internalised particle in neutrophils which have just completed phagocytosis (white 
arrows). (Images are representative of >11 cells found over 3 separate experiments with 
calpain staining still around the phagosome after phagosome closure).
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\
Figure 4.3.2.2.3: Calpain staining in neutrophils several m inutes after phagosome 
closure. Neutrophils were allowed to phagocytose human serum opsonised zymosan particles 
and then spread onto glass coverslips before being fixed, permeablised and stained for calpain. 
The coverslip was then searched for any cells which had lost calpain staining around the 
phagosome once the phagosome had closed. Once phagocytosis is completed calpain staining 
is no longer found to be concentrated around the internalised particle. (Images are 
representative of >15 cells over 3 separate experiments found with calpain staining absent from 
the phagosome after phagosome closure)
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Figure 4.3.2.2.4: Calpain sta in ing  in neu troph ils  during  chem otaxis. Neutrophils were 
allowed to spread onto glass coverslips coated with opsonised zymosan particles before being 
fixed, permeablised and stained for calpain. Calpain is concentrated at the leading edge in 
neutrophils which are undergoing chemotaxis (indicated by white arrows). (Images are 
representative of <20 cells over 3 experiments)
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4.4 Discussion
4.4.1 Calpain4-YFP in living cells during phagocytosis and shape change
When calpain 4 was over expressed in RAW264 cells its location was found to 
be cytosolic, with none found bound to the plasma membrane in resting cells. 
This was to be expected as calpain is a cytosolic protein (Goll et al., 2003).
Results from chapter 3 indicated that C2 domain proteins of differing calcium 
affinities are able to translocate readily in response to cytosolic calcium influx, 
suggesting that by virtue of its ‘C2 like’ domain, calpain would show 
translocation to the plasma membrane during cytosolic calcium influx.
However, no calpain4-YFP translocation was observed in response to either 
pharmacologically or physiologically stimulated calcium influx.
Both physiological and pharmacological stimulation of cells resulted in cytosolic 
calcium concentrations of higher than 500nm which would have been sufficient 
to stimulate translocation of classical C2 domains to the plasma membrane 
(section 3.3). It has also been shown in the previous chapter that calpains ‘C2 
like’ domain likely has a much lower calcium affinity than classical C2 domains 
(section 3.4). It may be the case that the cytosolic calcium concentrations 
reached in these experiments were not high enough to cause calpain 
translocation. This is unlikely though, since bulk cytosolic calcium 
concentrations higher than those shown here would not occur under 
physiological conditions. It has been shown however that it is possible for 
micro domains of high calcium concentrations to exist during calcium influx 
inside the plasma membrane wrinkles on neutrophils (Brasen et al., 2010). It is 
therefore possible that only the calpain already present within the membrane 
wrinkles at the time of calcium influx encounters calcium concentrations high 
enough to bind phosphatidyl serine in the plasma membrane and high enough
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to activate the protease. As such any excess calpain in the cytoplasm would 
remain inactive.
Another possible explanation is that in these experiments only the small subunit 
of p-calpain (calpain 4) was over expressed. Calpain 4 does not contain the 
‘C2 like’ domain or the protease domain and is only active when bound to its 
partner calpain 1 (Goll et al., 2003). This was considered the best approach to 
these experiments as any response seen would be as a result of endogenous 
calpain binding to the YFP tagged calpain 4 and could therefore be reliably 
interpreted as a normal response and not just a consequence of over 
expression. However it is possible that by only over expressing calpain 4 that 
any response was masked by an excess of calpain 4 in the cytosol. For 
example if there was more calpain 4 over expressed than there was 
endogenous calpain 1 in the cell then not all of the over expressed protein 
would be bound to calpain 1 and as such there would be an excess of inactive 
YFP tagged calpain 4 in the cytosol which may have masked any translocation 
of the active form. It is also possible that the over expressed calpain 4 did not 
bind with the endogenous calpain 1 and therefore all of the over expressed 
protein was inactive and thus there was no response.
One final possibility is simply that RAW264 cells don’t provide a good model of 
calpain activity as they are a mouse cell line and they are not neutrophils. 
However calpain is ubiquitously expressed in all cell types and is highly 
conserved between mouse and human (figure 4.4.1.1 and 4.4.1.2) and in the 
experiments conducted here the cytosolic calcium increase was artificial and so 
any difference in processes between the cells should be irrelevant.
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CPNS1_HUMAN MFLVNSFLKGGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGG— GGGGGGGGTA 
CPNS1_M0USE MFLVNSFLKGGGGGGGGGG-LGGGLGNVLGGLISGAAGGGGGGGGGGMGLGGGGGGGGTA
CPNS1_HUMAN MRILGGVISAlSEAAAQYNPEPPPPRTHYSNIEANESEEVRQFRRLFAQLAGDDMEVSAT 
CPNS1_M0USE MRI LGGVISAI SEAAAQYN PEPPPPRSHYSNIEANESEEVRQFRKLFVQLAGDDMEVSAT
CPNS1_HUMAN ELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKRWQAIY 
CPNS1_M0USE ELMNILNKWTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKKWQAIY
CPNS1_HUMAN KQFDTDRSGTICSSELPGAFEAAGFHLNEHLYNMIIRRYSDESGNMDFDNFISCLVRLDA 
CPNS1_M0USE KRFDTDRSGTIGSHELPGAFEAAGFHLNEHLYSMIIRRYADESGNMDFDNFISCLVRLDA
CPNS1_HUMAN MFRAFKSLDKDGTGQIQVNIQEWLQLTMYS 2 68 
CPNS1_M0USE MFRAFKSLDKNGTGQIQVNIQEWLQLTMYS 2 69
Figure 4.4.1.1: Am ino acid sequence com parison of m ouse calpain 4 and human calpain
4. Sequence are 95% identical. Differing amino acids are highlighted.
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CAN1_HUMAN MSEEIITPVYCTGVSAQVQKQRARELGLGRHENAIKYLGQDYEQLRVRCLQSGTLFRDEA
CAN1_M0USE MTEELITPVYCTGVSAQVQKKRDKELGLGRHENAIKYLGQDYETLRARCLQSGVLFQDEA
CAN1_HUMAN FPPVPQSLGYKDLGPNSSKTYGIKWKRPTELLSNPQFIVDGATRTDICQGALGDCWLLAA
CAN 1_M0U S E FPPVSHSLGFKELGPHSSKTYGIKWKRPTELMSNPQFIVDGATRTDICQGALGDCWLLAA
CAN1_HUMAN IASLTLNDTLLHRWPHGQSFQNGYAGIFHFQLWQFGEWVDVWDDLLPIKDGKLVFVHS
CAN1_M0USE IASLTLNETILHRWPYGQSFQDGYAGIFHFQLWQFGEWVDWIDDLLPTKDGKLVFVHS
CAN1_HUMAN AEGNEFWSALLEKAYAKVNGSYEALSGGSTSEGFEDFTGGVTEWYELRKAPSDLYQIILK
CAN1_M0USE AQGNEFWSALLEKAYAKVNGSYEALSGGCTSEAFEDFTGGVTEWYDLQKAPSDLYQIILK
CAN1_HUMAN ALERGSLLGCSIDISSVLDMEAITFKKLVKGHAYSVTGAKQVNYRGQWSLIRMRNPWGE
CAN1 MOUSE ALERGSLLGCSINISDIRDLEAITFKNLVRGHAYSVTGAKQVTYQGQRVNLIRMRNPWGE
CAN1_HUMAN 
CAN1 MOUSE
VEWTGAWS DS S S EWNN VDP YERDQLRVKME DGE FWMS FRDFMRE FTRLEICNLTP DALKS 
VEWKG PW S DS S YEWNKVDP YEREQLRVKMEDGE FWMS FRD FI RE FTKLEICNLT PDALKS
CAN1_HUMAN 
CAN1 MOUSE
RTIRKWNTTLYEGTWRRGSTAGGCRNYPATFWVNPQFKIRLDETDDPDDYGDRESGCSFV
RTLRNWNTTFYEGTWRRGSTAGGCRNYPATFWVNPQFKIRLEEVDDADDYDNRESGCSFL
CAN 1_HUMAN LALMQKHRRRERRFGRDMETIGFAVYEVPPELVGQPAVHLKRDFFLANASRARSEQFINL
CANl_MOUSE LALMQKHRRRERRFGRDMETIGFAVYQVPRELAGQP-VHLKRDFFLANASRAQSEHFINL
CAN1_HUMAN REVSTRFRLPPGEYWVPSTFEPNKEGDFVLRFFSEKSAGTVELDDQIQANLPDEQVLSE
CANl_MOUSE REVSNRIRLPPGEYIWPSTFEPNKEGDFLLRFFSEKKAGTQELDDQIQANLPDEKVLSE
CAN 1_HUMAN EE I DEN FKAL FRQLAGE DMEISVKELRTILNRIISKHKDLRTKGFSLESCRSMVNLMDRD
CAN1 MOUSE EE IDDN FKTLFSKLAGDDMEIS VKELQTI LNRI ISKHKDLRTNGFSLESCRSMVN LMDRD
CAN1_HUMAN 
CAN1 MOUSE
GNGKLGLVEFNILWNRIRNYLSIFRKFDLDKSGSMSAYEMRMAIESAGFKLNKKLYELII
GNGKLGLVEFNILWNRIRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLNKKLHELII
CAN 1_HUMAN TRYSEPDLAVDFDNFVCCLVRLETMFRFFKTLDTDLDGWTFDLFKWLQLTMFA 714
CAN1 MOUSE TRYSEPDLAVDFDNFVCCLVRLETMFRFFKLLDTDLDGWTFDLFKWLQLTMFA 713
Figure 4.4.1.2: Am ino acid sequence com parison of mouse calpain 1 and human calpain
1. Sequence are 89% identical. Differing amino acids are highlighted.
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4.4.2 Calpain in human neutrophils.
Despite no calpain translocation being observed upon cytosolic calcium 
increase in RAW264 cells expressing calpain4-YFP, when human neutrophils 
were fixed and stained for calpain expression calpain was found to be at the 
plasma membrane in spread neutrophils, around the phagosome during but not 
after phagocytosis and at the leading edge of neutrophils during chemotaxis 
and shape change. In all of these circumstances calpain is present in the right 
place and at the right time to play a role in neutrophil shape change. It may be 
the case that it is easier to see calpain enrichment at the plasma membrane in 
these cells than in living cells as these cells have been fixed and permeabalised 
before staining and as such any unbound and excess protein in the cytoplasm 
is washed away leaving only the material that is bound to the membrane thus 
making it easier to observe.
4.4.3 General Discussion
Despite the lack of evidence for the ability of calpain to translocate from 
observing YFP tagged calpain 4 in RAW264 cells, the results of the 
immunofluorescent staining for the location of calpain in human neutrophils 
provided compelling evidence that calpain is indeed present in the right place 
and at the right time to play a role in neutrophil shape change. Calpains 
substrates talin and ezrin are found in the neutrophil membrane wrinkles (Ivetic 
et al., 2002, Sampath et al., 1998) and cleavage of these substrates by calpain 
would allow the membrane to ‘unwrinkle’. As calpain is present at the plasma 
membrane during and immediately after neutrophil shape and calcium micro 
domains where calcium concentrations are high enough to trigger calpain 
activation could exist in these membrane wrinkles (Brasen et al., 2010) it is very 
likely that calpain cleavage of these substrate is causing the unwrinkling of the 
plasma membrane. However it still remains for this to be observed in real time 
and in living neutrophil like cells as these cells are notoriously difficult to 
transfect. These obstacles are addressed in the next chapter.
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CHAPTER 5
Expression of fluorescent proteins in neutrophil­
like cells
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w5.1 Introduction
It is clear from the preceding chapters that definitive evidence for an 
involvement of calpain-1 in neutrophil-like activities will only be achieved by 
studying neutrophil-like cells. In the earlier chapters, transfection has provided 
real time data of intracellular events. However, transfecting neutrophil-like cells 
is a major challenge.
In this chapter, the issues surrounding transfection of neutrophil-like cells are 
discussed and the attempts to solve the problem are presented.
5.1.1 Established methods of transfection
5.1.1a Calcium phosphate transfection
Calcium phosphate mediated transfection relies on the precipitates which form 
spontaneously between DNA and calcium phosphate when mixed in a 
supersaturated solution. The precipitate is then added to the cellular medium 
where it is taken up by the cells. The stability of the precipitate formed is 
influenced by a number a number of factors including the concentration of the 
calcium and phosphate in the solution, the temperature of the reaction, the DNA 
concentration and the reaction time. Less than one minute reaction time is 
usually suitable to bind all of the DNA in the solution and extending the reaction 
time can lead to the formation of aggregates which decreases the transfection 
efficiency when the precipitate is added to the cells (Jordan et al., 1996). The 
pH of the medium when the precipitate is added to the cells is also critical as 
this influences the saturation of the medium and whether or not the precipitate 
re-dissolves before it is taken up by the cells (Jordan and Wurm, 2004).
Osmotic shock of the cells once the precipitate has been added has been
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shown to increase transfection efficiency but this is not through increased 
precipitate uptake into the cells (Jordan and Wurm, 2004).
5.1.1b Electroporation
Batch electroporation involving large external electric fields passed through the 
cells via two large external electrodes was first described by Neumann et al in 
1982 who used a current passed through a solution of mouse myeloma cells 
and DNA using two electrodes to transfer DNA into the cells (Neumann et al., 
1982). This induces a high transmembrane potential which leads to 
electropermeabalisation of the cell membrane (Weaver and Chizmadzhev, 
1996). The exact mechanism of electropermeabalisation is not fully understood 
but in order for large molecules such as DNA to pass through the membrane 
the theory exists that electropermeabalisation must create pores in the lipid 
bilayer. Although there is much theoretical evidence for the existence of these 
pores in the membrane they have never actually been imaged (Weaver and 
Chizmadzhev, 1996). The pores form within 1ps but can take anywhere 
between 1s and 100s to close again (Weaver and Chizmadzhev, 1996). These 
pores are formed in the cell membrane only at particular voltages (1-20kV cm'1) 
and lengths of electrical pulses (1-5ps) (Sugar and Neumann, 1984). If either 
of these criteria are exceeded then complete breakdown of the membrane 
occurs and the cell ruptures (Weaver and Chizmadzhev, 1996). Higher 
voltages and longer durations of pulses lead to larger pores being formed in the 
membrane which are ultimately irreversible (Joshi and Schoenbach, 2000). 
Once the pores have formed in the membrane, DNA can then be transported 
into the cell via electrophoresis.
The exact molecular mechanisms which lead to gene expression through 
normal electroporation are still unknown. It is commonly believed that transient 
expression of the inserted gene can occur whilst the plasmid is in the cytoplasm 
of the cell but for the cell to become stably transfected, cell division must occur
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in which pores form in the nuclear membrane allowing the plasmid to enter the 
nucleus and potentially become integrated into the cells genome.
5.1.1c Nudeofection
Normal electroporation acts by forming pores across the plasma membrane 
when the voltage across the membrane reaches a set strength. This allows the 
DNA to enter the cell. However DNA cannot enter the nucleus until cell division 
occurs and the nuclear membrane becomes temporarily more permeable. 
Nudeofection through a combination of specialised electrical parameters and 
specific reagents means that DNA can pass through the plasma membrane and 
then through the nuclear membrane without having to wait for cell division to 
occur, resulting in a higher transfection rate. Also as the DNA is not held in the 
cytoplasm for a great length of time it is less susceptible to degradation. The 
exact molecular mechanism underlying nudeofection remains, however, 
unknown (Hamm et al., 2002). Despite this nudeofection has proved to be an 
efficient method of transfection for previously transfection resistant cell types 
such as stem cells (Aluigi et al., 2006) and immune cells (Maasho et al., 2004)
5.1.1d Lipofection
Lipofection utilises the complexes which are formed between cationic lipids and 
polyanionic DNA. These interact to form a liposome containing the DNA to be 
introduced into the cell. The liposome is taken up by the cell through 
endocytosis and during this process or once inside the cell the liposome 
becomes destabilised and releases its DNA into the cytoplasm. Destabilisation 
of the liposome is the critical step in this process as for a successful 
transfection the DNA must be released from the carrier once inside the cell. It 
is not known exactly how the liposome becomes destabilised as it is 
internalised but it is most likely the result of neutralisation by cellular ionic lipids, 
probably from fusion of the cell membrane with the liposome complexes as they
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are internalised (Koynova et al., 2005). This hypothesis is strengthened by the 
observation that liposomes containing lipid compositions mimicking the 
cytoplasmic facing monolayer of the plasma membrane release their DNA more 
quickly into cells (Xu and Szoka, 1996). It is suggested that after the liposome 
is internalised via endocytosis it destabilises the endosomal membrane which 
induces flip flop of the lipids in the endosome which form complexes with the 
liposome and neutralises the lipids in the liposome resulting in the release of 
the DNA.
5.1.1e Virus mediated gene transfer
The majority of viral mediated DNA transfer systems are based on retroviruses. 
Retroviruses are enveloped RNA viruses which contain 2 copies of a single 
stranded RNA genome. The key features of retroviruses which make them 
good vectors for use in transfection are; their reverse transcriptase enzyme 
which converts the viral RNA into double stranded DNA and their integrase 
enzyme which can insert the double stranded DNA that has been created into 
the host cells genome. Integration of viral DNA into the host cell genome 
occurs as part of the normal retrovirus life cycle (figure 5.1.1e).
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Figure 5 .1 .1.e: Schem atic representation o f the retroviral life cycle (adapted from 
http://www.nimr.mrc.ac.uk/viroloqy/bishoD/ (accessed 01/12/09). After initial binding the virus 
fuses itself to the host cell membrane and enters the cell. The virus then uncoats and reverse 
transcription and trafficking of DNA into the nucleus occurs. Once the DNA is in the nucleus 
integration of the viral DNA into the host cells genome occurs to create a pro virus. The viral 
DNA is then transcribed along with the cells other DNA. The cells own enzymes translate the 
RNA produced into new viral DNA. New virus is then assembled before the virus buds off from 
the cell. Further maturation then occurs before the virus can infect a new cell.
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Integration of the viral DNA into the host cells genome occurs via removal of 
dinucleotides from both the 3’ ends of the linear double stranded viral DNA, 
followed by a strand transfer reaction in which the 3’ hydroxyl ends of the viral 
DNA make staggered breaks in the host cells chromosomal DNA, the gaps 
between the viral DNA and the host cells chromosomal DNA are then repaired 
by the host cells own DNA ligase enzymes resulting in integration of the viral 
DNA into the host cells genome. This is the key step in achieving stable 
transfection through a retroviral vector (Coffin et al., 1997)
Retroviruses have 3 core genes that they require in order to replicate. These 
are the gag, pol and env genes. The gag gene encodes the core proteins of 
the virus, the pol gene encodes the viral reverse transcriptase, DNA 
polymerase and integrase and the env gene encodes the viral envelope 
proteins. A retroviral vector for use in transfection encodes replication 
incompetent retrovirus. Most of the coding region of the retroviral genome is 
replaced by the gene of interest. A packaging cell line that expresses the gag, 
pol and env genes is used to produce replication incompetent retrovirus that is 
carrying the gene of interest.
The packaging cell line is transfected with the retroviral vector in order to 
produce high titres of replication incompetent retrovirus. The virus does not 
need to be replication competent as there is no need for it to continue to 
replicate once it has infected the target cells and integrated its DNA into the 
target cell genome. The packaging cell lines contain the gag, pol and env 
genes on 3 different plasmids. This provides the necessary genes for the virus 
to be able to assemble and the bud from the packaging cells but the virus 
produced would still be replication incompetent. 3 separate recombination 
events would need to occur between the plasmids which encode the required 
genes and the viral genome in order to produce replication competent
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retrovirus. Once the retrovirus has been produced it can be used to transfect 
actively dividing target cells.
There are two main subtypes of the retrovirus family which are used for 
transfection. The most commonly used are the gamma retroviruses. These 
viruses can only transfect readily dividing cells as breakdown of the nuclear 
envelope is required for integration of the viral genome to occur. The other 
commonly used retroviral subtype is the lentivirus. These vectors are usually 
based on the HIV-1 virus and are able to transfect quiescent cells as they do 
not require cell division for integration of their genome to occur (Lindemann and 
Schnittler, 2009, Naldini et al., 1996).
Another type of virus used experimentally for transfection is the adenovirus. 
These viruses have a double stranded linear DNA genome and are less 
commonly used than the retroviruses (Lindemann and Schnittler, 2009).
5.1.2 Desirable cellular characteristics for successful transfection
Most transfection methods rely on cells being in an actively growing and 
dividing state. If a stable transfection is to be achieved then the genetic 
material introduced into the cell needs to get into the nucleus to stand a chance 
of being integrated into the genome. This can only be achieved during cell 
division when the nuclear envelope becomes more porous, with the exception 
of nudeofection. It is not just a stable transfection that requires active cells. 
Levels of protein synthesis in the cell have to be high enough that the gene that 
has been introduced into the cell is transcribed and translated and the desired 
protein is then expressed by the cell. Most methods of transfection are quite 
invasive to the cell and result in some level of damage whether it is through 
creating pores in the membrane through electroporation or introducing a virus 
into the cell. As such for a cell to be suitable for transfection it must be able to
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withstand these insults. This makes more robust and established cell lines 
more suitable than for example primary cells.
5.1.3 The problem with neutrophils...
Neutrophilic cells, such as primary neutrophils or neutrophillically-differentiated 
myeloid cell lines, do not synthesise significant amounts of protein and are 
terminally differentiated. They are also primary cells and are very sensitive to 
any manipulation. They are not able to survive common transfection 
techniques which involve forming pores in the cell membrane. They also do not 
survive for long enough once isolated from fresh blood for retroviral transfection 
to be successful. Even if it were possible to successfully introduce foreign 
genetic material into neutrophils, it would still be highly unlikely that they would 
go on to express the protein that the material encoded as they are terminally 
differentiated and are no longer synthesising significant amounts of protein, 
also they do not live long enough once isolated from the blood to synthesise 
any significant amounts of a new protein.
5.1.5 Aims of the chapter
The aim of this chapter is to establish a method of successfully expressing 
fluorescently tagged calpain in neutrophil-like cells such as differentiated 
myeloid cell lines and for the transfection to be stable enough that the gene is 
still expressed at sufficient levels so that useful fluorescence can be imaged 
using the confocal laser scanning microscope for experiments once the cells 
have differentiated.
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5.2 Materials and Methods
5.2.1 Transfection of human neutrophils using nudeofection
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). Neutrophils were transfected using the Amaxa nucleofector 
device as previously described (Johnson et al., 2006). 1.84x106 cells were 
centrifuged at 1800rpm for 5 minutes and re-suspended in 90pl nucleofector 
solution (kit T) and transferred to a cuvette. 5pg pmaxGFP plasmid was added 
to the cells to make the final volume in the cuvette 100pl and electroporated 
using programme T-27 on the Amaxa nucleofector device. Cells were 
recovered in 500pl pre-warmed RPMI and transferred to 6 well plates 
containing coverslips and 1ml pre-warmed RPMI per well (250pl transfected 
cells per well). Cells were incubated at 37°C in 5% C02 for 1 hour or 3 hours 
before they were observed under the confocal laser scanning microscope 
(CLSM) to assess the transfection frequency.
5.2.2 Transfection of myeloid cell lines using nudeofection
2x106 cells were transfected with Amaxa pmaxGFP using the Amaxa 
nucleofector device according to the manufacturer’s protocol. Cells were 
centrifuged at 2000rpm for 10mins and re-suspended in 100pl nucleofector 
solution (kit V). 2pg plasmid was added to the cells which were then 
transferred to a cuvette and electroporated using programme X-001 on the 
Amaxa nucleofector device. Cells were recovered in 500pl pre-warmed RPMI 
before being transferred to coverslips in a 6 well plate containing 500pl pre- 
warmed RPMI per transfection. Cells were incubated at 37°C in 5% C02 for 3 
hours before they were observed under the CLSM to assess the transfection 
frequency.
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5.2.3 Generation of retrovirus and retroviral transduction
5.2.3.1 Transformation of phoenix ecotropic packaging cell line to generate 
retrovirus suitable for transducing murine cell types
Phoenix ectropic packaging cells were prepared by seeding into a 6 well plate 
at a density of 5x105 cells/ml and incubated at 37 °C overnight. The next day 
the medium on the cells was replaced with fresh medium and cells were 
transfected with calpain 1-GFP plasmid using Fugene 6 transfection reagent 
according to manufacturer’s instructions. 6pl fugene 6 reagent, 1pg plasmid 
and 94pl serum free DMEM was used per well. Fugene was pipetted directly 
into DMEM with care taken not to touch the sides of the tube and incubated at 
room temperature for 5 minutes. Plasmid was added to the fugene mix and 
incubated at room temperature for at least 15 minutes. Fugene-DNA mix was 
added to each well and swirled so that it covers all the cells and cells are 
incubated at 37°C for 2 days. After 2 days the viral supernatant was harvested 
and centrifuged to remove any contaminating cells. The supernatant was 
filtered through a 0.45pm filter and 5pg/ml polybrene was added. Virus was 
frozen at -80°C for long term storage.
5.2.32 Transformation of phoenix amphotropic packaging cell line retrovirus 
suitable for transducing human cell types.
Phoenix ampotrophic packaging cells were seeded at a density of 1x106 
cells/ml in a 10ml flask and incubated at 37°C overnight. Cells were transfected 
with calpain 1-GFP plasmid using calcium phosphate transformation. Briefly, 
calcium phosphate precipitate was prepared with 45pg plasmid DNA, 45pl 
CaCI2, 450pl HeBs and sterile H2O to a final volume of 900pl. The DNA, CaC^ 
and H2O were prepared in one microcentrifuge tube and added to the HeBs one 
drop at a time whilst bubbling the HeBs. The mixture was vortexed and then 
incubated at room temperature for 20 minutes. The medium on the cells was 
replaced with fresh medium and 25pM chloroquine was added to the culture for 
5 minutes followed by the precipitate and the culture was incubated at 37°C
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overnight. The chloroquine decreases the pH in the endosomes that take up 
the DNA-calcium phosphate precipitate so that any enzymes in the endosomes 
which might degrade the DNA are inhibited. This increases the efficiency of the 
transfection. The following day the 15ml medium was replaced with 7.5ml fresh 
medium and the culture was incubated at 33°C overnight. This step is a 
compromise between getting the virus concentrated and creating optimal 
conditions for viral stability whilst at the same time maintaining the growth of the 
cells. On the final day the viral supernatant was harvested and centrifuged at 
1200rpm for 5 minutes to remove any contaminating cells. Supernatant was 
pipetted into 1ml aliquots in cryovials and snap frozen on liquid nitrogen. Virus 
was stored at -80 for long term storage.
5.2.3 3 Transduction of the MyPH8B6 cell line with jj-calpain-GFP retrovirus
Mouse myeloid progenitor cells were transduced with the calpain retrovirus 
produced by the packaging cell lines. 1.5x106 cells were centrifuged at 1500 
rpm for 5 minutes and re-suspended in 4.5ml calpain 1-GFP viral supernatant 
(and polybrene) containing SCF (10ng/ml) and oestrogen (1pM). Polybrene is 
a small positively charged molecule that when it comes into contact with the cell 
binds to the surface and neutralises the surface charge. This is helpful when 
infecting the target cells with retrovirus as it allows the viral glycoproteins to 
bind more efficiently to their receptors because it decreases the repulsion 
between the sialic acid containing molecules on the cell surface and the virions. 
Cells were seeded into a 6 well plate at 1.5ml per well and plate was 
centrifuged at 1500xg for 90 minutes. 2mls fresh medium was added and cells 
were incubated at 37°C overnight. The next day cells were harvested into a 
flask and fresh medium was added. GFP expressing cells were sorted using 
the MoFlo florescence activated cell sorter. Cells were cultured in medium 
containing oestrogen (1pM) and SCF (20ng/ml) and stocks were frozen in heat 
inactivated FCS containing 10% DMSO for long term storage at -80°C.
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5.2.3.4 Differentiation of the M yPH8B6 cell line into neutrophils
7x105 cells were centrifuged at 350xg for 5 minutes and washed 3 times in 
PBS. Cells were seeded at 7x104 cells/ml in 10ml OptiMem medium 
(Invitrogen) supplemented with 10% heat inactivated FCS, 1% glutamine, 
100pg/ml streptomycin, 100pg/ml penicillin, 30pM p-mercaptoethanol, SCF 
(20ng/ml) and G-CSF (20ng/ml). Cells were maintained in this medium for 4 
days until differentiation was complete. Additional medium was added daily to 
renew the growth factors.
5.2.3 Maturation and transfection of human cord blood derived 
neutrophils.
5.2.3.11solation of CD34+ cells from neonatal cord blood
CD34+ cells are haematopoietic stems cells which can be isolated from 
umbilical cord blood. Whilst still in their immature state these cells can be 
stably transfected using retroviral transduction. CD34+ cells were isolated from 
frozen mononuclear cord blood cells using a MiniMACS™ cell separator 
according to the manufacturer’s protocol. The MACS cell separation system 
works by labelling cells with specific monoclonal antibodies conjugated to 
magnetic microbeads. The MACS column consists of a spherical steel matrix 
and a high magnetic field is induced in the column when it is placed in the 
magnetic cell separator. The cells that are labelled with the magnetic antibody 
remain in the column and any other cells are washed out (figure 5.2.3.1). In the 
case of CD34+ cell isolation the cells are labelled with mouse anti-human CD34 
antibodies conjugated to magnetic microbeads. When the column is placed in 
the magnetic field the CD34+ cells are enriched in the column and all other cells 
are washed out. The column is then removed from the magnetic field and the 
CD34+ cells are eluted from the column.
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Figure 5.2.3.1: MACS separation of CD34+ cells from  m ononuclear cord blood cells.
CD34+ cells are labelled with magnetic antibodies. A magnetic field is applied to the column so 
that magnetically labelled CD34+ cells become enriched in the column and all other cells are 
eluted. The column is then removed from the magnetic field and a plunger is applied to the 
column in order to elute the magnetically labelled CD34+ cells. (Adapted from MACS website)
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7x105 cells were isolated in 1ml medium supplemented with IL-3, G-CSF, GM- 
CSF, Flt3 (5pg/ml), IL-6 (10pg/ml) and SCF (20pg/ml). Cells were cultured at a 
density of 2x105 cells/ml at 37°C/5%C02 overnight.
5.2.3.2 Transduction of CD34+ cells with p-calpain-GFP retrovirus
On the next 2 days of culture cells were infected with calpain 1-GFP retrovirus 
by transferring them to a RetroNectin® coated 24 well plate which had been 
presorbed with retrovirus as described previously (Darley et al., 2002). Briefly, 
an untreated 24 well dish was coated with 150pl RetroNectin® per well and was 
incubated for 2 hours on a shaker at room temperature. The RetroNectin® was 
removed and replaced with 1 % BSA solution and plates incubated at room 
temperature for a further 30 minutes. In the meantime 100pl polybrene solution 
was added to each 1ml vial of virus and the virus was then incubated at 37°C 
for 20 minutes. The BSA was then removed from the plate and immediately 
replaced with the retrovirus (1 well at a time so the well doesn’t dry out). The 
retrovirus was presorbed onto the plate by spinning at 4000rpm in a refrigerated 
centrifuge for 2 hours. After spinning the viral supernatant was removed from 
the plate and replaced with 1ml serum containing medium and incubated at 
room temperature for 5 minutes. The medium was then removed and replaced 
with CD34+ cells and the plate was incubated at 37°C overnight. The infection 
was repeated the next day with fresh virus.
5.2 3.3 Culture and maturation of transduced CD34+ cells into neutrophils
Cells were re-suspended at a density of 5x104 cells/ml in medium containing IL- 
3, G-CSF (5ng/ml) and SCF (20ng/ml). SCF promotes the survival of the stem 
cells in the culture whilst IL-3 stimulates the proliferation of all cells in the 
myeloid lineage. G-CSF specifically stimulates the survival, proliferation and 
differentiation of neutrophils and their precursors (Metcalf, 1985). Cells were 
maintained at a density of approx 4x105 cells/ml for 21-24 days until there were
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mature neutrophils present in the culture. Excess cells were frozen in high 
serum medium containing 10% DMSO to be kept for future use.
5.2.4 Single cell electroporation
As normal electroporation involves electroporating a batch of cells between two 
large external electrodes the entire cell membrane becomes permeabalised. 
This can be very damaging to the cell especially considering the length of time 
it can take for the pores to form. Using single cell electroporation electrical 
pulses are passed through a DNA filled micropipette to one small area of the 
cell membrane which the micropipette is in contact with. Using this technique 
only one small area of the cells membrane becomes permeabalised, as such 
this technique is much less damaging to cells than normal batch 
electroporation.
0.25mm silver wire was inserted through a glass capillary in the micropipette 
holder so that one end of the wire sits in the solution in the micropipette and 
that the other end of the wire is connected to the negative terminal (anode) of 
the Grass SD9 stimulator. A second 0.25mm silver wire acts as the ground 
electrode and was inserted into the cell solution and connected to the positive 
terminal (cathode) of the stimulator. This creates a circuit in which the 
negatively charged plasmid DNA will be pushed out of the micropipette and into 
the cell when the current is switched on (figure 5.2.4.1).
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Connected to -ve  terminal
Pipette diameter 0.5-1 uM
Connected to +ve terminal
Figure 5 .2 .4 .1: D iagram m atic representation of the setup of the apparatus for single cell 
electroporation (Haas et al., 2001). A 0.25mm silver wire inserted through the glass 
micropipette is connected to the negative terminal whilst a second silver wire attached to the 
positive terminal acts as the ground electrode. As plasmid DNA is negatively charged when the 
current is switched on it will be forced out of the pipette into the cell through the pores that are 
created in the membrane by the electric charge.
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The micropipette was filled with 2pl of Ipg/pl pmax GFP plasmid or 1pl Lucifer 
yellow or 1pl fura2 or fura-dextran (figure 5.2.4.2) for visualisation.
a) Lucifer Yellow  Spectrum b) Fura-2 Spectrum
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Figure 5.2.4.2: F luorescent spectrum  of Lucifer yellow  and cell im perm eant fura-2. (a)
Lucifer yellow is excited by wavelengths of light at 425nm and emits fluorescence at 550nm.
(b) The Ca2+ unbound form of fura-2 is excited at 380nm and emits fluorescence at 550nm.
3T3 cells which had been seeded onto a glass bottomed dish the previous night 
were used to test the system. The pipette was pushed against the cells so that 
it was in contact with the cell but not piercing the membrane. Cells were 
shocked with 0.5-1 second trains of 1ms long square pulses at 10V, 8V, 6V or 
4V and 200Hz (figure 5.2.4.3).
1ms
10 Volts
Figure 5.2.4.3: D iagram m atic representation of the electrical parameters used for the 
electroporation of single cells. The frequency and the length of the pulses remained the 
same for all experiments (200Hz and 1ms). The voltage was changed to either 10, 8 ,6 or 4 
Volts depending on the experiment.
-------  -------  14— -------  -------  -------
200Hz
4 -------------------------------------------------------------------------------------------------------------- ►
0.5-1 Seconds
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5.2.5 Transduction of human neutrophils and myeloid cell lines with GFP 
lentivirus.
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). Neutrophils were transduced with a GFP encoding lentivirus as 
previously described (Dick et al., 2009). Cells were transduced with 50,100, 
200 or 300pl GFP virus at either 4°C or 37°C and incubated for 4 hours or 24 
hours. Cells were fixed and analysed for GFP fluorescence using the Acuri flow 
cytometer. Live cells were imaged using the CLSM.
2x105 HL60 cells were transduced with 50 or 200pl GFP virus at 37°C for 48 
hours. Cells were fixed and analysed for GFP fluorescence using the Acuri flow 
cytometer. Live cells were imaged using the CLSM.
5.2.5.11maging of transfected cells
Confocal microscopy of live GFP expressing cells was performed using the 
resonant laser scanning Leica SP2 or SP5 confocal microscope system.
Images were acquired with a 63x oil immersion objective and the GFP was 
excited with a 488nm laser and the emitted light was collected between 510- 
560nm.
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5.3 Results
5.3.1 Nudeofection electroporation of human neutrophils
In order to establish the efficacy of conventional nudeofection for the 
expression of proteins in primary human neutrophils, a GFP-plasmid was used 
as an easily detectable fluorescent protein signal. However, no primary human 
neutrophils expressed GFP either 1 or 3 hour post transfection. This was in 
contrast to a previous report by (Johnson et al., 2006) despite using similar 
electroporation conditions and transfection reagents. The most notable effect of 
electroporation was neutrophil necrosis. It was concluded that primary human 
neutrophils could not be transfected by this method.
5.3.2 Nudeofection of myeloid cell lines NB4 and HL60
Given the zero-efficacy of transfection in primary neutrophils, two myeloid cell- 
lines were investigated, NB4 and HL60. In contrast with primary neutrophils, 
approximately 40% of NB4 cells expressed GFP one day after transfection.
This fell to around 2% by day 7 (figure 5.3.2.1). Similarly, approximately 5-10% 
of the HL60 cells expressed GFP one day after transfection but no cells 
expressed GFP by day 7 (figure 5.3.2.1). Neither of the cell lines became 
stably transfected, even with antibiotic selection. This meant that the cells 
could not be transfected before they were differentiated into neutrophil like cells 
(which itself takes 7-10 days, in which time the protein is lost).
Therefore the key technical challenge involved with this approach was being 
able to transiently transfect myeloid cells which have already differentiated into 
neutrophil-like cells. Post-differentiated HL60 cells failed to express GFP. 
However, it was possible to find a compromise between differentiation and high 
levels of transfection. It takes approximately 5-7 days for HL60 cells to
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differentiate in DMSO. When the cells were transfected at a time that they 
retained some of their protein synthesis function and were not yet fully 
differentiated, i.e. on day 2 or 3 of differentiation, some cells on day 5 
expressed GFP. However, as only 5% of undifferentiated HL60s cells 
expressed GFP on day 1 the further lowering of this on differentiation (fig
5.3.2.1) meant that it was difficult to find cells which were both successfully 
transfected and fully differentiated. This method was thus unreliable at best and 
most commonly the cells that were successfully transfected in this manner were 
those which had not fully differentiated.
5.3.3 Retroviral transfection of murine myeloid progenitor cells and 
human cord blood derived myeloid stem cells
An alternative approach was to transfect myeloid progenitor cells, which 
retained full protein synthetic capacity and which were available from murine 
and human sources. The aim was to transform these progenitor cells to mature 
neutrophils while retaining sufficient GFP for imaging.
5.3.3.1 Expression of calpain 1-GFP in mouse myeloid progenitor cells
Flow cytometry analysis revealed that immediately after transduction with the 
calpain1-GFP retrovirus only 2% of the cells expressed GFP. Cells were 
therefore sorted on the MoFlo florescence activated cell sorter to produce a cell 
population with greater than 90% of cells expressing the protein (figure
5.3.3.1.1). As cells underwent differentiation, expression of the calpain1-GFP 
protein decreased resulting in very low fluorescence in the fully mature 
neutrophils (figure 5.3.3.1.2)
143
5.3.3.2 Expression of calpain1-GFP in human cord blood derived myeloid stem 
cells (CD34+ cells).
Approximately 40% of CD34+ cells expressed GFP after cells had been 
transduced (figure 5.3.3.2.1a). The GFP expression varied considerably 
between individual cells in the population (figure 5.3.3.2.1). This may be due to 
differences in where the retrovirus integrates into the host cell genome. For 
example, if it integrates near a highly expressed gene with a strong promoter, 
expression will be high and vice versa. Another factor influencing the levels of 
GFP expression in the cell is at what stage of maturation the cell is at (see 
later).
CD34+ cells are immature myeloid stem cells. The cells were re-suspended at 
a density of 5x104 cells/ml in medium containing IL-3, G-CSF (5ng/ml) and SCF 
(20ng/ml) in order to differentiate into mature neutrophils. This process took 
approximately 21-23 days. The CD34+ cells have the potential to mature into 
any cell in the myeloid lineage. The G-CSF added to the culture medium 
"encourages” the cells to differentiate down the neutrophil pathway but other 
myeloid cell types are still present in the culture. Also the cells do no mature 
simultaneously so at any one time there are several stages of neutrophil 
development present in the culture. Once the cells have fully matured into 
neutrophils they only live for 2-4 days before they undergo apoptosis. This 
makes it difficult to predict the time point at which the highest number of 
neutrophils will be present in the culture.
Cytospin and wright-giemsa staining were used to observe nuclear morphology 
in order to find the number of mature neutrophils present in the culture. After 
23 days maturation the culture of calpain-GFP transduced cells contained 8.3% 
polymorphonuclear cells. The control culture contained 13.3% 
polymorphonuclear cells (figure 5.3.3.2.2). There was no significant difference
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in the maturation of calpain-GFP transduced cells and control cells (t-test:
p=0.16).
The number of cells expressing GFP decreased as the cells matured towards 
neutrophils (figure 5.3.3.2.1b). Flow cytometry analysis revealed that after a 
21 day maturation period, approximately 11% of cells were expressing GFP 
(figure 5.3.3.2.3a). This combined with the low numbers of neutrophils present 
in the culture made it difficult to find cells which were expressing GFP and were 
mature functioning neutrophils. Analysis of the side scatter found that less than 
1% of the total population of cells in the culture were both expressing GFP and 
had the high granularity which is characteristic of mature neutrophils (figure 
5.3.3.2.3b).
5.3.4 Single cell electroporation
In order to establish whether or not single cell electroporation was a viable 
technique for introducing foreign genetic material into hard to transfect cells 
such as myeloid cell lines and neutrophils, several different parameters were 
tested in order to optimise the technique. Initial optimisation of the technique 
was carried out using mouse 3T3 fibroblast cells and the fluorescent dye Lucifer 
yellow. This is because these cells are more robust and easy to transfect using 
normal established techniques. Therefore it was sensible to optimise the new 
technique using a cell type which has been shown to be easy to transfect in the 
past as it would be logical to assume that any problems with cell viability and 
transfection frequency would likely be a consequence of the method of 
transfection rather than the cell line being transfected. Lucifer yellow was used 
instead of plasmid DNA in the micropipette as it is fluorescent, therefore 
allowing instant visual confirmation of whether or not the contents of the 
micropipette had been delivered into the cell.
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There were several key features of the technique which needed to be 
investigated in order to find the optimal conditions for single cell electroporation. 
Firstly, a compromise had to be found between the applied voltage that the cell 
could survive and the successful introduction of fluorescent material into the 
cell. Secondly, the impact that the area of the cell membrane that was 
permeabilised had on cell survival and transfer of material into the cell was 
examined using different pipette tip diameters to deliver the electric charge to 
the cell. Different extracellular environments were also examined to see if an 
optimum environment could be established. And finally, different size 
molecules were introduced into the cell to confirm that the pores created in the 
membrane would be large enough for plasmid DNA to pass through.
5.3.4.1 Optimising single cell electroporation voltage
The advantage of using single cell electroporation over normal batch style 
electroporation is not only that the smaller area of the cell membrane is 
permeabalised but also that much lower voltages can be used. Different 
voltages were examined to see which was most efficient at introducing material 
into the cell whilst still maintaining cell viability.
Lucifer yellow was successfully introduced into 3T3 cells electroporated using a 
0.5-1 second train of 50Volt, 1ms, 200Hz square pulses and this did not cause 
immediate cell lysis (figure 5.3.4.1.1) However when cells were checked 
several minutes after the procedure, all cells which had been electroporated 
had necrosed, suggesting that this voltage was too high to maintain cell 
viability.
It was still possible to successfully introduce Lucifer yellow into 3T3 cells which 
were electroporated with 0.5-1 second trains of 10Volt, 1ms, 200Hz square 
pulses (figure 5.3.4.1.2). In order to establish long term cell viability which
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would be necessary should the technique be used for the introduction of foreign 
DNA into the cell the cells were monitored over a 24 hour period. All of the 
cells which had been electroporated had necrosed by the end of the 24 hours. 
The fluorescence levels in the cells was used as an indicator as to how much 
Lucifer yellow had been introduced into the cell and how much remained in the 
cytoplasm over the 24 hour period. The fluorescence levels of the cells that 
had been electroporated decreased exponentially after the procedure. Most 
cells were no longer fluorescent 1 hour after the procedure and all of the cells 
which had been electroporated were no longer fluorescent 3 hours after the 
procedure (figure 5.3.4.1.3). This suggested that the pores formed in the cell 
membrane by the electroporation did not close immediately after the cell had 
been electroporated.
When 3T3 cells were electroporated using just a single pulse of 10Volts it was 
still possible on occasion to successfully introduce Lucifer yellow into the cells.
It was necessary to hold the pipette to the cell for several seconds after the 
pulse had been delivered in order to allow particles to travel from the pipette 
into the cell through the presumably smaller hole in the membrane that was 
created with this technique. This technique was not nearly as reliable at 
introducing material into the cell and a much smaller amount of material was 
introduced with each attempt (figure 5.3.4.1.4).
5.3.4 2 The effect of the membrane permeabilised area on cell viability after 
single cell electroporation.
Pipette tip diameters of 1pm and 0.5pm were used to electroporate cells using 
0.5-1 second trains of 8V, 6V and 4V, 1ms, 200Hz square pulses to investigate 
whether the size of the area of membrane permeabilised had an effect on cell 
viability after electroporation. Lower voltages were used as it had been 
established in section 5.3.4.1 that the lowest voltage possible should be used to 
maintain cell viability.
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When delivering the electric charge through a pipette tip with a diameter of 1pm 
there was no change in cell survival and viability between the three different 
voltages (figure 5.3.4.2.1a). As with previous experiments, there were no cells 
containing visible amounts of Lucifer yellow after 3 hours (figure 5.3.4.2.1c), 
suggesting that even with these lower voltages the pores created were not 
closing immediately after the procedure.
Delivering the electric charge through a pipette tip with a smaller diameter of 
0.5 pm led to an increase in cell survival when compared to previous 
experiments. Some of the cells electroporated using 6V or 8V pulses survived 
until 24 hours after the procedure (figure 5.3.4.2.2a). Cell survival did not show 
any relationship to the voltage used for the electroporation. Great care had to 
be taken with this technique as in order for the electroporation to be successful 
using lower voltages the contact between the cell and the micropipette had to 
be as close as possible. Care must be taken to ensure that the contact is as 
close as possible without puncturing the cell membrane with the micropipette 
and bursting the cell. As with the previous parameters examined, most cells 
were no longer fluorescent after 3 hours. In one experimental run, a single cell 
(8V) was still fluorescent and alive after 24 hours (figure 5.3.4.2.2c). However, 
this cell had significantly less Lucifer yellow fluorescence than it had when it 
was initially electroporated. This had decreased exponentially over the initial 3 
hours post electroporation period but remained constant for the next 21 hours 
(figure 5.3.4.2.2c). This indicates that in this particular cell the pores formed in 
the membrane by the electroporation took 3 hours to close. Once pore closure 
had occurred, the cell was both viable and retained some electroporated 
material.
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5.3.4.3 The effect of different extracellular environments on cell viability after 
single cell electroporation.
As the pores formed in the ceil membrane by the electroporation took several 
hours to close, the components of the extracellular medium can pass into the 
cytoplasm as well as cytoplasmic component ‘leaking’ out into the extracellular 
medium. In order to minimise this and hopefully improve cell survival of the 
procedure the extracellular environment is very important. Ideally the 
extracellular environment would mimic that of the cytoplasm in order to 
minimise the exchange of materials between the cytoplasm and the 
extracellular medium whilst the pores are open. Creating a solution that is 
exactly identical in composition to the cytoplasm is not practical due to the 
number of different molecules all present at different concentrations in the 
cytoplasm, so several different solutions were tried in order to try and find the 
best compromise. The solution that the plasmid or Lucifer yellow is dissolved in 
is also important as this solution is transferred directly into the cell during the 
electroporation.
During nucleofection, a type of batch electroporation, the cells are bathed in a 
special nucleofector solution to maximise transfection frequency and cell 
survival. As this solution was limited in supply the cells were not bathed in the 
solution during the procedure but the Lucifer yellow in the pipette was diluted in 
nucleofector solution V before being introduced into the 3T3 cells by 
electroporation with 0.5-1 second trains of 10Volt, 1ms, 200Hz square pulses. 
Cells were monitored over 24hrs to see how long the cells survived for after the 
procedure and how long it took for the pores formed in the membrane to close. 
All of the cells electroporated died after 24hours. In most cases the 
fluorescence in the cells decreased exponentially indicating that the pores in 
the membrane were still open (figure 5.3.4.3.1). Only one cell still contained 
any visible Lucifer yellow after 1 hour and there was no visible Lucifer yellow in 
this cell after 3 hours (figure 5.3.4.3.1). This suggests that that the inclusion of 
nucleofector solution in the pipette did not increase the speed of pore closure.
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Based on a previous report stating that electroporation was successful when 
cells were bathed in mammalian saline during electroporation and tissue culture 
medium was added after the cells had been electroporated (Rae and Levis, 
2002), it was decided to attempt the single cell electroporation using these 
conditions. The Lucifer yellow in the micropipette was diluted in mammalian 
saline and the cells were bathed in the mammalian saline solution during the 
procedure. Cells were then electroporated with 0.5-1 second trains of 6Volt, 
1ms, 200Hz square pulses. The mammalian saline was then replaced with 
normal tissue culture medium after the cells had been electroporated. No cells 
survived more than 5 hours after the procedure and as with previous 
experiments, fluorescence levels of the cells decreased exponentially 
suggesting it took several hours for the pores in the cell membrane to close 
(figure 5.3.4.3.2).
As an alternative to minimal saline lucifer yellow was diluted in Krebs medium 
and the cells bathed in Krebs during the procedure. The cells were 
electroporated with 0.5-1 second trains of 6Volt, 1ms, 200Hz square pulses. 
This produced similar results to those shown when cells were bathed in 
mammalian saline. No cells survived more than 5 hours after electroporation, 
and fluorescence decreased exponentially indicating the pores in the cell 
membrane remained open for several hours after the procedure (figure 
5.3.4.3.3). Neither of these experiments suggest that saline or Krebs solution is 
a suitable extracellular environment to maximise cell survival during single cell 
electroporation.
5.3.4.4 Introducing different molecules into cells using single cell 
electroporation.
As electroporation did not result in transfer of material from the pipette into the 
cell 100% of the time it would be necessary to include a fluorescent marker as 
well as the plasmid DNA in the micropipette when attempting to introduce DNA
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into the cell to confirm that the electroporation had been successful. As Lucifer 
yellow emits fluorescence at the same wavelength as GFP (which is the 
fluorescent tag on the plasmids intended for use with this technique), it was not 
a suitable marker for use when the plasmid was being introduced into the cells. 
It was decided instead to use cell impermeant fura2 as this emits fluorescence 
at a UV wavelength which is sufficiently different to be distinguished from the 
fluorescence emitted by the GFP. This would allow cells which had been 
electroporated but were not expressing the protein of interest to be 
differentiated from those that were. Fura2 was successfully introduced into 3T3 
cells using a 0.5-1 second train of 10Volts, 1ms, 200Hz square pulses (figure 
5.3.4.4.1). As had been previously observed when introducing material into 
cells using single 10V pulses, the transfer of material from the pipette into the 
cell was improved when the pipette was held to the cell for several seconds 
after the electroporation.
Using the same parameters optimised in 3T3 cells fura2 was introduced into 
differentiated HL60 cells using a 0.5-1 second train of 10Volts, 1ms, 200Hz 
square pulses. However after the initial peak in fluorescence upon 
electroporation the fluorescence levels proceeded to decline in an exponential 
manner after which the cell died (figure 5.3.4.4.2). This again suggests the 
pore formed in the cell membrane during the electroporation procedure is not 
closing immediately afterwards therefore allowing the cytosolic contents of the 
cell to leak out and the surrounding medium to leak in resulting in cell death. 
This was observed using 3T3 cells but the cells survived much longer after the 
procedure than the HL60 cells.
Earlier experiments indicated that using a single pulse as opposed to a train of 
pulses to electroporate the cell resulted in a smaller hole forming in the 
membrane (section 5.3.4.1). It was hypothesised that a smaller hole in the 
membrane would be less damaging to the more sensitive HL60 cell. Fura2 was
151
successfully introduced into differentiated HL60 cells using a single pulse of 
10Volts. However, this was again followed by an exponential decrease in 
fluorescence of the cell once the pipette was removed and the cells died within 
20 minutes of being electroporated (figure 5.3.4.4.3).
When attempting to introduce plasmids into 3T3 cells using single cell 
electroporation Fura2 or fura d ext ran was loaded into the pipette as well as the 
plasmid to act as a marker to make sure that the cells had been successfully 
electroporated. None of the cells that were electroporated were alive 24hours 
later and as a consequence no GFP expression was seen. Fura dextran was 
used as it is a larger molecule and would be a good indicator as to whether the 
pores created in the cell membrane by the electroporation were large enough to 
allow something as large as a plasmid to pass through. It was harder to 
introduce fura dextran into cells as it is a large molecule and tended to 
aggregate when an electric charge was applied and get blocked in the pipette.
It was possible on some occasions to introduce fura dextran into cells so it was 
decided that the pores created by the electroporation were big enough for a 
large molecule such as a plasmid to enter the cell. It was therefore concluded 
that the plasmid was entering the cells but the cells were not surviving the 
procedure.
Separate batches of cells were electroporated with the GFP plasmid and fura2 
and were monitored over 3 hours to see if the expression of the GFP was quick 
and transient before the cells died. Most cells died by 2hrs and no GFP 
expression was observed.
It was concluded that single cell electroporation would not be suitable for 
transfection of myeloid cells as long term survival of cells was poor.
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5.3.5 Lentiviral transfection of human neutrophils
A previous report has stated that it is possible to transiently transfect primary 
human neutrophils using lentiviral mediated transduction (Dick et al., 2009). 
Lentiviral transduction seemed plausible as lentiviruses to not require actively 
dividing cells in order to integrate their DNA into the cells genome and are 
readily able to infect quiescent cells. Dick et al used flow cytometry to analyse 
the transfection frequency after the neutrophils had been transduced with the 
lentivirus. As such a similar protocol was followed in these experiments where 
neutrophils were transduced with a GFP lentivirus for 4 hours before analysis. 
Flow cytometry analysis revealed a higher number of neutrophils to be 
apparently GFP positive as the volume of lentivirus used for transduction was 
increased, (figure 5.3.5.1). However no GFP positive cells could be found when 
the transduced neutrophils were analysed with confocal microscopy.
It has also previously been noted that lentiviral transduction efficiency is higher 
when cells are transduced at lower temperatures (Pearce and Brennan 2010 
unpublished personal communication). Subsequently cells were transduced at 
both 4°C and 37°C both with the 4 hour incubation times as used by Dick et al 
and 24 hour incubation times. Flow cytometry analysis revealed that a higher 
number of neutrophils were apparently GFP positive when cells were 
transduced at 37°C and that the number of cells that were apparently GFP 
positive decreased when the incubation time was increased to 24 hours (figure
5.3.5.2). Again there were no GFP positive cells identified when cells were 
observed using confocal microscopy for any of these conditions.
These results lead to the possibility that the ‘GFP positive’ cells identified by the 
flow cytometry analysis are necrosed cells exhibiting auto fluorescence. This 
would follow as a higher volume of lentivirus used for transduction is likely to 
lead to more cell necrosis. Also neutrophils gradually start to undergo 
apoptosis immediately after they are released into the blood stream. As such
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neutrophils rarely survive for more than 24 hours after they have been isolated 
from fresh blood. This process of apoptosis occurs more quickly at 37°C than it 
does at4°C. This would explain the results seen when the cells were incubated 
at different temperatures.
Dick et al reported donor variation in the transduction efficiency of neutrophils. 
This was also observed with neutrophils from three different healthy volunteers 
which were transduced with GFP lentivirus for 4 hours at 4°C (figure 5.3.5.3). 
This however probably resulted from neutrophils from different donors 
undergoing apoptosis at different rates after they are isolated from the blood.
5.3.6 Lentiviral transfection of myeloid PLB-985 cells
As the lentiviral transduction method was unsuccessful in primary human 
neutrophils, it was tried in myeloid PLB-985 cells instead. Incubation of PLB- 
985 cells with GFP lentivirus for 48 hours produced a cell population where 70- 
90% of the cells were producing GFP (figure 5.3.6.1). The percentage of cells 
producing GFP increased as the volume of lentivirus that they were incubated 
with increased.
These cells became stably transfected with the GFP gene carried by the 
lentivirus. When the cells were differentiated into neutrophil like cells they still 
expressed the GFP protein (figure 5.3.6.2). So loss of the construct during 
differentiation was not a problem with this method of transfection as it had been 
with others (see section 5.3.2). The cells which had been differentiated and still 
expressed GFP were still able to phagocytose zymosan particles (figure
5.3.6.3) showing that the transfection had not impacted upon the neutrophil like 
characteristics of these cells. Phagocytosis was complete within around 1 
minute, a similar time to that taken by primary human neutrophils.
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Differentiated PLB-GFP cells were also able to phagocytose multiple zymosan 
particles further confirming their neutrophil like characteristics (figure 5.3.6.4).
It was concluded that this approach could generate functionally competent 
human phagocytes with sufficient GFP signal to permit physiological 
experiments. This is the method of transfection that will be used for the 
remainder of the project.
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Figure 5.3.2.1: The average transfection frequencies of HL60 cells and NB4 cells when 
transfected with the pm axGFP plasmid using the Amaxa nucleofector device. Neither cell 
line becomes stably transfected, even with antibiotic selection. NB4 cells express GFP at 
higher levels initially and as a result express the protein for slightly longer than the HL60 cells, 
(data representative of <300 cells over 3 separate experiments).
156
Figure 5.3.3.1.1: MyPH8B6 cells expressing calpain1-GFP. MoFlo cell sorting isolated a 
population of cells of which approximately 90% of the population were expressing GFP.
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Figure 5.3.3.1.2: M yPH8B6 cells imaged as they undergo differentiation into mature 
neutrophils. Cells lose GFP expression once they become fully differentiated.
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Figure 5.3.3.2.1: Expression of calpain1-G FP in hum an um bilical cord blood derived 
CD34+ myeloid stem  cells at different tim e points after transfection, a) GFP expression in 
CD34+ cells on day 1 after transduction with the calpain1-GFP retrovirus, b) GFP expression in 
CD34+ cells after 23 days differentiation.
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Figure 5.3.3.2.2: CD34+ control cells and C D34+ cells transduced with calpain1-GFP  
retrovirus after 23 days differentiation. Cells were cytospun and stained with wright-giemsa 
stain. There is no difference in nuclear morphology between the control cells and the calpain l- 
GFP transduced cells.
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Figure 5.3.3.2.3: Flow cytom etry analysis o f C D34+ control cells and CD34+ cells 
transduced with calpain-GFP retrovirus after 21 days o f differentiation, a) Approximately 
11% of calpain1-GFP transduced cells were expressing GFP after 21 days differentiation, b) 
Analysis if side scatter showed that less than 1% of the population were granular enough that 
they could potentially be neutrophils and were also in the group that were still expressing GFP.
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Figure 5.3.4.1.1: An exam ple o f luc ife r ye llo w  being in troduced into 3T3 cells by single 
ce ll e lectropora tion  using a 0.5-1 second tra in  o f 50V, 1ms 200Hz square pulses (n=5).
Within 0.77 seconds the Lucifer yellow had been introduced into the cell. The cell was still 
glowing 13 seconds later.
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Figure 5.3.4.1.2: An exam ple o f 3T3 ce lls e lectroporated w ith  0.5-1 second trains o f 1ms 
long square pulses at 10V and 200Hz (n=8). Multiple cells were easily electroporated in a 
short space of time.
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Figure 5.3.4.1.3: Lucifer yellow introduced into 3T3 cells using electroporation by 0.5-1 
second trains of 10V, 1ms, 200Hz pulses (n-8). a) Fluorescence of the cells decreased 
exponentially after electroporation. Most cells were dead within 1 hour, no cells survived longer 
than 3 hours. Each line represents a single cell electroporated, b) An example of one of the 
cells shown in the graph (indicated by the bold red line in (a)) showing fluorescence at 0, 1 and 
3 hours post electroporation.
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Figure 5.3.4.1.4: 3T3 cells electroporated using single 10V pulses. In the few cases (n=3) 
where it was possible to introduce Lucifer yellow into the cells using this method much less 
material was introduced than when using trains of pulses and it was necessary to hold the 
pipette to the cell for some time after electroporation to allow particles to travel from the pipette 
into the cell.
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Figure 5.3.4.2.1: Lucifer yellow  introduced into 3T3 cells using a larger (-1  pm) pipette tip 
diam eter and 0.5-1 second trains of 8V, 6V o r 4V, 1ms, 200Hz pulses (n-7). a) Cell viability 
scored from 1-5 with 1 being ‘cell has died and detached from coverslip’ through to 5 being a 
healthy cell’. No overall difference in cell viability was observed between the voltages tested, 
b) Shows an example of a cell electroporated with 6V trains of pulses, illustrating how the 
fluorescence of the cell decreased and the cell necrosed over time after the procedure, c) 
Fluorescence intensity of cells electroporated. Lucifer yellow was successfully introduced into 
the cells but the fluorescent intensity decreased exponentially after electroporation.
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Figure 5.3.4.2.2: Lucifer yellow introduced into 3T3 cells using a sm aller (~0.5pm) pipette 
tip diam eter and 0.5-1 second trains o f 8V, 6V or 4V, 1ms, 200Hz pulses (77=8). a) Cell 
viability scored from 1-5 with 1 being ‘cell has died and detached from coverslip’ through to 5 
being a healthy cell’. Two of the cells electroporated survived the procedure for 24 hours. This 
however showed no relationship to the voltage used to electroporate them, b) Shows an 
example of a cell electroporated with 8V trains of pulses, illustrating how the fluorescence of the 
cell decreased for the first 3 hours after the procedure before remaining constant, c) 
Fluorescence intensity of cells electroporated. Lucifer yellow was successfully introduced into 
the cells. The fluorescent intensity decreased exponentially after electroporation with all cells 
apart from one showing no fluorescence after 5 hours.
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Figure 5.3.4.3.1: Lucifer yellow  introduced into 3T3 cells along with nucleofector solution 
V using electroporation by 0.5-1 second trains o f 10V, 1ms, 200Hz pulses (n=8). a) 
Fluorescence of the cells decreased exponentially after electroporation. Most cells were dead 
within 1 hour, no cells survived longer than 3 hours, b) An example of one of the cells shown in 
the graph (indicated by the bold red line in (a)) showing fluorescence at 0, 1 and 3 hours post 
electroporation.
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Figure 5.3.4.3.2: Lucifer yellow  (diluted in m am m alian saline) introduced into 3T3 cells 
(bathed in m am m alian saline) using 0.5-1 second trains of 6V, 1ms, 200Hz pulses (n-5).
a) In most cases fluorescence decreased exponentially after the procedure. The one cell that 
was the exception to this was no longer fluorescent after 5 hours, b) An example of one of the 
cells shown in the graph (indicated by the bold red line in (a)) showing fluorescence at 0, 1 and 
3 hours post electroporation.
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Figure 5.3.4.3.3: Lucifer yellow  (diluted in Krebs buffer) introduced into 3T3 cells (bathed 
in Krebs buffer) using 0.5-1 second trains of 6V, 1ms, 200Hz pulses (r>=5). a) In most 
cases fluorescence decreased exponentially after the procedure. The one cell that was the 
exception to this was no longer fluorescent after 5 hours, b) An example of one of the cells 
shown in the graph (indicated by the bold red line in (a)) showing fluorescence at 0, 1 and 3 
hours post electroporation.
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Figure 5.3.4.4.1: An example of cell im perm eant fura2 introduced in a 3T3 cell using 
single cell electroporation using 0.5-1 second train o f 10V, 1ms, 200Hz pulses (n=6). 
Fura2 was successfully introduced into the cell. Transfer of material from the pipette into the 
cell was improved if the pipette was held to the cell for several seconds after electroporation.
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Figure 5.3.4.4.2: Cell im perm eant fura 2 introduced into differentiated PLB-985 cells 
using single cell electroporation with a 0.5-1 second train of 20V, 1ms, 200Hz pulses. The
pulse was applied at t=15 seconds, a) Fluorescence decreased in an exponential manner 
immediately after the electroporation followed by cell death.
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Figure 5.3.4.4.6: Cell im perm eant fura2 introduced into differentiated PLB-985 cells 
using a single pulse of 10V. The pulse was applied at t=28 seconds. Fluorescence 
decreased exponentially after the pipette was removed.
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Figure 5.3.5.1: % of neutrophils apparently GFP positive after lentiviral transduction  
when analysed with flow  cytom etry. % neutrophils which are apparently GFP positive 
increases when cells are treated with increasing volumes of GFP virus.
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Figure 5.3.5.2: % of neutrophils apparently GFP positive after lentiviral transduction at 
different tem peratures when analysed with flow  cytom etry. Cells were incubated with 
200pl virus for 4 or 24hr at 4°C or 37°C. The % of neutrophils which are apparently GFP 
positive increases when the cells are incubated with virus at 37°C rather than 4°C. Incubation 
with the virus for 24hrs leads to a decrease in cells which are GFP positive.
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Figure 5.3.5.3: Donor variation in apparent levels of GFP expression in neutrophils as
reported by Dick et al. Neutrophils were isolated from three healthy volunteers and transduced 
with GFP lentivirus for 4 hours at 4°C. Apparent levels of GFP expression when analysed by 
flow cytometry after 4 hours varied by individual.
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Figure 5.3.6.1: GFP expression in PLB-985 cells transduced with GFP lentivirus. PLB-985 
cells were transduced with GFP virus for 48hrs at 37°C. Cells were transduced with either 50pl 
or 200pl GFP virus, (a&b) Over 90% of the cells transduced with 200pl virus were expressing 
GFP after 48hrs. (c) Cells were still expressing GFP 5 days post transfection. It was concluded 
that the cells may be stably transfected.
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PLB-985-GFP cells (200pl PLB-985-GFP cells (50|jl
virus) differentiated in virus) differentiated in
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Figure 5.3.6.2: GFP expression in PLB-985 cells 9 days a fte r transfection . PLB-985-GFP 
cells differentiated in 1.3% DMSO for 9 days. Cells are still expressing GFP after differentiation 
and display characteristics of successful differentiation (i.e. adhesion to glass, irregular 
morphology and extended membrane processes, multilobed nuclei, phagocytosis)
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Figure 5.3.6.3: An exam ple o f a GFP transduced PLB-985 cell phagocytosing an 
opsonised zym osan partic le  a fter 5 days d iffe ren tia tion  in 1.3% DMSO (n<3). HL60 cells 
which had been transduced with GFP were grown in culture for 2 weeks prior to differentiation 
for 5 days in 1.3% DMSO. After 5 days differentiation cells were able to phagocytose serum 
opsonised zymosan particles. This particular example took 1 minute 4 seconds to completely 
engulf the particle.
F igure 5.3.6.4: GFP transduced HL60 cell w hich had phagocytosed at least 4 opsonised 
zym osan partic les after 5 days d iffe ren tia tion  in 1.3% DMSO. HL60 cells which had been 
transduced with GFP virus were grown in culture for 2 weeks before being differentiated for 5 
days in 1.3% DMSO. After 5 days differentiation cells were incubated with opsonised zymosan 
particles for 30 minutes. After 30 minutes most cells had taken up one or more zymosan 
particles. This cell is an example of a cell which had taken up 4 zymosan particles.
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5.4 Discussion
The work in this chapter has established the unsuitability of a number of 
widely-used methods for transfecting neutrophils and myeloid cells. This is 
because (i) terminally differentiated cells have few recovery mechanisms and 
the “insult” of transfection results in their death by necrosis or apoptosis and (ii) 
both mature human neutrophils and functionally competent phagocytes 
terminally differentiated from cell lines synthesis very little protein. It was 
necessary to develop a methodology which gave a highly efficient transfection 
of the growing precursor cells (cell line) such that sufficient expressed protein 
remained when protein synthesis was shut-down during terminal differentiation.
5.4.1 Transfection of myeloid cell lines using nudeofection
The work presented in this chapter showed that although undifferentiated HL60 
and NB4 cells were more easily transfected than differentiated or partially 
differentiated cells, the expression of the protein was very transient. It was not 
possible to achieve stable transfection of these cells, but it was possible to 
transfect NB4 cells that had been partially differentiated. Although these cells 
retained the protein when fully mature, they did not display any neutrophil-like 
characteristics such as phagocytosis or a cytosolic calcium signal in response 
to fMLP. They therefore, were not suitable to use in this project.
Another myeloid cell line, HL60s expressed transfected protein after 
differentiation but this was too transient to be able to reliably produce cells that 
were both differentiated and had the protein. When differentiated though these 
cells display many neutrophil-like characteristics (Mollinedo et al., 2008). It is 
possible that HL60 cells were more difficult to transfect than the NB4 cell line as 
they were slightly further along the maturation pathway towards neutrophils 
when they were immortalised and as such their potential for producing new 
proteins is decreased when compared to that of NB4 cells. This may also be
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why when differentiated, the HL60 cell line displays many more neutrophil like 
characteristics than the NB4 cell line.
It has not been possible to successfully transfect mature neutrophils by 
nudeofection despite previous reports claiming that the technique works 
(Johnson et al., 2006). This is probably because neutrophils are terminally 
differentiated cells which are no longer undergoing cell division or producing 
significant amounts of new protein and these are essential features needed if a 
cell is to be successfully transfected. These same problems apply when trying 
to transfect mature (differentiated) HL60 cells.
5.4.2 Retroviral transduction of mouse myeloid progenitor cells and 
human cord blood derived stem cells
Retroviral transfection was investigated as a more promising method of 
achieving a more stable level of transfection in neutrophil like cells.
The MyPH8B6 cell line is a mouse myeloid progenitor cell line isolated and 
immortalised from mouse bone marrow (McDonald et al.). These cells can be 
cultured in an immortalised state in the presence of oestrogen or can be 
differentiated into neutrophils when cultured in the presence of G-CSF. CD34+ 
myeloid progenitors are isolated from human cord blood samples. These are 
human myeloid progenitor cells which can be differentiated in the presence of 
IL-3, G-CSF and SCF over 21-24 days. These cells differentiate into all types 
of myeloid cells including neutrophils, although some reports state that 
neutrophils produced in this manner are not fully functional (Dick et al., 2008).
It was possible to stably transfect both of the above mentioned cell types with 
the pMX-Mu-calpain-EGFP retroviral vector before the cells were differentiated. 
However the expression of the protein decreased as the cells differentiated.
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This decrease in expression was also observed when the MyPH8B6 cells were 
transfected with another construct, dectin 1 (McDonald et al.).
The decrease in the expression of the gene as the cells differentiate is likely to 
be dependent upon where in the genome the gene is integrated when the cell is 
infected with the retrovirus. Many genes are ‘switched off during the 
differentiation process and if the calpain-GFP construct was integrated into one 
of these genes then expression of calpain-GFP would also be decreased as the 
cells differentiate. The calpain-GFP protein which has already been produced 
by the cell before it started to differentiate would still be free in the cytoplasm, 
The amount of active protein remaining would depend on the life-time of the 
protein in the cytosol as it is degraded after differentiation. Although stability of 
calpain-GFP in the cytosol is not known, this effect would account for the 
decrease in fluorescence seen during the differentiation process.
5.4.3 Single cell electroporation
Single cell electroporation has been reported to be successful in a number of 
different cell types (Haas et al., 2001, Rae and Levis, 2002). However, the 
work here shows that it is only successful under very specific parameters. Cells 
were sensitive to the voltage applied, the diameter of the pipette tip and the 
extracellular environment. Although the transfer of material into the cells was 
very successful, the long term viability of the cells after the procedure was 
always a problem. Instead of closing the electroporation pores immediately 
after the electric current had stopped and the pipette was the removed, the 
pores remained open for a number of hours. This inevitably led to cell death.
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5.4.4 Lentiviral transduction of human neutrophils
It has been previously reported that it was possible to transfect neutrophils 
using the lentiviral method of transfection (Dick et al., 2009). This study used 
flow cytometry to determine the levels of transfection. When samples of 
neutrophils which had been transduced with GFP lentivirus were analysed 
using flow cytometry it did appear that they had increased levels of GFP 
expression. However, when these same samples were imaged using the 
CLSM no GFP expressing cells were found. Some of the cells which were 
dead or necrosed exhibited some auto fluorescence though. The increase in 
GFP positive cells found by the flow cytometer when cells were incubated with 
increased amounts of virus could simply be due to increasing numbers of dead 
cells which are auto-fluorescent. The same explanation can be applied to 
explain the increase in GFP positive cells found when cells were incubated at 
37°C as opposed to 4°C as it is known that once out of the body, neutrophils 
undergo spontaneous apoptosis when incubated without the G-CSF or GM- 
CSF (Simon, 2003). As this is a biological process it naturally occurs faster at 
37°C than it does at 4°C. It is unlikely that this is a method that can be applied 
to mature neutrophils as they lack the characteristics that are necessary for a 
successful transfection as discussed in sections 5.1.3 and 5.4.1.
5.4.5 Lentiviral transduction of myeloid PLB-985 cells
Although lentivirus as a method of transfection was unsuccessful for mature 
neutrophils, the technique was more successful when used to transduce 
undifferentiated PLB-985 cells. A PLB-985 cell line stably expressing GFP was 
generated using this technique and sufficient GFP was retained by the cells 
after they were full differentiated. There was no decrease in GFP levels during 
differentiation as had been observed when CD34+ cells or MyPH8B6 cells were 
transfected with the retrovirus. This may be due to the integration site of the 
gene in the host cells genome as discussed in section 5.4.4 in relation to 
retroviruses; or it could be that GFP is more stable in the cytoplasm as the cells
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differentiate than is the calpain-GFP expressed in CD34+ cells and MyPH8B6 
cells. The ability of lentiviruses to transfect cells which are not dividing may 
have meant that the efficiency of the transduction before the cells were 
differentiated was higher than that achieved with the retrovirus and as such the 
effect of the decrease in expression of the gene as the cells differentiate was 
minimised. The decrease in expression during differentiation may become 
more evident when a larger gene is transduced into the cells. However this 
technique was found to be the most efficient and reliable of all of those that 
were investigated and is the main technique which will be used to express 
fluorescently tagged proteins in PLB-985 cells for the future of this project.
5.4.6 Overall discussion
Achieving a level of transfection in myeloid cell lines which is stable enough that 
the protein of interest is still expressed when the cells are fully matured into 
neutrophil like cells is a hard task, and this has only rarely been reported. There 
are just two stably transfected HL60 cell lines generated, one expressing Akt- 
GFP (Servant et al., 2000) and the other p67-phox-GFP (van Bruggen et al., 
2004). In addition to this, some success has been reported in transiently 
expressing proteins in HL60s. HL60s which have been transiently transfected 
have been reported by Lacelle et al (Lacalle et al., 2007) and Huttenlocher 
(Nuzzi et al., 2007). Despite these few successes, these cells are notoriously 
difficult to transfect and are rarely used in such studies. However, this 
technique is essential for the success of this project, as it is not possible to 
transfect mature neutrophils. It is essential to find an amenable and most 
appropriate model to investigate the importance of calpain in neutrophil 
spreading. After investigating several techniques, it was decided that the best 
way to achieve this was through lentiviral transduction of undifferentiated PLB- 
985 cells. This was the only method which achieved levels of transfection 
stable enough that the protein was still being expressed by the cells after they 
were fully differentiated. The reasons for this have been discussed in the 
previous sections. Nucleoporation, a modified form of traditional
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electroporation, did not result in stable or high levels of transfection. Retroviral 
transfection of human cord blood stem cells and an immortalised mouse 
neutrophil cell line resulted in a higher level of transfection. However as this 
was not stable, by the time the cells were fully differentiated and functionally 
mature, the levels of protein retained in the cytoplasm were too low to be 
useful. Single cell electroporation proved to be a reliable way of introducing 
foreign material into cells but long term survival of the cells using this technique 
was never achieved. Although this technique may not be appropriate for the 
introduction of genetic material into cells it may still serve a function for more 
short term studies. Despite a report that lentiviral mediated transduction of 
neutrophils is possible (Dick et al., 2009), it was not possible to repeat this 
success. As such lentiviral mediated transduction of undifferentiated PLB-985 
cells will be the technique used to express fluorescently tagged proteins in 
neutrophil like cells for the remainder of this project
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CHAPTER 6
Expression of fluorescently tagged calpain in
PLB-985 cells
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6.1 Introduction
The lentiviral method established in the last chapter was shown to be a 
successful technique for expressing protein in PLB-985 cells. A stably 
expressing PLB-985-GFP cell line was generated using this technique and 
sufficient GFP was retained by the cells after they were full differentiated.
In this chapter, the outcome of adopting this approach will be presented.
6.1.1 PLB-985 cells
PLB-985 cells are a human myeloid leukaemia cell line, grown in suspension 
which can be differentiated into neutrophil like cells. PLB-985 cells are from the 
same source and are genetically identical to the more commonly termed HL60 
cell line (Drexler et al., 2003). They are thought to have arisen through cross 
contamination during the establishment of the HL60 cell line. They can be 
differentiated into neutrophil like cells by incubation in 1.3% DMSO as has been 
described for the HL60 cell line (Collins et al., 1978, Jacob et al., 2002, 
Mollinedo et al., 2008). When in their undifferentiated state it is possible to 
transiently transfect PLB-985 cells. This cannot be achieved in neutrophils. 
These two features are the two most important features of this cell line for this 
study as if a stable transfection can be achieved and then the cells 
differentiated then they provide an ideal model for observing that potential 
effects of genetic manipulation on neutrophils.
6.1.2 Lentiviral transfection
As established in the previous chapter transfection of the PLB-985 cell line 
using lentiviral transduction is the only reliable technique to achieve stable 
levels of transfection in this cell line. This is achieved by exploiting the 
lentiviruses natural ability to integrate its own DNA into the host cells genome in
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quiescent, non rapidly dividing cells. The full molecular basis of retroviral and 
lentiviral transduction have been discussed in detail in the previous chapter.
6.1.3 Aims of the chapter
The aim of this chapter is to use the lentiviral approach to express calpain 
constructs in PLB-985 cells.
The objectives are:
• To construct GFP tagged calpain 1, calpain 4 and calpain 
1 (domain III)
• To clone GFP tagged calpain 1, calpain 4 and calpain 1 (domain 
III) into separate lentiviral expression vectors
• To produce 3 different lentiviruses expressing GFP tagged 
calpain 1, calpain 4 and calpain 1 (domain III) respectively.
• To produce 3 PLB-985 cell lines stably expressing GFP tagged 
calpain 1, calpain 4 and calpain 1 (domain III)
These aims will be achieved using a range of standard molecular biological and 
transfection techniques to produce the GFP tagged calpain, lentiviral 
expression vectors and the final lentivirus. The 3 lentiviruses produced will then 
be used to transduce PLB-985 cells with the aim of achieving a stable 
transfection.
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6.2 Materials and Methods
6.2.1 Generation of calpain plasmids
6.2.1.1 Cell line screen for calpain 1 and calpain 4 expression
40 different cell lines and tissues were screened for calpain 1 and calpain 4 
expression using CAPN1/C2F1, CAPN1/C2R1, Calp1R1 and Calp4R1 primers. 
P Actin was used as a control. The general PCR program was followed (figure 
6.2.1.1.1), altering the annealing temperature depending on the primers used.
6.2.1.2 RNA isolation from white blood cells
White blood cells were isolated from the blood of healthy volunteers as 
explained in section 2.4.1. The cells were lysed by repeated pipetting in 1ml 
TRI reagent, followed by 5 minute incubation at room temperature. 200pl 
chloroform was added and the cells were vortexed for 15 seconds before being 
incubated for a further 5 minutes at room temperature. The sample was 
centrifuged at 12000g for 15 minutes at 4°C. After centrifugation the top phase 
of the liquid contains the RNA. This top phase was transferred to a fresh 
eppendorf tube. 500pl isopropanol was added to precipitate the RNA, this was 
incubated for 10 minutes at room temperature, before being centrifuged at 
12000g for 10 minutes at 4°C. The RNA was then found in the pellet at the 
bottom of the tube. The supernatant was removed and the pellet was washed 
in 1ml 75% ethanol and vortexed. The pellet was centrifuged for a further 15 
minutes at 7500g at 4°C. The pellet was air dried at 55°C before being re­
suspended in 50pl pre-warmed DEPC water. RNA concentration was then 
quantified using a spectrophotometer.
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6.2.1.3 Generation of white blood cell cDNA
White blood cell cDNA was generated by reverse transcription PCR from the 
white blood cell RNA using the Precision qScript™ reverse transcription kit 
according to the manufacturer’s protocol. cDNA was diluted 1:3 in H20.
Quality checking of cDNA was performed using PCR for p actin and calpain 
expression was checked using CAPN1/C2F1, CAPN1/C2R1, Calp4F1 and 
Calp4R1 primers
6.2.1.4 TOPO cloning (for generation of GFP tagged calpain)
Calpain 1 and calpain 1 domain III were amplified from white blood cell cDNA 
using Invitrogen™ Platinum® Taq DNA polymerase high fidelity according to 
the manufacturer’s instructions. Calpain 4 was amplified from HECV cDNA 
using the same technique. PCR products were then cloned into Invitrogen™ 
Vivid Colors™ pcDNA™ 6.2 EmGFP/TOPO mammalian expression vectors 
according to the manufacturers protocol. TOPO cloning takes advantage of the 
terminal transferase activity if Taq polymerase which adds a single 
deoxyadenosine to the 3’ end of PCR products. The TOPO vector is supplied 
in a linearised format with a single overhanging 3’ deoxythymidine and 
topoisomerase covalently bound to the vector. The topoisomerase cleaves the 
phosphodiester backbone of the overhanging 3’ deoxythymidine of the vector 
which covalently links the deoxyadenosine from the PCR product to the 
deoxythymadine from the vector. This allows for efficient cloning without the 
need for creating restriction sites on PCR products.
Plasmids were transformed into Invitrogen oneshot® top10 E.coli cells 
according to the manufacturers protocol. Briefly, plasmid is transformed into 
chemically competent E.coli (OneShot® TOP10 cells) by adding the plasmid 
the cells and then incubating the cells on ice and then heat shocking to 
permeabalise the cell membrane to allow the plasmid to enter. Nutrient rich
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SOC medium is added to increase the efficiency of the transformation. Bacteria 
were then spread onto Ampicillin selective LB agar plates at different 
concentrations in order to grow one plate containing evenly spaced colonies. 
Plates were incubated overnight at 37°C.
The following day 10 colonies were chosen at random and were checked for 
the presence and orientation of the insert by PCR with T7 forward primer and 
an insert specific reverse primer. A ~90bp product was observed when the 
insert was present in the wrong orientation and a larger product was observed 
when the insert was present in the correct orientation. No product at all was 
observed when there was no insert present. Colonies which contained the 
insert in the correct orientation were inoculated into LB medium containing 
100ug/ml Ampicillin and were grown overnight at 37°C whilst shaken at 
200rpm. Plasmids were then transformed into TOP10 E.coli and amplified as 
described in section 2.4.
6.2.1.5 In-Fusion Advantage PCR cloning (for generation of lentiviral plasmids)
Calpain 1-GFP, calpain 4-GFP and calpain 1 domain lll-GFP were amplified 
from their TOPO vectors using Phusion™ Hot Start High Fidelity DNA 
Polymerase (New England Biolabs) according to the manufacturer’s protocol 
using primers with 15bp extensions which are homologous to the ends of the 
linearised vector. The amplified PCR products are then cloned into the 
linearised Lenti-SxW vector by homologous recombination with the linearised 
vector using the In-Fusion Advantage PCR cloning kit (Clontech) according to 
the manufacturer’s instructions. Plasmids were then transformed into TOP10 
E.coli and amplified as described in section 2.4.
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6.2.1.6 Plasmid Sequencing
All plasmids for which there were known primer sites before, after or within the 
insert were sequenced. The resulting sequences were then entered into a 
BLAST search to confirm that the plasmids contained the correct insert.
6.2.2 Generation of lentivirus
293T packaging cells were prepared by seeding into a T175 tissue culture 
flasks and incubating at 37°C overnight so that the cells are sub confluent by 
the morning of transformation. Cells were transformed using Effectene 
transfection reagent (Qiagen). Briefly, 2pg of plasmid of interest (CAPN1, 
CAPND3 or CAPNS1-GFP Lenti plasmids), 1.5pg P8.91 plasmid and 1pg 
pMD2G plasmid were mixed with buffer EC to a final volume of 600pl.
Plasmids P8.91 and PMD2G encode the viral DNA and the DNA for the viral 
envelope. These are transduced on separate plasmids to minimise the chance 
of recombination occurring and wild type virus being produced. 32 pi of 
enhancer was added to the plasmid-buffer mixture and the solution was 
vortexed then incubated at room temperature for 5 minutes. 120 pi effectene 
reagent was then added to this and the solution was vortexed again and then 
incubated at room temperature until a precipitate formed. During this time the 
medium on the cells is replaced with fresh complete medium. 5ml complete 
medium is then added to the transfection complexes and mixed before adding 
the transfection complexes to the cells. The cells were then incubated at 37°C 
for 48hours.
After 48 hours the medium from the cells was harvested and centrifuged at 
1500rpm for 10 minutes to remove any debris. The harvested medium was 
then ultracentrifuged at 26000rpm for 4 hours. The supernatant was removed 
and the pellet of lentivirus was re-suspended in 300 pi medium. Virus was 
frozen at -80°C for long term storage.
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6.2.3 Transduction of PLB-985 cells
PLB-985 cells were transduced with GFP tagged calpain construct by 
incubating 2x106 cells with 200pl purified viral supernatant for 48 hours. After 
48 hours cells were spun out of the viral supernatant and the culture medium 
was replaced with fresh medium and cells were allowed to recover.
6.2.4 Protein expression analysis
Protein expression in transduced cells was analysed by confocal microscopy 
and western blotting
6.2.4.1 Western blotting
Approximately 5x106 cells per sample were spun down and re-suspended in 
2ml neutrophil lysis buffer with an additional 2pl protease inhibitor. Samples 
were incubated on ice for 1 hr, vortexing every 15 minutes. Samples were 
boiled for 10 minutes before being centrifuged at 14000rpm for 5 minutes. The 
pellet was discarded and the supernatant was retained. Sample buffer and 
reducing agent were added to the sample before the sample was run for 1 hr at 
150V, 55mA on a TRIS acetate 3-11 % gel.
Following electrophoresis the protein in the gel was transferred to a membrane 
by western blotting for 1 hr at 30V, 200mA in a buffer-tank blotting apparatus.
Non specific binding was blocked by washing the membrane in milk solution. 
The membrane was washed in 10% milk with tween for 1 hour before being 
incubated overnight at 4°C. The following day the membrane was washed for a 
further 1 hour in 10% milk with tween before 3x10  minute washes in 3% milk 
with tween. A 1 in 5000 dilution of anti-GFP-HRP antibody in 3% milk with
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tween was incubated with the membrane for 1 hour at room temperature. 
Unbound antibody was removed by 3 x 10 minute washes in TBS with tween 
followed by 2 x 10 minute washes in TBS only. For exposure 2ml exposure 
reagent A and 2ml exposure reagent B was added to the membrane for 
2minutes before the membrane was exposed for 1, 5, 7 and 12 minutes 
respectively.
6.2.5 Cytosolic calcium elevation experiments
Pharmacologically stimulated cytosolic calcium increase was achieved by 
treating the cells with a cocktail containing 10pM ionophore, 5pM thapsigargin 
13mM CaCI2 as described in section 2.9. Physiologically stimulated cytosolic 
calcium influx was achieved by treating the cells with formylated peptide 
(fMLP). Cytosolic calcium concentration was monitored using fura red calcium 
indicator as described in section 2.8. All experiments were imaged using a 
Leica SP2 confocal microscope.
190
94°C
5min
Initial
denatu ration
94°C
1min
Denatu ration
35 Cycles
Annealing
55°C
72°C
1min
72°C
7min
Extension
1min
Final 
extension
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6.3 Results
6.3.1 Generation of white blood cell cDNA
In order to establish a source of calpain 1 and calpain 4 (calpain small subunit 
CAPNS1) several different cell lines and tissues were screened for Calpain 1 
and Calpain 4 expression. Calpain 1 and Calpain 4 were expressed in a 
number of cell lines at different levels (figure 6.3.1.1). Interestingly, HL60 cells 
had detectable mRNA for calpain 1 but no detectable small sub unit and 
leukocytes (WBC) had very little detectable small sub-unit compared to calpain- 
1. White blood cell cDNA was successfully generated as described in section
6.2.1.3 (figure 6.3.1.1)
6.3.2 Generation of plasmids containing GFP tagged calpain
Calpain 1, calpain 4 (small subunit) and domain III from calpain 1 were 
successfully amplified from white blood cell cDNA (figure 6.3.2.1). Different 
PCR conditions and primer combinations yielded different results so the 
conditions which produced the highest yield and most specific generation of 
product were used for the generation of GFP tagged calpain. In order to 
generate GFP tagged calpain 1, calpain 4 and calpain 1 domain III the PCR 
fragments generated from the WBC cDNA were cloned into Invitrogen™ Vivid 
Colors™ pcDNA™ 6.2 EmGFP/TOPO mammalian expression vectors as 
described in section 6.2.1.4. As these vectors already contain GFP, this 
generated GFP tagged calpain. 3 plasmids were successfully generated using 
this strategy:
• CAPN1-GFP TOPO (GFP tagged calpain 1)
• CAPND3-GFP TOPO (GFP tagged domain III (C2 like domain) 
from calpain 1)
• CAPNS1-GFP TOPO (GFP tagged calpain 4)
Sequencing with T7 forward primers (described in Appendix IV) which bind the 
TOPO plasmid just before the insert site so that that plasmid is sequenced
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forward from there confirmed the presence of the correct insert in the plasmids 
(See appendix VI)
6.3.3 Generation of lentivirus plasmids containing GFP tagged calpain
CAPN1-GFP, CAPND3-GFP and CAPNS1-GFP were successfully amplified 
from their respective plasmids as described in section 6.2.1.5 (figure 6.3.3.1). 
The amplified calpain-GFP fragments were successfully cloned into LentiSxW 
vectors as described in section 6.2.1.5. This was confirmed by plasmid 
sequencing (See appendix 9-17). Plasmids were sequenced with LentiSxW 
Forward and LentiSxW Reverse primers (described in section 2.1.4). These 
primers bound upstream and downstream of the CAPN-GFP insert and allowed 
for sequencing from both ends of the insert to confirm the presence of the 
CAPN and the GFP tag. The sequencing reaction can only reliably sequence 
~500bp, therefore in the case of the CAPN1-GFP insert which was greater than 
1000bp in length the plasmid was also sequenced with CAPN1/C2 forward and 
CAPN1/C2 reverse primers (described in section 2.1.4) which bind in the 
middle of the CAPN1 sequence. Overlapping of these sequences with the 
sequences from reactions with the LentiSxW primers allowed for sequencing of 
the entire insert.
6.3.4 Transduction of PLB-985 cells
PLB-985 cells were successfully transduced with CAPN 1-GFP and CAPNS1- 
GFP with nearly all cells expressing some level of GFP 48 hours post 
transfection, detected by CLSM (figure 6.3.4.1). This level of GFP expression 
was maintained over several weeks and cells were considered to be stably 
transfected (figure 6.3.4.2). The distribution of GFP signal within PLB-985 was 
global for CAPNS1-GFP but CAPN 1-GFP was excluded from the nucleus 
(figures 6.3.4.1 and 6.3.4.2).
193
In the case of the CAPN1D3-GFP lentivirus, 48hrs post transfected, cells were 
expressing low levels of GFP, visualised by CLSM (figure 6.3.4.3). However 
over expression of CAPN1D3 caused cell death and 1 week post transfection 
all cells were dead. The transduction was repeated on 3 separate occasions 
with 2 separate batches of lentivirus. In all transfections, the cells died within 1 
week.
6.3.5 Analysis of protein expression of PLB-985 celis after transduction
In order to establish whether the stably expressed protein was the desired 
construct, protein was extracted and analysed by Western blotting using an 
anti-GFP antibody. Disappointingly, PLB-CAPN1GFP cells were only 
expressing GFP alone and although there was calpain4-GFP present in the 
PLB-CAPNS1GFP cells there was also free GFP expressed (figure 6.3.5.1).
6.3.6 Calpain 4 -  GFP activity in response to elevated cytosolic calcium
As it had been established that some GFP tagged calpain 4 was present in the 
PLB-CAPNS1GFP cell line its ability to translocate in response to elevated 
calcium was analysed. GFP tagged calpain 4 did not translocate in response to 
elevated cytosolic calcium whether stimulated with fMLP or pharmacologically 
(figure 6.3.6.1)
194
/ / / / / / ^
^  A *
f e o ^ v 4 $ * 4 - ^
J *  J >#  Jp
in  I I  12 13 14 15 16 17 IX 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
CAPN1 mid seq 
325bp
CAPNS1 mid seq 404bp 
I Beta actin 588bp
Figure 6.3.1.1: Cell line screen for calpain 1 and calpain 4 expression. A variety of cells lines were screened for calpain 1 and calpain 4 
expression. HL60 cells had detectable levels of calpain 1 expression (top panel) but no detectable calpain 4 expression (middle panel) and white blood 
cells (WBC) had high levels of calpain 1 expression but lower levels of calpain 4 expression
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588bp 
404bp 
325bp
Figure 6.3.2.1: w hite blood cell cDNA quality check and calpain expression check. The
ubiquitously expressed p actin gene was amplified by PCR to check the quality of the white 
blood cell cDNA (p actin band size ~588bp). A small portion of calpain 1 and calpain 4 were 
amplified by PCR to confirm expression of the genes of interest in the white blood cell cDNA 
(calpain 4 band size ~404bp, calpain 1 band size ~325bp). Primers used are described in 
appendix IV.
2145bp.
Figure 6.3.3.1: Calpain 1, calpain 4 and calpain 1 dom ain III (C2) amplified from  WBC  
cDNA. The genes of interest, CAPN1 ((calpain 1) ~2145bp), CAPN1D3 ((‘C2 like’ domain) 
~516bp) and CAPNS1 ((calpain 4) ~807bp) were amplified from white blood cell cDNA ready to 
be cloned into the TOPO GFP plasmid. The primers that were used to amplify the plasmids are 
indicated in the figure labels and can be found in appendix IV.
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Figure 6.3.4.1: C alpain1-G FP, calpainD3-G FP and calpain4-G FP am plified from TOPO  
plasmids. GFP tagged calpain 1, calpainD3 and calpain 4 were amplified from the TOPO 
plasmids so that the gene of interest, already tagged with GFP could be cloned into the Lenti 
SxW plasmid. Fragments were amplified with primers described in appendix IV with extensions 
homologous to the plasmid they were to be inserted into.
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Go
PLB-985 CAPN1-GFP PLB-985 CAPNS1-GFP
Figure 6 .3 .4 .1 : PLB-985 cells 48 hours after transduction with CAPN1-GFP or C APNS1- 
GFP len tiv irus . All cells were expressing GFP. GFP was excluded from the nucleus in the 
PLB-985-CAPN1-GFP cells but not in the PLB-985-CAPNS1-GFP cells.
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PLB-985 CAPN1-GFP PLB-985 CAPNS1-GFP
Figure 6.3.4.2: PLB-985 cells 4 weeks after transduction with CAPN1-GFP or CAPNS1- 
GFP lentivirus. Cells were still expressing GFP 4 weeks post transfection indicating that that 
cells had become stably transfected.
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Figure 6.3.4.3: PLB-985 cells 48 hours after transduction with CAPN1D3-GFP lentivirus.
Cells were expressing GFP after initial transduction with the CAPN1D3-GFP lentivirus although 
at quite a low level.
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3 MW ladder 235 45.0 0.47 1.65
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5 Lane 3 band 6 (GFP) 297 0.60 1.40 24.98 27kDa
6 Lane 4 band 3 (GFP) 290 0.58 1.42 26.50 27kDa
7 Lane 5 band 1 (CAPN4-GFP) 204 0.41 1.74 54.74 55kDa
8 Lane 5 band 3 (GFP) 287 ! 0.58 1.43 27.18 27kDa
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CAPN1GFP and PLBCAPNS1-GFP had free GFP protein in them. There is evidence of a small amount of CAPN1-GFP present but not enough to be 
certain. CAPNS1-GFP cells had both GFP bound to calpain4 and free GFP. b,c,d) Further analysis comparing the Rf values of the bands in the gel to 
the Rf values of the standards in the molecular weight ladder confirmed the correct molecular weights for the free GFP and the GFP bound to calpain4.
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either fMLP to stimulate a pharmacological calcium influx (b) or ionomycin and thapsigargin to stimulate a 
pharmacological calcium influx (c). Cells were also loaded with fura red to monitor cytosolic calcium 
concentration. GFP fluorescence and fura red fluorescence were monitored simultaneously throughout 
the experiment, a) Cytosolic calcium concentration was calculated from the fura red fluorescence and was 
raised through both pharmacological (10pM ionomycin and 5pM thapsigargin in medium containing 13mM 
calcium) and physiological (fMLP) stimuli. Calpain 4 GFP did not translocate in response to either 
stimulus, b) fMLP. c) 10pM ionomycin and 5pM thapsigargin in medium containing 13mM calcium.
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6.4 Discussion
6.4.1 Effect of over expression of calpains C2 like domain on cell survival
Attempts to produce a cell line that was stably over expressing domain 3 (C2 
like domain) from p calpain failed as over expression of this domain alone was 
lethal to the cell line used in this study. However over expression of whole p 
calpain or whole calpain 4 had no effect on cell viability. Knock out studies in 
mice have shown that knocking out calpain 4 in mice is lethal as the mice die 
during embryonic development (Arthur et al., 2000) but knocking out calpain 1 
has no effect on mice survival or general phenotype (As am et al., 2001). As 
such there has been no previous suggestion that this particular domain of 
calpain plays a crucial role in cell survival. Calpain undergoes a conformational 
change to become activated (Hosfield et al., 1999). It may be the case that in 
normal physiological circumstances the ‘C2 like’ domain of calpain is only 
exposed when calpain is in its active state and thus not exposed the majority of 
the time. Expressing the ‘C2 like’ domain alone would result in the ‘C2 like’ 
domain being active in the cytoplasm all the time. It may be the case that 
having calpains C2 like domain constitutively active is blocking other C2 domain 
proteins from binding the plasma membrane and thus blocking them from 
functioning, this would have detrimental effect on the activity of the cell. 
However this phenomenon was not seen in the short term when classical C2 
domains are over expressed in a variety of cell lines so it is therefore unlikely 
that this is the case here. The exact role of domain 3 (‘C2 like’ domain) in 
calpain 1 activation as well as membrane targeting is still unknown. Until more 
is understood it would be difficult to speculate on why it’s over expression is 
lethal to this particular cell line.
6.4.2 Transduction of PLB-985 cells with CAPN1-GFP and CAPNS1-GFP
Lentiviral transduction of the PLB-985 cell line produced stably transfected cell 
lines. However the GFP which was expressed by these cell lines was no longer 
bound to the calpain as intended. DNA sequence analysis showed that the
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calpain, the GFP tag and the ‘linker molecule’ linking the two were all present in 
the lentiviral vector used to generate the lentivirus. It can therefore be assumed 
that the linker molecule may be being cleaved by a non specific process when 
the protein is expressed in the cells. This would be unusual but no other 
obvious explanation immediately presents itself. The nature of the time 
constraints imposed on this project meant that this problem could not be fully 
addressed. If it were the linker molecule between the calpain and the GFP tag 
being cleaved that is the cause of this problem then one possible solution would 
be to create the GFP tagged calpain in a different way. i.e. as a direct fusion 
without the need for a linker molecule. This could be achieved using the In- 
Fusion Advantage PCR cloning technique used to insert the calpain-GFP 
products into the lentiviral expression vector and this is a possible direction to 
move toward in the future. Some GFP tagged calpain 4 was found to be 
present intact in the PLB-CAPNS1GFP cell line. In this cell line the calpain4- 
GFP did not translocate in response to elevated cytosolic calcium 
concentrations. The potential reasons for over expressed calpain 4 not 
translocating in response to high calcium concentrations were discussed in 
section 4.4.1. Another possible explanation for the translocation not being 
visible in this case is that in this cell line there was also a substantial amount of 
free GFP which had been cleaved from the calpain 4. This GFP free in the 
cytoplasm would not translocate and would act to further mask any possible 
translocation of the GFP tagged calpain 4, perhaps to the extent that it is 
undetectable.
6.4.3 Overall discussion
Despite the setbacks suffered in this chapter lentiviral transfection still remains 
the most successful and efficient method of stably transfecting myeloid cell 
lines which as discussed in the previous chapter is still difficult to achieve and 
has only been successful in a two cases (Servant et al., 2000, van Bruggen et 
al., 2004). If time allowed for some minor changes to the constructs
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themselves then it remains likely that it can be successful for this project as well 
and it remains a possible technique for the future.
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CHAPTER 7
Membrane dynamics during phagocytosis
human neutrophils
7.1 Introduction
Phagocytosis involves an apparent expansion of the surface area of the 
neutrophil which is sufficient to enclose the particle to be internalised. In 
addition, the fusion of granules specifically to the phagosome would be 
expected to increase its surface area. Whatever the mechanism for the 
psuedopodial membrane expansion, there may be an accompanying process to 
retrieve membrane and so regulate the amount of surface area during and after 
the process. Although this has been explored previously, the work presented in 
this chapter presents data which sheds light on the process.
7.1.1 Phagocytosis
Phagocytosis is the internalisation of foreign pathogens in response to the 
activation of opsonin receptors on the neutrophil surface. These are Fc 
receptors or (32 integrins. Activation of these receptors triggers a signalling 
cascade which ultimately results in actin polymerisation and extensive 
membrane and cytoskeletal reorganisation leading to the extension of 
membrane pseudopodia around the pathogen and internalisation of the 
pathogen (Jutras and Desjardins, 2005, Lee et al., 2003). The pseudopodia 
extend around the pathogen following the path of receptor activation in what is 
known as the ‘zipper mechanism’ (figure 7.1.1.1) (Jutras and Desjardins, 2005). 
Once the pathogen has been fully engulfed by the phagosome and internalised 
a process called phagosome maturation occurs. This is the results of ‘kiss and 
run’ fusion of granules with the phagosome which add and remove contents 
from the phagosome (Lee et al., 2003). This process is triggered by a cytosolic 
calcium increase (Jaconi et al., 1990) and the rank order of granule fusion (i.e. 
secretory vesicles, gelatinase granules, specific granules and azurophil 
granules) with the phagosome at a particular time is also calcium dependent 
(Sengelov et al., 1993). This process leads to the phagosome gaining various 
degradative enzymes (myeloperoxidases, hydrolases and NAPDH oxidase) all 
necessary for the final step in phagocytosis, pathogen destruction.
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Figure 7.1.1.1: The process of C3bi m ediated phagocytosis from  pathogen recognition to 
pathogen destruction, i) Pathogen detection and redistribution of CD11b/CD18 to site of 
pathogen, ii) Interaction of CD11b/CD18 on neutrophil with C3bi on bacteria induces 
pseudopodia formation, iii) Pseudopodia extend around the pathogen following the path of 
receptor activation -  zipper mechanism’, iv) Phagosome closes and granules begin to release 
their contents into the phagosome, v) Bacteria is destroyed inside the phagosome.
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7.1.2 Membrane expansion and retrieval
The plasma membrane of the neutrophil is covered in surface wrinkles of 
approximately 300nm in length (Bruehl et al., 1996, Shao et al., 1998), covering 
30-40% of the cell surface (Bruehl et al., 1996). During phagocytosis large 
pseudopodia are able to extend around particles with a surface area of up to % 
of that of the cell, and when a neutrophil spreads its apparent surface area 
increases two fold (Hallett and Dewitt, 2007). It has therefore been suggested 
that these wrinkles provide a source of extra membrane for neutrophil shape 
change such as spreading and phagocytosis. The focus of this thesis so far 
has been on how the membrane is unwrinkled to provide this extra plasma 
membrane but it is also worth noting that a mechanism for membrane retrieval 
and how the wrinkles are reintroduced into the plasma membrane is yet to be 
fully addressed. It has been reported that phagocytosis of gram positive non 
opsonised bacteria by neutrophils is accompanied by the formation of 
“pinosomal structures” around the phagosome (Bauer and Tapper, 2004).
7.1.3 Aims o f the chapter
The aim of this chapter is to investigate this hypothesis the “pinosomal 
structures” form the basis of excess membrane retrieval after phagocytosis. To 
do this, it was necessary to observe neutrophil phagocytosis of opsonised 
zymosan particles in the presence of fluorescent extra cellular fluid phase 
markers in real time.
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7.2 Materials and Methods
7.2.1 Neutrophil phagocytosis in the presence of Lucifer yellow
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). Neutrophils were incubated with 50pg/ml lucifer yellow (50pg/ml) 
and 100pg/ml opsonised zymosan particles for 30 minutes at 37°C. Cells were 
then visualised and checked for the presence of pinosomes using the CLSM. 
Z-stacks were taken to visualise the location of the pinosomes in 3 dimensions. 
3D reconstruction of images was performed using IMARIS software.
7.2.2 Neutrophil phagocytosis in real time in the presence of Lucifer 
yellow
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). 50pg/ml lucifer yellow and 10pg/ml opsonised zymosan particles 
were added to the cells immediately prior to the experiment. Z-stacks and time 
series were taken as the cell phagocytosed in order to visualise the appearance 
of the pinosomes in time and space. 3D reconstruction and analysis of images 
was performed using IMARIS software.
7.2.3 Neutrophil phagocytosis in real time in the presence of rhodamine 
dextran.
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). 250pg/ml rhodamine dextran and 10pg/ml opsonised zymosan 
particles were added to the cells immediately prior to the experiment. Dextran 
was used to determine if the pinosomes which were being formed were caused 
by transient binding of granules to the pinosome which only bind long enough to 
allow small molecules to diffuse from the phagosome into the granule. 
Rhodamine dextran is 10,000 MWt and is excited at 540nm and emits 
fluorescence at the red end of the spectrum. Z-stacks and time series were
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taken as the cell phagocytosed in order to visualise the appearance of the 
pinosomes in time and space. 3D reconstruction and analysis of images was 
performed using IMARIS software.
7.2.4 Neutrophil phagocytosis in real time in presence of fluorescein 
conjugated BSA
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). Cell membranes were stained with PKH26 red fluorescent cell 
membrane stain (Sigma). 1% fluorescein conjugated BSA and 10pg/ml 
opsonised zymosan particles were added to the cells immediately prior to the 
experiment. BSA is a protein of 68kDa which when tagged with the fluorescein 
molecule is excited at 488nm and emits light in the green region of the 
spectrum. Cell membranes were stained with PkH26 red membrane stain 
(Invitrogen) in order to try and visualise whether the pinosomes were formed 
from the cells plasma membrane or were derived from existing granules within 
the cell. Z-stacks and time series were taken as the cell phagocytosed in order 
to visualise the appearance of the pinosomes in time and space. 3D 
reconstruction and analysis of images was performed using IMARIS software.
7.2.5 Neutrophil phagocytosis in real time with fluoroscein conjugated 
BSA added after the phagosome had closed.
Neutrophils were isolated from healthy volunteers as previously described 
(section 2.3). 10pg/ml opsonised zymosan particles were added to the cells 
immediately prior to the experiment. Cells were allowed to phagocytose and as 
soon as the phagosome had closed 1 % fluoroscein conjugated BSA was added 
to the cells to visualise whether the pinosomes were formed from the plasma 
membrane of the membrane that was surrounding the phagosome. Z-stacks 
and time series were taken as the cell phagocytosed in order to visualise the
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appearance of the pinosomes in time and space. 3D reconstruction and 
analysis of images was performed using IMARIS software.
7.3 Results
7.3.1 The formation of pinosomes/fiuid filled inclusions during 
phagocytosis
In order to investigate the relationship between phagocytosis and the formation 
of pinosomes/fluid filled inclusions, Lucifer yellow was used as a fluorescent 
marker of the extracellular fluid phase. In neutrophils which were incubated for 
30 minutes with zymosan particles and Lucifer yellow, Lucifer yellow was found 
in the phagosome itself as well as in other inclusions throughout the cell. This 
was not observed in cells which had not phagocytosed any of the zymosan 
particles (figure 7.3.1.1). In order to visualise this process in real time, the 
process of phagocytosis in lucifer yellow containing medium was monitored and 
the appearance of fluid filled inclusions was recorded in real time. The first fluid 
filled inclusion appeared immediately after phagosome closure and fluid filled 
inclusions continued to appear up to 5 minutes after phagosome closure (figure 
7.3.1.2). In all but one experiment the fluid filled inclusions did not appear until 
after phagosome closure and in most cases the number of fluid filled inclusions 
steadily increased after phagosome closure until a plateau was reached (figure 
7.3.1.3a). This plateau was most likely the result of an equilibrium between 
some of the fluid filled inclusions disappearing from the confocal plane while 
others replace them. The total number of inclusions formed and the time they 
took to form varied between cell and donor (figure 7.3.1.3a). The volume of 
fluid filled inclusions and their distance from the phagosome and the plasma 
membrane was analysed using IMARIS 3D reconstruction software. No 
relationship was found between the volume of the fluid filled inclusion and the 
distance of the inclusion from the phagosome (figure 7.3.1.3b), however there 
was some correlation between the volume of the inclusion and the distance 
from the plasma membrane (figure 7.3.1.3c). This correlation suggests that the 
further away from the plasma membrane the inclusions travel, the smaller they 
became.
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7.3.2 Phagocytosis in the presence of rhodamine dextran and Lucifer 
yellow.
In order to establish whether the fluid filled inclusions were forming from 
transient binding of cytoplasmic granules to the phagosome where the binding 
time is so transient that there is only enough time for small molecules to diffuse 
from the phagosome into the granules cells were allowed to phagocytose in the 
presence of the larger fluorescent marker, rhodamine dextran (MWt 10,000) as 
well as the smaller fluorescent marker Lucifer yellow. Both of these markers 
were added to the extracellular fluid. Fluid phase inclusions containing Lucifer 
yellow were visible but there were no visible fluid filled inclusions containing 
rhodamine dextran (figure 7.3.2.1)
7.3.3 Phagocytosis in the presence of fluorescein conjugated BSA
In order to confirm the results observed when cells were allowed to 
phagocytose in the presence of rhodamine dextran, the experiments were 
repeated using a difference molecule, BSA conjugated to fluorescein. As the 
BSA is conjugated to fluorescein which is more highly fluorescent than 
rhodamine this would indicate whether or not the lack of visible fluid phase 
inclusions observed when using the rhodamine dextran was true or whether it 
was due to the molecule not being highly fluorescent enough to be detected in 
the small quantities found in the inclusions. Fluid filled inclusions were clearly 
visible in cells allowed to phagocytose with fluorescein-BSA in the extracellular 
fluid with the first inclusion forming just after phagosome closure and inclusions 
continuing to form for more than 5 minutes after the phagosome had closed 
(figure 7.3.3.1). In order to try and establish whether the fluid filled inclusions 
were forming from the plasma membrane or from existing vesicles in the cell, 
the cell membrane was stained with PKH26 red membrane marker and 
fluorescein-BSA was added to the extracellular fluid and phagocytosis was 
recorded. No correlation was found between the location of the fluid filled
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inclusions and the membrane marker although the membrane marker could 
clearly be seen around the phagosome (figure 7.3.3.2)
7.3.4 Establishing the location of fluid uptake
In order to establish whether the fluorescent marker found in the fluid filled 
inclusions after phagosome closure was coming from the phagosome or from 
the extracellular fluid fluorescein-BSA was added to the cells either before or 
after phagosome closure. When fluorescein-BSA was added after phagosome 
closure no fluid filled inclusions were observed, even more than 7 minutes after 
phagosome closure (figure 7.3.4.1a). However, when the fluorescein-BSA was 
added to the cells before phagosome closure and therefore was taken up into 
the phagosome, fluid filled inclusions were observed consistently (figure 
7.3.4.1b). This suggests that the fluid filled inclusions observed after 
phagocytosis are derived from the phagosome rather than the extracellular 
fluid.
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a)
Figure 7.3.1.1: An exam ple of neutrophils that had been incubated with opsonised  
zym osan with Lucifer yellow  for 30 m inutes (n>10). a) Fluid phase inclusions were found in 
neutrophils that had phagocytosed zymosan b) but were not found in neutrophils that had not 
undergone phagocytosis.
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Figure 7.3.1.2: Fluid phase inclusions appearing in real time as the neutrophil engulfs 2 zymosan particles (n>5). Lucifer yellow was added to 
the solution containing the neutrophils before zymosan was added and cells were allowed to phagocytose (zymosan highlighted by circles). The first 
fluid phase inclusion appears at 17.4 seconds, just after the phagosome has closed and fluid phase inclusion continue to appear up to 5 minutes after 
phagosome closure.
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Figure 7.3.1.3: Analysis o f the characteristics of fluid phase inclusions, (with IMARIS 
software) a) In all but one case the fluid phase inclusions did not appear until after the 
phagosome had closed. In most cases the number of fluid phase inclusions in the cell 
increased steadily after phagosome closure before reaching a plateau. The time this took 
varied depending on the cell, b) There was no relationship between the volume of the fluid 
phase inclusion and the distance from the phagosome (Spearmans correlation coefficient did 
not exceed the critical value at p=0.05) but c) there was some relationship between the volume 
of the fluid phase inclusion and the distance from the plasma membrane (Spearmans 
correlation coefficient exceeded the critical value of 0.358 at p-0.05).
218
Rhodamine Dextran 
Fluorescence
Lucifer Yellow 
Fluorescence
Bright Field Image
Figure 7.3.2.1: Example o f flu id  phase inc lus ions in cells w hich had been incubated w ith  zymosan in Lucifer ye llow  and rhodam ine dextran
(n>10). Fluid phase inclusions containing Lucifer yellow were visible but fluid phase inclusions containing rhodamine dextran could not be found. This 
may be due to the differing strength of the lasers used to detect the Lucifer yellow fluorescence and the rhodamine dextran fluorescence.
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Figure 7.3.3.1: An example o f flu id  phase inclus ions occurring in real tim e after the phagosome has closed around a zymosan partic le  (n=3). 
Fluoroscein tagged BSA (FI-BSA) was added to the solution containing the neutrophils before zymosan was added and cells were allowed to 
phagocytose. FI-BSA was used instead of Lucifer yellow as it has a higher molecular weight in order to rule out the possibility that the reason no 
inclusions were observed when the cells were incubated in rhodamine dextran was that high molecular weight molecules could not pass into the 
pinosomes. The first pinosome appears at 22 seconds, just after the phagosome had closed and pinosomes were still appearing 5 minutes after the 
phagosome had closed. The pinosomes were clearly visible suggesting that there was no problem with large molecular weight molecule getting into 
them.
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Fluid phase inclusion 
which looks like it is 
budding off from the 
phagosome but does 
not appear to have any 
red membrane around it
Membrane around 
phagosome stained with 
PkH26 red membrane 
stain
F igure 7.3.3.2: An exam ple  o f  a neu troph il sta ined w ith  PkH26 red membrane stain and 
then incubated in FI-BSA and  zym osan partic les (n-6). Co localisation analysis was 
performed using ImageJ in o rder to see whether any of the red fluorescent membrane co 
localised with any of the green fluorescent fluid phase inclusions. The white areas on the 
image show the areas where there  is co localisation. Pearsons R value was -0.2 indicating that 
there was no correlation and in  fact a small degree o f inverse correlation, indicating that there 
was no association with the p lasm a membrane and the fluid filled inclusions.
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Figure 7.3.4.1: N eutroph ils  incubated w ith  zym osan and allowed to phagocytose. 
F luorescein tagged BSA added to  the neu troph il so lu tion  e ither before or imm ediately 
a fter the phagosom e closed (rt-4). a) When fluorescein BSA was added after the 
phagosome had closed (at 25s in picture a)) no fluid phase inclusions were observed, even 7 
minutes after phagosome closure by which time earlier experiments showed that several fluid 
phase inclusions had formed, b) When fluorescein BSA was added before the phagosome 
closed or before phagocytosis had started fluid phase inclusions were observed to form in the 
usual way. This suggests that the fluid phase inclusions form from the membrane around the 
phagosome and not the rest of the plasma membrane.
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7.4 Discussion
7.4.1 The formation of fluid filled inclusions during phagocytosis.
The results presented in this chapter confirm the appearance of fluid filled 
inclusions in the cytoplasm during phagocytosis and confirm the findings of a 
previous report which stated that phagocytosis was accompanied by the 
appearance of pinosomal structures (Bauer and Tapper, 2004). These results 
show that the fluid filled inclusions do not begin to appear in the cytoplasm until 
after phagosome closure and that the number of inclusions present increases 
over time until a plateau is reached. No correlation was found between the 
volume of the fluid filled inclusion and the distance of the inclusion from the 
phagosome that would suggest a relationship between the inclusion and the 
phagosome. However some correlation was found between the volume of the 
inclusion and the distance of the inclusion from the plasma membrane which 
suggested that the closer to the plasma membrane the inclusion was the 
greater the volume of the inclusion was likely to be. This raised the possibilities 
that the inclusions were coming from the plasma membrane and splitting off 
into smaller vesicles as they moved into the cell or that smaller vesicles were 
fusing together as the moved towards the plasma membrane. As the results 
discussed later in this section will suggest, both situations may be occurring.
7.4.2 Granule fusion and membrane retrieval
During the phagosome maturation stage of phagocytosis neutrophil granules 
fuse with the phagosomal membrane in a process known as ‘kiss and run’ 
fusion. During ‘kiss and run’ fusion the granule partly fuses with the 
phagosomal membrane and the contents of the granule and the phagosome 
are exchanged (Burgoyne and Morgan, 2003). It is therefore possible that the 
fluid filled inclusions observed here are a result of granules fusing with the 
phagosome in a ‘kiss and run’ fashion and in doing so taking up some of the 
fluorescent extracellular fluid marker from the phagosome. In order to answer 
this question two approaches were adopted. During ‘kiss and run’ fusion
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smaller molecules would pass between the granule and the phagosome more 
readily than larger molecules as the rate of diffusion depends of inverse square 
root of the molecular weight (Berg, 1993). Therefore the experiments from 
earlier in the chapter were repeated using larger fluorescent molecules as 
markers of the extracellular fluid. BSA (68kDa) with a fluorescein tag was taken 
up just as readily into the fluid phase inclusions as the smaller Lucifer yellow 
marker was suggesting that larger size did not inhibit uptake into the fluid filled 
inclusions and that if these inclusions were the result of granule fusion with the 
phagosome then the granule had to remain bound to the phagosome for long 
enough to allow the diffusion of a 68kDa protein from the phagosome into the 
granule. This probably rules out transfer of material during the “flickering “ of 
the prefusion pore, whose diameter is about the same size as a single gap 
junction (2nm) which permit diffusion of molecules less than 1kDa (Aimers, 
1990). The second approach adopted to verify if the fluid filled inclusions were 
a result of granule fusions was to stain the plasma membrane with PKH26 
membrane marker. The marker clearly stained the plasma membrane and the 
membrane around the phagosome but could not be found around the fluid filled 
inclusions. This suggests that the membrane for these inclusions did not come 
from the plasma membrane or the phagosomal membrane and therefore must 
be from existing vesicles or granules within the cell.
7.4.3 Confirming the location of fluid uptake
The results discussed in the previous section suggest that the location of fluid 
uptake is likely to be from the phagosome rather than the extracellular fluid.
The location of fluid uptake was confirmed to be from the phagosome by adding 
the extracellular fluid marker before or after phagosome closure. The location 
of fluid uptake fits with the hypothesis of membrane retrieval from the 
phagosome and with the hypothesis that the fluid is being taken up from the 
phagosome by granule fusion.
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However, it should be noted that in neutrophils which had assumed a round 
shape, larger inclusion formed at the cell edge away from the phagosome (see 
e.g. fig 7.3.3.1). This opens the possibility that a second route for the formation 
of inclusion was directly from the plasma membrane and that this occurred as 
part of the restoration of cell surface area after completion of phagocytosis.
7.4.4 General discussion
The aim of this chapter was to investigate whether or not fluid filled inclusions 
observed in the neutrophil cytoplasm after phagocytosis are a result of active 
membrane retrieval after phagocytosis. There is evidence presented here to 
suggest that is the case; the source of the fluid uptake is the phagosome, large 
proteins are readily taken up suggesting a slow process to allow time for these 
proteins to diffuse and the size of the fluid filled inclusions increases as they 
move closer to the plasma membrane suggesting that the inclusions fuse 
together before their membrane is reinserted into the plasma membrane. 
There are contradictions however. If the inclusions were coming from the 
phagosome and fusing before being inserted into the plasma membrane then 
the size of the inclusion should decrease as you move closer to the 
phagosome. No correlation between volume of inclusion and distance from 
phagosome was found though. Also when the plasma membrane was stained 
using PKH26 membrane marker, no marker of plasma membrane was found 
around the inclusions despite the marker being clearly visible around the 
phagosome. This points to an alternative hypothesis that the fluid filled 
inclusions are the result of ‘kiss and run’ fusion of neutrophil granules with the 
phagosome during which the granules deposit some of their contents into the 
phagosome and in turn take up some of the phagosomes contents. It does 
remain possible however that the reason that no membrane marker was seen 
around the inclusions is simply that they are so small and perhaps the 
membrane marker was not concentrated enough that it is not visible on such 
small quantities of plasma membrane. In order to fully solve these doubts it 
would be useful in the future to repeat some of the experiments with a different
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membrane marker to see if the same outcome was observed and conduct 
further experiments into the relationship between the distances of the inclusion 
from the phagosome to see if any relationship can be found.
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CHAPTER 8
General Discussion
8.1 Introduction
Neutrophils are the most predominant type of white blood cell in the body and 
they are the first leukocytes to enter an area of inflammation, where they 
phagocytose microorganisms and kill them by generating toxic free radicals. 
However when inappropriately activated in inflammatory conditions such as 
Chronic Obstructive Pulmonary Disease they can cause extensive damage to 
tissues. When activated neutrophils first need to leave the blood stream in 
order to move to the area of inflammation. They do this by rolling along the 
blood vessel endothelium binding transiently via selectins to facilitate rolling and 
then integrins on the neutrophil bind ICAM-1 on the blood vessel endothelium 
where they adhere and spread out before they extravasate from the blood 
vessel into the tissue. Despite much being known about the molecules that 
trigger neutrophil extravasation, very little is known about the mechanism by 
which the neutrophil leaves the blood stream including the route that the 
neutrophil takes through the endothelium and how the neutrophil is able to 
spread onto the endothelium. Spreading onto the endothelium before leaving 
the bloodstream is a key step in the process of extravasation. If the key 
molecule(s) involved in this spreading step could be inhibited then this would 
provide potential therapeutic targets for the treatment of inflammatory diseases.
When a neutrophil spreads on the blood vessel endothelium the surface area of 
the cell increases by two fold (Dewitt and Hallett, 2007). It is most likely that the 
reservoir of extra membrane required for neutrophil spreading comes from the 
‘un-wrinkling’ of the neutrophil membrane as it spreads out.
Biophysical experiments have shown that there is only a limited amount of slack 
in the wrinkles in the neutrophil membrane (Herant et al., 2005, Herant et al., 
2006). L-selectins and p2 integrins, involved in neutrophil rolling and adhesion 
are found on the neutrophil membrane wrinkles. L-selectin is found on the 
apical surface of neutrophil membrane wrinkles (Bruehl et al., 1996, Erlandsen
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et al., 1993) and p2 integrins are found on the cell body between the membrane 
wrinkles (Erlandsen et al., 1993). This would be a logical position if the 
neutrophil did unwrinkle its membrane during spreading as during extravasation 
neutrophils first roll along the blood vessel endothelium binding transiently via 
selectins before they spread and make firm adhesions via p2 integrins. L- 
selectin is bound to the actin cytoskeleton by the linker molecule ezrin (Ivetic et 
al., 2002) and p2 integrin is anchored between the plasma membrane and the 
cytoskeleton via talin (Sampath et al., 1998), both members of the ERM family 
of proteins. Cleavage of these molecules would release the membrane when 
the neutrophil is activated and it is proposed that these hold the membrane 
wrinkles in place in resting neutrophils like a ‘molecular velcro’ (Dewitt and 
Hallett, 2007).
It is known that neutrophil spreading is directly linked to an increase in cytosolic 
calcium concentration as a large rise in cytosolic calcium accompanies 
neutrophil spreading and un-caging cytosolic Ca2+ or IP3 provides an increase 
in Ca2+ large enough to trigger neutrophil spreading (Pettit and Hallett, 1998a). 
This raises the possibility that an enzyme or second messenger activated by 
the cytosolic calcium signal which triggers neutrophil spreading and 
phagocytosis is actively increasing the amount of membrane available.
Calpain is a Ca2+ activated protease which has been shown to cleave the linker 
molecule talin in vitro. Calpain 1 or p-calpain is the predominant calpain found 
in neutrophils (Goll et al., 2003). It is made up of a large proteolytic subunit 
(80kDa) and a small regulatory subunit (30kDa). Each subunit is then made up 
of several different domains. Domains 1 - 4  make up the large subunit and 
domains 5 and 6 make up the small subunit (Goll et al., 2003). The C2 like 
domain in found in domain 3 on the large subunit enables the protein to 
translocate to the plasma membrane and bind phosphatidylserine in areas of 
high calcium.
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(j Calpain (calpain 1) requires unusually high calcium concentrations to be 
activated, around 30 pM (Michetti et al., 1997). During calcium influx there are 
areas of calcium concentrations high enough to activate calpain just below the 
plasma membrane, especially within the membrane wrinkles (Brasen et al., 
2010, Davies and Hallett, 1998). It was postulated that calpain’s C2 like 
domain may enable it to translocate from the cytoplasm and bind to the 
phosphatidylserine on the membrane where calcium is highest. These factors 
would ensure that calpain is activated specifically at the plasma membrane. 
Therefore calpain inhibition poses a potential therapeutic target for the 
treatment of inflammatory disease as calpain inhibition has the potential to 
inhibit neutrophil spreading.
The aims of this thesis were to show that calpain translocation and activation 
occurs during morphological change, including spreading and phagocytosis.
A number of challenges were encountered in achieving these aims.
Neutrophils are terminally differentiated cells with a lifespan of only 3-4 days 
and as such widely used methods of transfecting these cells are not viable in 
neutrophils. Even myeloid cell lines are not easily transfected using 
conventional methods. There are just two stably transfected HL60 cell lines 
generated (Servant et al., 2000, van Bruggen et al., 2004). In addition to this, 
some success has been reported in transiently expressing proteins in HL60s 
(Lacalle et al., 2007, Nuzzi et al., 2007). As such considerable effort was spent 
in establishing an efficient method for stably transfecting myeloid cell lines for 
use in this study and a phagocytic macrophage cell line (RAW264) which was 
easy to transfect had to be used as a model cell line for the majority of 
experiments. Although these cells were easier to transfect than the myeloid cell 
lines they were not as efficient at phagocytosis as primary neutrophils and as 
such studying phagocytosis as part of membrane expansion was difficult in 
these cells. Despite these challenges a method of stably transfecting myeloid
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cell lines was established as well as further evidence of the role of calpain in 
neutrophil shape change.
8.2 Results presented in this thesis
8.2a C2 domain translocation during phagocytosis
The calcium influx triggered by phagocytosis is sufficient to trigger C2 domain 
translocation. C2 domain translocation occurred before phagosome closure 
suggesting that calcium influx starts before closure of the phagosome with 
some suggestion that C2 domain proteins translocate first to the membrane 
around the phagosome before the rest of the plasma membrane. This 
suggests that the initial source of calcium influx is from the calcium channels in 
the membrane around the phagosome.
8.2b Activity of C2 domains in apoptotic cells
Total C2 domain translocation is diminished but not completely abolished in 
apoptotic cells. The rate of translocation however remained the same. The 
decrease in the amount of C2 domain translocation is most likely due to there 
simply being less phosphatidyl serine on the inner leaflet of the plasma 
membrane for the C2 domain to bind and as such the rate of translocation 
remains the same.
8.2c Location of calpain in apoptotic neutrophils
Despite translocation of classical C2 domains being diminished but not 
completely abolished in apoptotic cells p-calpain (which contains a ‘C2 like’ 
domain) is completely absent from the membrane in apoptotic neutrophils. This 
suggests that calpains ‘C2 like’ domain does not act in the same manner as a
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typical C2 domain and has a lower calcium affinity than the classical C2 domain 
from protein kinase C used in these studies. This suggested that if the calcium 
affinity of calpains ‘C2 like’ domain was lower than that of classical C2 domains 
then calpain would only be present at the membrane where calcium 
concentration was at its highest such as in the membrane wrinkles during 
calcium influx (Brasen et al., 2010, Davies and Hallett, 1998) where it could 
specifically cleave its substrates and allow membrane ‘unwrinkling’ and cell 
spreading.
8.2d Calpain is located at the plasma membrane in activated human 
neutrophils
Calpain was found to be located uniformly at the plasma membrane in human 
neutrophils spread on glass and at the leading edge in neutrophils which were 
spread and undergoing chemotaxis. Calpain was also found to be located 
around the phagocytic cup during and immediately after phagocytosis but was 
not found around the phagosome when phagocytosis was complete. This 
suggested that calpain is present in the right place and at the right time to play 
a role in neutrophil shape change.
8.2e Calpain4-YFP activity in living cells during phagocytosis and shape 
change.
Calpain4-YFP over expressed in RAW264 cells was found to be located in the 
cytoplasm in resting cells. Calpain4-YFP did not translocate in response to 
increases in cytosolic calcium concentration. Potential reasons for this were 
discussed in detail in section 4.4. But briefly, as it has been established that 
calpains ‘C2 like’ domain probably has a low calcium affinity it is possible that 
only the calpain already within the membrane wrinkles at the time of calcium 
influx encounters calcium concentrations high enough to bind phosphatidyl 
serine in the plasma membrane.
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8.2f Lentiviral transduction is the most efficient method for the stable 
transfection of myeloid cell lines.
A number of widely-used methods are unsuitable for transfecting neutrophils 
and myeloid cells. Lentiviral transduction was established to be the best method 
of transfection as it gave a highly efficient transfection of the growing precursor 
cells (cell line) such that sufficient expressed protein remained when protein 
synthesis was shut-down during terminal differentiation.
8.2g Possible mechanism of membrane retrieval after neutrophil shape 
change
Fluid filled inclusions appear in the cytoplasm after phagosome closure during 
phagocytosis. Large proteins are readily taken up into the inclusions and they 
are derived from the phagosome and appear to coalesce as they approach the 
plasma membrane. This suggests that the cell is potentially retrieving the 
excess membrane from the phagosome for reinsertion into the plasma 
membrane. There is another potential explanation for these results though. It 
is possible that the inclusions are the results of ‘kiss and run’ fusion of granules 
with the phagosome as when the plasma membrane was marked with a 
membrane marker none of this marker was found around the inclusions despite 
it being clearly visible around the phagosome.
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8.3 Future Prospects
The work presented in this thesis has raised some interesting new questions as 
well as some old questions which are yet to be answered.
• The location of calcium influx during phagocytosis.
• The effect of phosphatidyl serine externalisation on C2 domain 
translocation was only investigated in one C2 domain with a high calcium 
affinity in this thesis, further work should be done to investigate this 
effect in different C2 domain proteins with different calcium affinities.
• Here it has only been established that the calcium affinity of calpains ‘C2 
like’ domain is likely to be lower than that of the C2 domain from PKCy, a 
more definitive answer would be useful.
• It is yet to be established how calpain translocates to the plasma 
membrane in real time.
• If the fluid filled inclusions observed after phagosome closure are a 
method of membrane retrieval then the exact mechanism of this remains 
unknown.
8.3.1 Calcium influx during phagocytosis
Phagocytosis involves extensive membrane expansion and is a calcium 
dependent process (Edberg et al., 1995, Kobayashi et al., 1995). The results 
presented in this thesis show C2 domain translocation occurs during 
phagocytosis. C2 domain (C2y) binding to the phosphatidyl serine in the 
plasma membrane means that the localised calcium concentration which 
results from Ca2+ influx must be high (probably in excess of at least 7pM for 
maximum effect) (Kohout et al., 2002) at the plasma membrane indicating that 
the plasma membrane calcium channels must be open so that the calcium at 
the plasma membrane is high enough to stimulate C2 domain binding. The C2 
domain translocation occurred before phagosome closure suggesting that the 
plasma membrane calcium channels were open before phagosome closure.
Not all of the cells displayed C2 domain translocation during phagocytosis but it
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is widely accepted that calcium influx is not obligatory for the internalisation 
phase of phagocytosis (Dewitt et al., 2003, Jaconi et al., 1990) so this is not 
surprising. There is evidence to suggest that the initial increase in calcium 
concentration responsible for particle internalisation is caused by release of 
calcium from intracellular stores and not from calcium influx (Steinckwich et al.). 
However, the released Ca2+ would need to elevate Ca2+ near the plasma 
membrane to at least 7pM to be responsible for the C2 domain translocation.
As bulk cytosolic Ca2+ rarely exceeds 1pM, and the Ca2+ release sites are 
usually within the cell rather than at the membrane, this is unlikely.
Previous studies have reported a localised increase in cytosolic calcium 
concentration around the phagosome during phagocytosis (Jaconi et al., 1990). 
There has been controversy over the contribution of calcium influx and store 
depletion to this localised calcium increase. It has been shown that intracellular 
calcium stores translocate to the phagosome during phagocytosis and it has 
been postulated that release of calcium from these stores is responsible for the 
local calcium increase around the phagosome (Stendahl et al., 1994).
However, more recently, evidence has shown a decrease in calcium 
concentration in the phagosome after phagosome closure (Lundqvist- 
Gustafsson et al., 2000). This calcium concentration decrease was inhibited by 
blocking plasma membrane calcium channels. This suggests that the increase 
in calcium concentration around the phagosome could be the result of calcium 
influx from the phagosome. Further experiments investigating C2 domain 
translocation during phagocytosis could provide further insight into this. 
Preliminary evidence presented in this thesis suggests that C2 domains can 
translocate first to the plasma membrane around the phagocytic cup before the 
plasma membrane around the rest of the cell. This was however before 
phagosome closure and the C2 domain quickly translocated to the rest of the 
plasma membrane. Further experiments using C2 domains with differing 
calcium affinities would provide more evidence as to the first plasma membrane 
calcium channels to open during phagocytosis. This will provide evidence as to 
the source of the increase in calcium concentration around the phagosome as
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well as further insight into what calcium channels may play a role in the calcium 
influx during phagocytosis.
8.3.2 Effect of phosphatidyl serine concentration on C2 domain 
translocation
C2 domains most likely bind to phosphatidyl serine in the plasma membrane in 
a calcium dependent manner through co-operation between calcium binding 
and phosphatidyl serine binding (Nalefski and Falke, 1996). During apoptosis 
~50% of the total phosphatidyl serine is externalised to the outer leaflet of the 
plasma membrane (Martin et al., 1995) and is therefore unavailable for C2 
domain proteins to bind to. In this study translocation of a C2 domain with a 
high calcium affinity (from protein kinase C y) was diminished but not abolished 
in apoptotic cells. The rate of translocation remained the same but the total 
amount of C2 domain bound to the plasma membrane decreased. The 
decrease in the total amount of 02 domain bound to the plasma membrane was 
most likely due to there simply being less phosphatidyl serine available for the 
02 domains to bind. However, the fact that the rate of translocation remains 
unchanged in apoptotic cells suggests that calcium may be the limiting factor in 
02 domain-phosphatidyl serine binding. Therefore further experiments 
investigating the translocation of 02 domains with lower calcium affinities would 
provide further insight into the role of calcium in C2 domain-phosphatidyl serine 
binding.
8.3.3 Calpains ‘C2 like' domain
Domain III of calpain is known as a ‘C2 like domain as it bears amino acid 
sequence homology to classical C2 domains (Goll et al., 2003). However, there 
is yet to be any significant evidence of the functional similarity of calpains ‘C2 
like’ domain to classical C2 domains. It has been shown in this thesis that 
despite classical C2 domains with high calcium affinities translocating in
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apoptotic cells in which phosphatidyl serine on the inner leaflet of the plasma 
membrane is decreased, calpain is completely absent from the membrane in 
apoptotic neutrophils. This suggests that calpains ‘C2 like’ domain does not 
function in the same way as the classical C2 domain used in this study. The 
[Ca2+]1/2 of the C2 domain used in this study was 0.7pM, it follows that as 
calpain was not at the plasma membrane in apoptotic neutrophils but the 
classical C2 domain as still able to translocate in apoptotic cells that the 
[Ca2+]1/2 of calpains ‘C2 like’ domain must be higher than 0.7pM. It would be 
useful to further pinpoint the calcium affinity of calpains ‘C2 like’ domain, either 
by comparison with other classical C2 domains or through expression of just 
the domain III from p-calpain as attempted in this thesis, to gain an idea of 
under what circumstances it would translocate to the plasma membrane. It is 
highly likely that calpains ‘C2 like’ domain has a very low calcium affinity as 
calpain also requires a very high calcium concentration to be activated. 
Therefore it would be logical for calpain to only be found at the plasma 
membrane where calcium concentrations are high enough for it to be activated 
(Brasen et al., 2010, Davies and Hallett, 1998). It would therefore be in the 
right place to cleave its substrates, talin and ezrin (Ivetic et al., 2002, 
Shcherbina et al., 1999) which hold the plasma membrane wrinkles in place 
(Ivetic et al., 2002, Sampath et al., 1998) and cause the membrane to unwrinkle 
and allow the neutrophil to spread.
8.3.4 Calpain translocation
Translocation of p calpain from the cytosol where it is present in resting cells to 
the plasma membrane is a key step if it is involved in neutrophil shape change. 
Results presented in this thesis show that calpain is present at the plasma 
membrane where shape change is taking place in human neutrophils. This 
means that calpain is present in the right place and at the right time to be 
activated by the high calcium concentrations in the plasma membrane wrinkles 
during calcium influx (Brasen et al., 2010, Davies and Hallett, 1998) and able to 
cleave its substrates allowing the membrane to ‘unwrinkle’ and the neutrophil to
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spread. This translocation has yet to be observed in real time however.
Calpain 4-YFP over expressed in the RAW264 cell line failed to translocate 
upon cytosolic calcium increase. The potential reasons for this are discussed 
fully in section 4.4.1. Over expression of calpain 1 with a fluorescent tag in a 
myeloid cell line would provide a more definitive answer. This approach was 
addressed in this thesis but a considerable amount of time had to be spent 
developing the most appropriate method of transfecting myeloid cell lines. 
Although a suitable method was eventually established the time constraints of 
this project meant that this final step could not be seen through to completion. 
Once translocation has been established the exact role that calpain plays in 
neutrophil spreading would need to be addressed. It has been shown that 
calpain inhibition disrupts neutrophil shape change (Parr C, unpublished 
observation). Next, evidence would need to be sought that calpains target 
substrates are undergoing cleavage at the plasma membrane upon cytosolic 
calcium increase. Preliminary data suggests that the calpain substrates talin 
and ezrin are being cleaved during cytosolic calcium influx in human neutrophils 
(Elumalai G, unpublished observation). Finally it will need to be confirmed that 
calpain is indeed activated and causing the cleavage of these substrates (talin 
and ezrin) when it is at the plasma membrane under the very specific calcium 
conditions involved in neutrophil spreading in order to confirm the role of 
calpain in neutrophil spreading.
8.3.5 Membrane retrieval
If neutrophils undergo extensive membrane expansion during processes which 
involve shape change such as spreading and phagocytosis then there must be 
a mechanism for retrieving the excess membrane after the process is complete. 
Pinosome like structures have been reported to accompany phagocytosis in 
human neutrophils (Bauer and Tapper, 2004, Botelho et al., 2002) and it has 
been postulated that these may play a role in membrane retrieval. This has 
been investigated in this thesis. Although an alternative hypothesis for the 
existence of these pinosome like structures has been proposed, that they come
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about as a result of ‘kiss and run’ fusion of granules with the phagosome, 
evidence still remains that they may be a sign that membrane recycling is 
occurring. This thesis has focused on the mechanism by which neutrophil 
membrane wrinkles are released to expand the plasma membrane and allow 
shape change to occur. If the excess membrane produced for neutrophil shape 
change is indeed retrieved and recycled back into the plasma membrane then 
further research needs to be carried out into a mechanism by which the excess 
membrane is reinserted into the plasma membrane and how the plasma 
membrane wrinkles are reintroduced, if they are at all.
8.4 Conclusion
Neutrophil spreading and membrane expansion is a complicated process and 
studying any process in neutrophils is always challenging as neutrophils are 
terminally differentiated cells which are not amenable to the genetic 
manipulations that can be used to study various processes in many other cell 
types. Even myeloid cell lines which can be differentiated into phagocytic 
neutrophil like cells and can be of use in modelling neutrophil behaviour are 
notoriously problematic when it comes to common genetic manipulation 
techniques such as transfection. Despite these many challenges an effective 
method of establishing stable expression of a transfected gene in myeloid cell 
lines has been established. It has been shown that p calpain is present in the 
right place and at the right time to play a critical role in the control of neutrophil 
membrane expansion. It is postulated that calpain is able to move from the 
cytoplasm to the plasma membrane where it is present during membrane 
expansion by virtue of its ‘C2 like’ domain. It has been shown that this ‘C2 like’ 
domain has a much lower calcium affinity than classical C2 domains and as 
such calpain would only be present at the plasma membrane in areas where 
calcium concentration is at its highest i.e. within the membrane wrinkles. Here 
the calcium concentration is also high enough to activate the protease and 
enable calpain to cleave its substrate, talin and ezrin, which hold the membrane 
wrinkles in place. This would lead to ‘unwrinkling’ of the plasma membrane
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allowing for the membrane expansion that is needed for the neutrophil to 
spread.
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Appendix I -  General reagents
Acridine Orange Sigma-Aldrich, Poole, U.K.
Agar Sigma-Aldrich, Poole, U.K.
All Trans Retinolc Acid (ATRA) Sigma-Aldrich, Poole, U.K..
Amaxa N ucleofector solution T Lonza, Cologne, Germany
Amaxa N ucleofector solution V Lonza, Cologne, Germany
Ampicillin Sigma-Aldrich, Poole, U.K.
Annexin V FITC Invitrogen, Paisly, U.K.
p -  Mercaptoethanol Sigma-Aldrich, Poole, U.K..
P -  Estradiol Sigma-Aldrich, Poole, U.K.
Boric acid Duchefa Biochemie, Haarlem, Netherlands
Bovine Serum Album in (BSA) Sigma-Aldrich, Poole, U.K.
MACS CD34 micro bead kit Miltenyi Biotec, Surrey, U.K.
CaCI2 Sigma-Aldrich, Poole, U.K.
Chloroform Sigma-Aldrich, Poole, U.K.
Chloroquine Sigma-Aldrich, Poole, U.K.
Dextran (m ol. W t. 70,000) Sigma-Aldrich, Poole, U.K..
Diethyl Pyrocarbonate (DEPC) Sigma-Aldrich, Poole, U.K.
Dil Invitrogen, Paisly, U.K.
Dimethyl sulphoxide (DM SO) Sigma-Aldrich, Poole, U.K.
DMEM Flow Laboratories, Paisley, U.K.
EDTA Sigma-Aldrich, Poole, U.K.
Effectene transfection reagent Qiagen, Crawley, U.K.
EGTA Sigma-Aldrich, Poole, U.K.
Ethanol Fisher Scientific, Leicester, U.K.
Ethidium bromide Sigma-Aldrich, Poole, U.K.
Fetal Calf Serum (FCS) Sigma-Aldrich, Poole, U.K.
Fibronectin Sigma-Aldrich, Poole, U.K.
Ficoll-Paque Amersham Biosciences, Uppsala, Sweden
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F lu o -4  sa lt Invitrogen, Carlsbad, California, U.S.A.
F luo -4 -A M Invitrogen, Carlsbad, California, U.S.A.
F lt3 Peprotech, London, UK
fM L P Sigma-Aldrich, Poole, U.K.
F u g en e  6 Promega UK, Southampton, U.K.
Fura-2  d extran Molecular Probes, Eugene, Oregon, U.S.A.
F ura-red Molecular Probes, Eugene, Oregon, U.S.A.
G lu tam in e Sigma-Aldrich, Poole, U.K.
G lyc in e Sigma-Aldrich, Poole, U.K.
G lycero l Sigma-Aldrich, Poole, U.K.
G ra n u lo cy te -C o lo n y  S tim ulating  F acto r (G - 
C SF)
Peprotech, London, UK
G ra n u lo cy te -M acro p h ag e  C o lony  
S tim ula ting  F ac to r (G M -C S F)
Peprotech, London, UK
H eparin C P Pharmaceuticals Ltd, W rexham , U.K.
H epes Fisher Scientific, Leicester, U.K.
H orse  S erum Sigma-Aldrich, Poole, U.K.
In fus ion  A d van tag e  P C R  c lon ing  kit Takara Bio Europe/Clontech, France
ln te rleu k in -3  (IL -3) Peprotech, London, UK
ln terleu k in -6  (IL -6 ) Peprotech, London, UK
lo n om ycin Calbiochem, Nottingham, U.K.
Iso p ro p ano l Sigma-Aldrich, Poole, U.K.
K anam ycin Sigma-Aldrich, Poole, U.K.
KCI Sigma-Aldrich, Poole, U.K.
k h 2p o 4 Sigma-Aldrich, Poole, U.K.
L u c ife r ye llo w Sigma-Aldrich, Poole, U.K.
M ach ery -N ag e l N uc leob o n d®  Extra M axi kit Abgene, Surrey, U.K.
M ethan o l Fisher Scientific, Leicester, U.K.
M g C I2 Sigma-Aldrich, Poole, U.K.
M g S 0 4 Sigma-Aldrich, Poole, U.K.
N a2C 0 3 BDH Laboratory Supplies, Poole, U.K.
N aC I Sigma-Aldrich, Poole, U.K.
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NaHC03 Fisher Scientific, Leicester, U.K.
Na2HP04 Sigma-Aldrich, Poole, U.K.
NaOH Sigma-Aldrich, Poole, U.K.
NiCI2 Sigma-Aldrich, Poole, U.K.
OneShot®Top10 e.coli Invitrogen, Paisly, U.K.
Opti-Mem Invitrogen, Paisly, U.K.
Para formaldehyde Sigma-Aldrich, Poole, U.K.
Penicillin Sigma-Aldrich, Poole, U.K.
PkH 26 red membrane marker Sigma-Aldrich, Poole, U.K.
Polybrene Sigma-Aldrich, Poole, U.K.
Protease Inhibitor Cocktail Sigma-Aldrich, Poole, U.K.
Propidium Iodide Sigma-Aldrich, Poole, U.K.
RetroNectin® Takara Bio Europe, France
Phusion Hot Start high fidelity DNA 
polymerase
N ew  England Biolabs, Hitchin, U.K.
Precision qScript™ reverse transcription 
kit
PrimerDesign Ltd, Southampton, U.K.
Reducing agent Invitrogen, Paisly, U.K.
Rhodamine dextran Invitrogen, Paisly, U.K.
Running buffer Invitrogen, Paisly, U.K.
RPMI Flow Laboratories, Paisley, U.K.
Sample buffer Invitrogen, Paisly, U.K.
Sodium acetate Sigma-Aldrich, Poole, U.K.
Stem cell factor (SCF) Peprotech, London, UK
Streptomycin Sigma-Aldrich, Poole, U.K.
Staurosporine (STS) Sigma-Aldrich, Poole, U.K.
Thapsigargin Sigma-Aldrich, Poole, U.K.
TRI reagent Sigma-Aldrich, Poole, U.K.
TRIS acetate pre-cast 3-11% gel Invitrogen, Paisly, U.K.
TRIS-CI Duchefa Biochemie, Haarlem, Netherlands
Triton-X100 Sigma-Aldrich, Poole, U.K.
Trypsin Sigma-Aldrich, Poole, U.K.
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T ryp to n e Duchefa Biochemie, Haarlem, Netherlands
T w een -20 Sigma-Aldrich, Poole, U.K.
Y e a s t E x trac t Duchefa Biochemie, Haarlem, Netherlands
Z ym o san  A Sigma-Aldrich, Poole, U.K.
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Appendix II -  Cell lines
HL60 (hum an prom yelocytic leukaem ia) European Cell Culture Collection
NB4 (hum an prom yelocytic leukaem ia) European Cell Culture Collection
PLB-985 (hum an prom yelocytic leukaem ia) DSMZ
NIH 3T3 (m ouse fibroblast) European Cell Culture Collection
RAW  264 (m ouse m onocyte m acrophage) European Cell Culture Collection
M yPH8B6 Dr P Taylor and Dr J McDonald
Phoenix am potrophic packaging cells Dr P Taylor
Phoenix ecotropic packaging cells Dr R Darley
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Appendix III -  Antibodies
A nti-calpain1 (6C-12) Santa Cruz, Caine, UK
G oat anti-m ouse IgG FITC Santa Cruz, Caine, UK
goat anti-m ouse IgG Rhodam ine Santa Cruz, Caine, UK
A nti-G FP-H R P Santa Cruz, Caine, UK
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Appendix IV -  Primers
T7F TAATACGACTCACTATAGGG 52 Sigma Chemicals, Poole, U.K.
BGHR CCTCGACTGTGCCTTCTAG 62 Sigma Chemicals, Poole, U.K.
B Actin F ATGATATCGCCGCGCTCA 68 Sigma Chemicals, Poole, U.K.
B Actin R CGCTCGG TGAGGA TCTTCA 67 Sigma Chemicals, Poole, U.K.
Capn1EXF1 A TG TCGGAGGAGA TCA TCA 61 Sigma Chemicals, Poole, U.K.
Capn1EXF2 A TG TCGGAGGAGA TCA TCAC 62 Sigma Chemicals, Poole, U.K.
Capn1EXR1 TGCAAACATGGTCAGCT 59 Sigma Chemicals, Poole, U.K.
Capn1ExR2 TGCAAACATGGTCAGCTG 63 Sigma Chemicals, Poole, U.K.
C2EXF1 CCCGACGCCCTCAAGA 67 Sigma Chemicals, Poole, U.K.
C2EXF2 CCCGACGCCCTCAAG 65 Sigma Chemicals, Poole, U.K.
C2EXR1 GTCATCCAGCTCCACAGTC 61 Sigma Chemicals, Poole, U.K.
C2EXR2 G TCA TCCAGCTCCACAGTCC 65 Sigma Chemicals, Poole, U.K.
Calp4EXF1 ATGTTCCTGGTTAACTCGTTC 60 Sigma Chemicals, Poole, U.K.
Calp4EXF2 ATGTTCCTGGTTAACTCG 55 Sigma Chemicals, Poole, U.K.
Calp4EXR1 GGAATACATAGTCAGCTGC 55 Sigma Chemicals, Poole, U.K.
Calp4EXR2 GGAATACATAGTCAGCTGCAG 59 Sigma Chemicals, Poole, U.K.
CAPN1/C2F1 CAGTTCAAGA TCCGGCTG 62 Sigma Chemicals, Poole, U.K.
CAPN1/C2R1 GAGGGCACCACCACATACTC 65 Sigma Chemicals, Poole, U.K.
Calp4F1 TGACACGACACCCTGA 58 Sigma Chemicals, Poole, U.K.
Calp4R1 CCACTCCTGGA TGTTCA 58 Sigma Chemicals, Poole, U.K.
SxWF ACGCGTGCGGCCGC 73 Dr P Brennan
SxWR GGATCCCGGGCTCGAG 68 Dr P Brennan
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Appendix V -  Plasmids
C 2-gam m a-YFP T.Gadella, University of Amsterdam, 
Amsterdam, The Netherlands.
C 2-beta-R FP T.Gadella, University of Amsterdam, 
Amsterdam, The Netherlands
pEYFP-C1-Calpain  4 S.Gil-Parrado Klinikum der Universitat, 
Muchen, Germany
pM X-pCalpain-EG FP construct A.Huttenlocher, University of Wisconson, 
Wisconsin, U.S.A.
Vivid Colours™  pcDNA™ 6.2/Em G FP- 
G W /TO PO ®
Invitrogen, Paisly, U.K.
LentiSxW Paul Brennan, Cardiff University, Cardiff, UK
LentiGFP Paul Brennan, Cardiff University, Cardiff, UK
P8.91
Paul Brennan, Cardiff University, Cardiff, UK
pMD2G
Paul Brennan, Cardiff University, Cardiff, UK
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Appendix VI -  Equipment
Equipment Source
A m axa nulceofector device
E ppendorf In jectm an m icrom anipulator
E ppendorf 5629 m icrom anipulator
W PI m icrom anipulator
E ppendorf Fem tojet pressure contro ller
Grass SD9 S tim ulator
M icropipette  Puller P2000
M icropipette capillaries
Rapid m onochrom ator - Delta RAM
Nikon Eclipse inverted m icroscope
IC100 Intensified CCD camera
Red sensitive cam era
LPS-220b lam p pow er supply
Filters, d ichroic mirrors
Beam Splitter
M icroscope stage heater
CLSM C onfocal m icroscope SP2
CLSM C onfocal m icroscope SP5
Single 488nm  line laser
ISIS Intensified CCD camera
F luorim eter Fluolog 3
UV filte r
BD Accuri C6 Flow cytom eter
Lonza, Cologne, Germany 
Eppendorf, Hamburg, Germany 
Eppendorf, Hamburg, Germany 
WPI, Florida, U.S.A.
Eppendorf, Hamburg, Germany
Sutter Instruments, Novato, California, U.S.A. 
Sutter Instruments, Novato, California, U.S.A. 
PTI, Surbiton, U.K.
Nikon, Kingston-upon-Thames, U.K.
PTI, Surbiton, U.K.
Watec, Tsuruoka-shi, Japan 
PTI, Surbiton, U.K.
Omega Optical Inc F ilte rs ,, Stanmore, U.K. 
Cairn Research Instruments, Faversham, U.K. 
Linkam Scientific Instruments, Tadworth, U.K. 
Leica, Milton Keynes, U.K.
Leica, Milton Keynes, U.K.
Laser Physics, Milton Green, U.K.
Photonic Science Ltd, Robertsbridge, U.K. 
SPEX CertiPrep, Metuchen, Watford, U.K. 
Chroma Filters, Stanmore, UK 
Accuri Cytometers Lyd, St Ives, U.K.
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Appendix VII -  Software
Im age M aster 1.4b8 PTI, Surbiton, U.K.
M icrosoft Excel 2010 Microsoft, Redmond, Washington, U.S.A.
Paintshop Pro Version 4.15 SE Jasc Software Inc., Minnesota, U.S.A.Eden 
Prairie,
M icrosoft PhotoEditor 3.0 Microsoft, Redmond, Washington, U.S.A.
G if A nim ator (32-bit) Alchemy Mindworks Inc., Ontario, Canada
H yperCam  Version 1.34.00 Shareware
M icrosoft Paint Version 5.1 Microsoft, Redmond, Washington, U.S.A.
Adobe Photoshop 7.0 Adobe Systems Inc, San Jose, California, 
U.S.A.
Leica A pplications Suite Advanced  
Fluorescence Lite
Leica Microsystems
M icrosoft W ord 2010 Microsoft, Redmond, Washington, U.S.A.
Im age J NIH, Bethesda USA
IM ARIS im aging softw are Bitplane Scientific Software
DNA Baser v3 Heracle Biosoft HCL
Accuri C flow  softw are Accuri Cytometers Ltd, St Ives, U.K.
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Appendix VIII -  Buffers and Solutions
Balanced Salt Solution (BSS)
0.13M NaCI 
2.6mM-KCI 
8.0mM-Na2HPO4 
1.83mM-KH2P04
DEPC water
5% Diethyl Pyrocarbonate (DEPC) dissolved in distilled water and autoclaved 
before use.
Dextran
6% of 70kDa dextran dissolved in BSS (6g in 100ml), aliquoted and stored at 
4°C until use
0.0 5 M EOT A
1g KCI
5.72g Na2HP04 
1g KH2P04 
40g NaCI 
1.4g EDTA
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All dissolved in 5 litres distilled water and pH adjusted to 7.4 and autoclaved 
before use.
Ethidium Bromide
One hundred milligrams of ethidium bromide powder was dissolved in 10ml of 
distilled water. Container was wrapped in aluminium foil to protect solution from 
sunlight and stored safely before use.
Hepes buffered Krebs
120mM-NaCI
25mM-Hepes
4.8mM-KCI
1.2mM-KH2P04
1.2mM-MgSO4.7H20
1.3mM-CaCI2.2H20
0.1% Bovine Serum Albumin (BSA)
LB agar
10g Tryptone 
5g Yeast extract 
10g NaCI 
15g Agar
Dissolved in 1 litre of distilled water and pH adjusted to 7.0 and autoclaved. 
Before use the solution was heated to a liquid and cooled slightly before adding 
selective antibiotic. The solution was then poured into 10cm2 petri dish plates
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and allowed to cool and solidify before being inverted and stored at 4°C until 
needed.
LB broth
10g Tryptone 
5g Yeast extract 
10g NaCI
Dissolved in 1 litre distilled water and pH adjusted to 7.0, autoclaved and 
cooled before adding selective antibiotic and stored at room temperature.
Neutrophil lysis buffer 
50mM Hepes 
150mM NaCI 
10% glycerol 
1% Triton X-100 
1.5mM MgCfe 
5mM EGTA 
5mM EDTA 
1mM Na3P04 
0.5% w/v SDS
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10x TBS
121 g TRIS 
400.3g NaCI
Dissolved in 5 litres distilled water and pH adjusted to 7.4
Transfer buffer
0.03M TRIS base 
0.2M glycine 
10% methanol 
0.2% w/v SDS
Tris-Boric acid-EDTA (TBE) buffer (5x cone)
1.1M Tris-CI 
900mM Boric acid 
25mM EDTA 
pH8.3
Trypsin (25mg/ml)
500mg trypsin dissolved in 20ml 0.05mM EDTA and filtered through a 0.2pm 
filter. For use in cell culture one 250pl aliquot was diluted in a further 10ml 
0.05M EDTA.
270
Appendix IV -  Plasmid sequences
calpain, small subunit 1 [Homo sapiens]
Score = 699 bits (378), Expect = 0.0
Identities = 381/382 (99%), Gaps = 1/382 (0%)
Strand=Plus/Plus
ACATGATCGCAGCATGGTGGCCGTGATGGATAGCGACACCACAGGCAAGCTGGGCTTTGA 7 8
GGAATTCAAGTACTTGTGGAACAACATCAAAAGGTGGCAGGCCATATACAAACAGTTCGA138 
I I I I  I I I I  I I  I I I I I I I I  I I I  I I I  I I  I I I I I I I  I I  I I  I I I  I I  I I I I I I I  I I I I I I I I I  I I
Query 19
Sbj ct 584
Query 79
Sbj ct 64 3
Query 139
Sbj ct 703
Query 199
Sbj ct 763
Query 259
Sbj ct 823
Query 319
Sbj ct 883
Query 379
Sbj ct 943
I I I I I I I I I I I  I I I I I I I I I I I II  II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I
I I I I I I I I I I I I I II I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I
BLAST search results using sequence from pEYFP-C1 -calpain 4 plasmid sequenced with 
calp4F1 forward primer
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calpain, small subunit 1 [Homo sapiens]
Score = 1354 bits (733), Expect = 0.0 
Identities = 736/737 (99%), Gaps = 1/737 (0%)
Strand=Plus/Minus
AGAGATTTG-AGGCACGGAACATGGCGTCCAGCCTGACCAAGCAGCTGATGAAGTTGTCA 7 8
I I I  I I I  I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I  I I  I I I I  I I I  I I I I I I I I I I I I I I
AAATCC ATGTTCCCACTTTCATCTGAGTAGCGTCGGATGATCATGTTATAGAGATGCTCA13 8 
I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I  I I I I I I I I I I  I I  I I I
Query 20
Sbj ct 894
Query 79
Sbj ct 834
Query 139
Sbj ct 774
Query 199
Sbj ct 714
Query 259
Sbj ct 654
Query 319
Sbj ct 594
Query 379
Sbj ct 534
Query 439
Sbj ct 474
Query 499
Sbj ct 414
Query 559
Sbj ct 354
Query 619
Sbj ct 294
Query 679
Sbj ct 234
Query 739
Sbj ct 174
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I  I I I I  I I I I  I I I I  I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I
I I  I I  I I I I I I I I I I I I I
BLAST search results using sequence from pEYFP-C1-calpain 4 plasmid sequenced with
calp4R1 reverse primer
272
Hom o s a p ie n s  c a l p a i n  1 , ( r n u / I )  l a r g e  s u b u n i t  (C A P N 1 ) ,  mRNA 
L e n g t h  =  3 0 0 “'
S c o r e  = 1 4 4 3  b i t s  ( 7 8 1 ) ,  E x p e c t  = 0 . 0  
I d e n t i t i e s  = 8 8 5 / 9 2 8  (9 6 % ) ,  G a p s  = 3 6 / 9 2 8  (3% ) 
S t r a n d = P l u s / P l u s
Q u e r y 14 G G GT-TCAG -CC-AG TG CAG -AGC AG CG G G CCAG GG AG CTG GG CC TG GG CC GC CATGAG A
I N I  I 1 1 1 I I  1 1 I I  1 1 1 1 1 1 1 1 1 1 I I  1 I I  1 1 1 I I  1 1 1 1 1 1 1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 
GGGTGTCAGCCCAAGTGCAGAAGCAGCGGGCCAGGGAGCTGGGCCTGGGCCGCCATGAGA
69
S b j  c t 1 8 1 2 4 0
Q u e r y - 0 ATGCCATCAAGTACCTGGGCCAG G ATTATG AGCAG CTG CG G G TG CG ATG CCTG CAG AG TG
1 1 1 1 I | 1 I 1 I 1 1 1 | | 1 | 1 1 | 1 | 1 | | I 1 1 1 1 | 1 I 1 1 I 1 1 1 1 I I | | | | | I 1 1 | I 1 I 1 1 | | 1 |
1 2 9
S b j  c t 2 4 1
M  1 I I  1 1 1 I I  I I  1 I I  1 I I  1 ! I I  I I  1 i I I 1 | I I  I I  1)  1 1 1 1 1 I I I  1 1 I I  ! 1 I !  1 1 J J I M  1 
ATGCCATCAAGTACCTGGGCCAG G ATTATG AGCAG CTG CG G G TG CG ATG CCTG CAG AG TG 3 0 0
Q u e r y 1 3 0 GGACCCTCTTCCGTGATG AG GCCTTCCCCCCG G TACCCCAG AGCCTG GG TTACAAG GACC
I I | 1 | 1 | 1 1 I 1 I I I 1 1 | I 1 1 I | 1 1 1 | 1 | | 1 I | 1 1 | | 1 | | | 1 1 | 1 I M  I 1 1 ! I 1 | 1 1 1 1 | 1
1 8 9
S b j c t 3 0 1
t I 1 1 1 M  I I  ! 1 i I 1 H  M  i i 1 I I  1 I I  M  i I I  1 1 1 I I  1 1 1 M  I I  I I  1 1 1 1 1 1 ! 1 1 1 I I  I I  1 
GGACCCTCTTCCGTGATGAG GCCTTCCCCCCG G TACCCCAG AGCCTG GG TTACAAG GACC 3 6 0
Q u e r y 1 9 0 TG G GTCCCAATTCCTCC AAG ACCTATG G C ATC AAG TG G AAG CG TCCCACG G AACTG C TG T
1 1 1 1 I I  1 I I  1 1 I I  i 1 1 1 1 1 1 1 I I  1 I I  I I  I I  1 1 1 1 1 1 1 1 1 1 I I  I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TG G GTCCCAATTCCTCC AAG ACCTATG G C ATC AAG TG G AAG CG TCCCACG G AACTG C TG T
2 4 9
S b j  c t 3 6 1 4 2 0
Q u e r y 2 5 0 CAAAC CCCCAG TTCATTG TG G ATG G AGCTACCCG CACAGACATCTG CCAG G G AG CACTG G
! I 1 { I 1 1 | | 1 1 I 1 | 1 1 1 1 1 1 1 I I  1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 1 1 1 | 1 1 1 1 1 1 1 1 1 1 I I  1 1
3 0 9
S b j  c t 4 2 1
i M  i ! i 1 ! 1 i H  1 ! I I  ! I I  I I  1 I I  ! 1 1 I I  1 1 I t  1 1 1 I I  I 1 H  1 M  1 I 1 1 I I  I I  I I  1 I I  1 1 
C AAAC CCCCAG TTCATTG TG G ATG G AGCTACCCG CACAGACATCTG CCAG G G AG CACTG G 4 8 0
Q u e r y 3 1 0 G G G ACTG CTG G CTCTTGG CG G CCATCG CCTCCCTCACTCTCAACG ACACCCTCCTGCACC
U  1 ! M  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  1 I I  I I  1 1 1 1 1 1 1 I I  I I  I I  1 1 1 1 1 1 1 1 1 1 
G G G ACTG CTG G CTC TTG G CG G CCATTG CCTCCCTCACTCTCAACG ACACCCTCCTG CACC
3 6 9
S b j  Ct 4 8 1 5 4 0
Q u e ry 3 70 G AG TG G TTCCGCACG G CCAG AG C TTCCAG AATG G CTATG CCG G CATCTTCCATTTC CAG C
i ! 1 1 i I i 1 i i 1 1 1 i 1 i i 1 i 1 1 1 l 1 1 1 i t 1 1 1 l 1 l 1 1 ! 1 1 1 1 1 1 1 1 l 1 1 1 1 1 1 1 1 1 1 1 1 I 1
4 2 9
S b j c t 5 4 1
M  i i 1 M  1 I ! 1 I M  1 1 1 I i I I  I i I I  I I  1 1 I I  11 i 1 M  I I  11 I I I  I I I  1!  1 1 1 I I  1 1 I t  I 1 
G AG TG G TTCC G C ACG G CCAG AG C TTCCAG AATG G CTATG CCG G CATCTTCCATTTC CAG C 6 0 0
Q u e ry 4 30 TG TG 3CAATTTG G G GAG TG GG TG G ACG TGG TCGTG G ATG ACCTG CTG CCCATCAAGG ACG
I ' 1 1 1 1 . 1 1 l 1 1 1 1 : 1 i 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ] 1 1 1 1 1 1 1 1 t 1 1 1 1 1 1 1 1 1 1 1
4 8 9
S b  j  c t 6 0 1
' i i 1 I ; i 1 : 1 ! : 1 '■ 1 1 , ! i 1 1 I i 1 1 ! 1 i 1 I I  i ! 1 1 1 I I  I I I  1 1 1 I I  M  ! I I  M  1 I I  1 i 1 
TGTGGCAATTTGGGGAGTGG GTGG ACG TG GTCG TGG ATG ACCTG CTG CCCATCAAG GACG 6 6 0
Q u e r y 4 90 G GAAGCTAGTC-TTCGTGCACTCTGCCG AAG G CAACG AG TTCTG G AG CG CCCTG CTTG AGA
I | i 1 | | | ' | | | | | | 1 | 1 | | I I 1 I | | 1 | | 1 I | 1 I I | |  I | 1 I 1 I 1 1 1 1 I 1 I I 1 1 1 | 1 I 1 1 1 1
5 4 9
S b j c t 6 61
I I  I M  ! h  i I I I I i i I ! | ! ! 1 I I  1 1 I I  1 1 1 ! 1 1 I !  1 1 1 1 1 1 1 1 I I  1 I 1 I I I I  M  1 1 I I  I I  
G G AAG CTAG TGTTCG TGCACTCTG CCG AAG G CAACG AG TTCTG G AG CG CCCTG CTTG AG A 1 2 0
Q ue r  y 5 5 0 AGG CC TATGC CAAG G TAAATGGCAGCTACGAGGCCCTGTCAGGGGGCAGCACCTCAGAGG
i I 1 i i ; 1 ' > 1 i I i ; i ; i I : t 1 i : : i i 1 j i 1 i i I I 1 I I | I 1 ! i | 1 I 1 1 1 ' I 1 I 1 i j i i 1 1 I
6 0 5
S b j  c t “ 21
1 1 h  1 1 l 1 1 1 ; 1 i 1 ! 1 1 1 i M  1 1 1 I l 1!  1 1 1 h  1 1 1 1 1 1 1 1 1 1 1 1 1 M  1 1 | 1 1 1 1 1 1 1 1 1 
AGG CCTATGCCAAG GTAAATGGCAGCTACGAGGCCCTGTCAGGGGGCAGCACCTCAGAGG ^ 8 0
Q u e ry 6 1 0 GCTTTGAGGACTTCACAG G CG G GG TTACCG AG TG GTACG AG TTG CG CAAG G CTCCCAG TG
i i 1 : i 1 | 1 ! I M  | | | j I I I I M  I 1 I 1 I 1 1 1 I 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 I I 1 1 1 1
6 6 9
S b j c t - 8 1
1 1 1 ! : ; i : 1 : ! 1 ! 1 ! 1 1 i I I  ! i < ! i 1 • 1 i ! M  1 1 1 I I  I I  1 1 M  i 1 1 1 1 1 1 1 t ! l  1 M  1 M  
G CTTTGAGGACTTCACAG G CG G GG TTACCG AG TG GTACG AG TTG CG CAAG G CTCCCAG TG 8 4 0
Q u e ry 67 0 A C C 7 C T .AC CAGAT CATCCTCAAGG CG CTG G AG CG G G GcTCCCTG CTG G G CTG CTCCATAG
1 1 1 i 1 i i 1 < 1 1 i 1 1 1 1 1 i ' 1 1 1 : 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
^ 2 9
S b j c t 6 41
1 ! 1 1 : 1 ! I 1 1 ! 1 1 1 I !  1 I ! 1 1 1 ! 1 1 I I  1 1 1 1 I I  1 1 1 1 I I  1 H  11 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
ACC TC TAC C AG A T CATCCTCAAGGCGCTGGAGCGGGGCTCCCTGCTGGGCTGCTCCATAG 9 0 0
Q u e ry - 3 0 A C A TC TC C A G C G TTC TA G A C A T G G A G G C C A TC A C TTTC A -G A A G T-G G TG A A G G G C -A TG
, , . j , • 1 i , L . : j I . , | , i 1 1 I , ; 1 l | . 1 1 1 1 i r 1 1 1 1 [ ( | I 1 { I 1 1 | | f I I I
^ e e
S b j c t 901
j 1 1 : ! I . a  i ; 1 1 ! 1 1 1 ! 1 ! 1 ! I 1 1 M  I I  1 1 ! 1 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  M l
A C A TC TC C A G C G TTC TA G ACATG G AG G C CATCACTTTCAAG AAG TTG G TG AAG G G CCATG 9 6 0
Q u e ry “ 67 C -T A C T C T G T G A C -G G G -C -A -G C A G -T G A -C T A C -G A A G C -A G T T G -T G A G C -T G A T C -
1 I . i i i 1 i 1 , 1 , > ! : ■ 1 1 : 1 ...................1 I I  I I  I I  1 1 1 1 1 1 1 1 1 1
8 3 4
S b j c t 961
1 1 1 1 1 1 ! 1 M i 1 i 1 ; 1 I I 1 1 1 1 i 1 1 1 1 1 I I  i l  I I  I I  I I I I I I I I I I
CCTACTCTGTGACCGG G G CCAAGCAG G TG AACTACCGAG G CCAGG TG G TG AG CCTG ATCC1 0 2  0
Que r  y 8 3 5 G -A T G C C G A -C C C -T G G G -C G A G T T G A A T T G -A C G G -A G C -T G -A -C G A C A G C T C C T C A -
i i . i i i i  i i i  i i < i i i i i i i  i i i  i i i i i i i  i i  i i i i i i i i i i i i i i
8 84
S b j  c t 1 0 2 1
I i i i i  i i  i i i  i i i  i i i  i i m  i i i  i i i i m i  i i  i i i i i i . ..................... ...
GGATGCGGAACCCCTGGGGCGAGGTGGAGTGGACGGGAGCCTGGA.GCGACAGCTCCTCAG10 8  0
Q u e rv 8 8 5 A -T G -A -C A -C G T G -A C C -A T -T G A A C G  90 5
S b j c t 1 0 8 1 AG TG G AACAACG TG G ACCCATATGAACG  1 1 0  8
BLAST search results using sequence from calpain1-GFP retroviral plasmid sequenced with
capn1ExF1 forward primer
273
H om o s a p ie n s  c a l p a i n  1 ,  t n u / I )  l a r g e  s u b u n i t  [C A P N 1 ) ,  mRNA, L e n g t h = 3 0 0 7 ,
I d e n t i t i e s  = 9 5 1 / 9 7 2  (9 8 % ; , G a p s  = 1 7 / 9 7 2  (1% )
Q u e r y 16 G G TG C TG A-CTCTCG CAG G TTG ATG -ACTG CTCTG AG CG CG CC CG AG ACG CATTG GC CAG 7 3
1 1 1 1 I I  1 1 1 1 1 t 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 i ! 1 1 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 ! 1 1
S b  j  c t 15 98
! M  I I  I I  ! M  ) M  I I  M I I  I I  i 1 1 1 1 J 1 I I  1 I !  1 ! I 1 M  M  1 1 1 I I  1 M M  1 1 1 M M 
GGTGCTGACCTCTCGCAG G TTGATG AACTG CTCTG AGCGCGCCCG AGACG CATTG G CCAG 153 9
Q u e r y ‘ 4 GAAGAAG TCACG CTTCAAG TG TACG GCCG GCTGG CCCACCAGCTCCG G AG G G ACCTCG TA133
I I I I I I  I i I I I 1 M I I I I 1 I I 1 1 I | I 1 I 1 I 1 1 1 1 > 1 1 1 1 1 1 1 I 1 1 1 1 I 1 I I 1 1 1 1 1 1 1 1 1
S b j  c t 15  38
M  1 ! 1 1 1 M  1 I f  M I I  I I  1 M  1 1 I 1 1 I I  M  1 1 M  1 1 1 1 I I  1 1 1 I I  I I  1 I I I  1 M  1 I !  1 1
GAAGAAGTCACGCTTCAAG TG TACG GCCG GCTGG CCCACCAGCTCCG G AG G G ACCTCG TA147 9
Q u e r i ­ 1 3 4 GACCGCGAAGCCAATAGTCTCCATGTCGCGGCCGAAGCGGCGCTCGCGGCGACGGTGCTT
1 1 1 1 1 1 1 J 1 ) ! I 1 1 ! 1 1 1 1 I 1 1 I 1 1 1 1 1 1 1 1 1 . ....................... ... 1 1 1 ! 1 1 1 1 1 1 1 1 1 I 1 i 1
1 9 3
s t  i  c  t 1 4 7
............  ' ! 1 ! 1 1 1 I M  I 1 i 1 M  1 1 1 1 1 1 1 1 1 I I  1 I I  1 1 1 1 I I  1 I I  i 1 i I I  1 i 1 1 I I  I 1 I I
G ACCG CG AAG CCAATAGTCTCCATGTCGCGGCCGAAGCGGCGCTCGCGGCGACGGTGCTT14 1 9
Q u e r y 1 9 4 CTG CATAAGGGCGAGCACGAAGCTGCAGCCTGACTCGCGGTCCCCGTAGTCGTCCGGGTC2 53
I j 1 i ;  1 M  1 M 1 ! N  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Sb j  c t 1 4 1 9
M 1 1 ' 1 ! | | ! I I  | 1 | | | | 1 [ f i I I  f 1 | | i l  | | j { 1 1 [ 1 1 1 | | i I | I I  1 | (  I I  I I  I I  ( 1 I )
CTG CATAAG G G CG AG C ACG AAGCTGCAG CCTGACTCGCGG TCCCCG TAG TCG TCCG G G TCl3 5 9
Q u e r y 2 5 4 ATCCG TCTCATCCAGCCG GATCTTG AACTG AG G G TTCACCC AG AAG G TG G CTG G G TAG TT 3 1 3
S b  j  c t 1 3 5 8
: 1 1 1 ! ! ! : ! ! ! ! !  I [ M 1 1 1 I M  M  11 M  M  I I  I I  1 1 1 I I  I I I  111 1 I I  1 1 I I I  1 I I  1 1
A TC C G TC TC ATC CAG C CG G ATCTTG AACTG AG G G TTCACCC AG AAG G TG G CTG G G TAG TT12 99
Q u e r y 5 1 4 TCGGCAGCCCCCCGCC-GTGCTCCCCCGCCGCCAGGTGCCTTCGTAGAGTGTGGTGTTCCA 3 7 3
S b j  c t 12 98
i i i i i i i i i i i i i 1 i i i i 1 i i i i i i i i i i i i t i i i i i i i i i i i i i i i i i i i i i i i i i i i i
TCGGCAGCCCCCCGCGGTGCTCCCCCGCCG CCAG GTG CCTTCG TAGAG TG TG GTGTTCCA12 3 9
Q u e r y 3 7 4 TTTGCGG ATGG TCCGG CICTTGAG G GCGTCG GG TG TG AGG TTG CAG ATCTCCAG G CG GG T 4 3 3
S b ;  c t 1 2 3 8
1 1 i : 1 1 1 ' 1 1 1 1 . ' 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1
TT7G CG G ATG G TCCG G CTCTTG AG G GCGTCGG G TG TG AG G TTG CAG ATCTCCAG GCGG G T117 9
Q u e ry 4 34 G AG CTCCCG CATG AAG TCTC G G AATG ACATCC AG AAC TCCCC G TC CTCCATCTTG ACCC G 4 9 3
S b j  c t 1 1 ” 6
i i i i : i i i i i i i i i i t i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
G AAC TC C C G C A TG AA G TC TC G G A ATG A C A TC C A G A AC TC C C C G TC C TC C A TC TTG A C C C G 11 1 5
Q u e r y 4 94 G AG CTG G TCC CG TTCATATG G G TCCACG TTG TTC CAC TCTG AGG AG CTG TCG CTCCAG G C 5 5 3
S b j  c t 1 1 1 8
1 l 1 1 ' 1 1 1 1 1 1 1 1 1 1 1 | 1 1 1 1 1 1 1 1 1 1 | 1 1 1 1 1 | | 1 1 | 1 1 | 1 1 1 | 1 1 1 1 1 1 1 1 1 1 1 1 1
G AG C TG G TCC CG TTCATATG G G TCCACG TTG TTC CAC TCTG AG G AG CTG TCG CTCCAG G C10 5 9
Q u e ry 5 54 TCCCGTCCACTCCACCTCGCCCCAG G G GTTCCG CATCCG G ATCAG G CTCACCACCTG GCC
! 1 : . .............. ... ! 1 1 1 1 I 1 I 1 1 1 1 1 ! I 1 ! 1 ! 1 1 I 1 1 1 1 1 1 1 1 1 1 I 1 ! 1 1 ! 1 I I  I 1 1 1 1 1 1 I
6 1 3
Sb j  c t 105-8
! i 1 1 i i 1 ' i I 1 M 1 1 1 1 1 1 1 1 1 ! 1 1 1 M  1 1 1 M 1 1 1 1 I I  1 M  11 1 M  1 1 1 M  1 I t  1 1 1 1 
TCCCGTCCACTCCACCTCGCCCCAG G G GTTCCG CATCCG G ATCAG G CTCACCACCTG GCC 9 9 9
Q u e r y 614 TC G G TA G TTCACCTG CTTG G CCCC G G TC ACAG AG TAG G CATG G C CCTTCACCAACTTCTT
1 1 1 : i 1 , 1 i ; 1 1 1 i 1 1 1 1 ' i 1 1 i 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ! I I  1 1 1
6 7 3
S b  j  c t 9 ,8
! ! ! i ! M : i 1 I i ' 1 i ! 1 1 M 1 1 1 1 i 1 ; ! 1 ! l  1 1 1 1 1 i M  11 I I  I 1 1 1 ! 11 1 i I I  1 I I  1 1 1 
TC G G TA G T7C A C C TG C T7G G CCCC G G TC ACAG AG TAG G CATG G C CCTTCACC AACTTC TT 9 3 9
Q u e r y 67 4 G AA A G TG A7G G C CTCCATG TCTAG AACG CTG G AG ATG TCTATG G AG C AG CCC AG CAG G -A
1 ' ; 1 1 1 1 i l i I i 1 i 1 1 ] 1 ! 1 1 i i l 1 I 1 1 1 i 1 1 1 1 1 1 1 j 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
7 3 2
S b  j  c t 23  8
1 I i 1 I I I 1 i i I I M i | ; I I  I I  I 1 1 i 1 1 1 M ! | 1 I I  H  1 H  1 1 1 1 1 H  I I  ! 1 1 H  I I  1 1 
G AA A G TG A - GGCCTC CAT GT C TAG AACG CT G G AG ATG 1 C T A T  GGAGCAGCCCAGCAGGGA 8 7 9
Q u e r y - 3 3 G CCCCGCTCCAGCGCCTTG AG GATG ATCTG G TAG AG GTCACTGG G AGCCTTG CG CAACTC
i i i i ■ i i 1 1 i i 1 i , I i i i i i i i i i i i i i i i ' i i i i t i i i i i i i i i i i i i i i i i i l  l M i
7  92
Sb j  c t 8 7 8
1 I 1 ’ i 1 1 ' i I I 1 I I  l 1 I l 1 1 1 1 1 1 1 1 1 1 I i I I 1 I 1 1 I 1 I !  1 I 1 I !  11 I 1 1 1 1 I 1 M  1 1 
GCCCCGC7CCAGCG CCTTG AG G ATGATCTG G TAG AG G TCACTG G G AG CCTTGCGCAACTC 8 1 9
Q u e r y -  93 G TACCACTCG G TAACCCCCG CCTGT GAAG TCCTCAAAG CCCTCTGAG G TG CTG CCCCCTG
i 1 i i , i ‘ 1 , < 1 1 1 . 1 i l l '  1 1 1 i : i 1 1 1 1 1 i 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
8 5 2
Sb j  c t 818
i 1 I i i n  I i 1 I i 1 i 1 I 1 n  i i I i 1 i 1 I i 1 1 1 1 i 1 I !  1 11 1 1 I I  I 1 11 I I I 1 I I I I
G TA C C A C TC G G 7A A C C C C -G C C TG TG A AG TC C TC A AA G C C C T CTGAGGTGCTGCCCCCTG -  6  0
Q u e ry 8 5 3 A C A G G G C C T C G 7 A G C T G C C A T T T A C C T T G G C A T A G -C -T -C T C A -G C A G C G C -C T C C A G A
1 I I ■ ; i 1 ! 1 1 I 1 1 1 1 1 1 1 1 ' 1 I ! ' I 1 1 I 1 ’ 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  1 1 1 1 I 1 1
9 0 7
S t  j  c t ~£S
1 1 1  i h  1 i 1 | | 1 1 1 i 1 1 1 1 1 1 I 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  1 1 1 1 1 1 1 
A C A G G G G C 7C G 7A G C 7G C C AT71AC C 7T GGCATAGGCCTTCTCAAG CAG G GCGCTCCAG A " 0 0
Q u e r y 9 0 8 A C TC G TG G C -T7C G G C -G A G T G C A C G G A A C A C TA G C A TC C -G TC C T-G A A TG G -C A G C A G
i i i i i i t i  i i ; I I I i : i I I i ; ■ 1 i 1 1 : I I 1 I I I I  1 1 1 1 1 I I  I I I  1 1 1 1 1 1
9 62
S b j  c t 6 9 9
1 1 1 1 1 1 11 1 1 1 1 1 1 | 1 1 1 1 1 I : 1 I 1 1 I 1 1 1 1 1 I I I  1 1 1 1 1 I I  I I I  1 1 1 1 1 1 
ACTCG TTG C C TTC G G C AG A G TG C AC G -AA C A C TA G C TTC C C G TC C TTG A -TG G G C AG C A G 6 42
Q u e r y 96 3 GT CAATCCACG A 9 " 4
Sb j  c t 641
I I I !  i 1 i : i 1 
G TC A -TC C A C G A  631
BLAST search results using sequence from calpain1-GFP retroviral plasmid sequenced with
capn1R1 reverse primer
274
H om o s a p ie n s  c a l p a i n  1 ,  ( n u / I )  l a r g e  s u b u n i t  (C A P N 1 ) ,  mRNA 
L e n g t h = 3 0 0 '
S c o r e  =  1 6 7 6  b i t s  ( 9 O ' ) ,  E x p e c t  = 0 . 0  
I d e n t i t i e s  = 5 5 5 / 9 7 5  ( 9 8 % ! ,  G a p s  = 1 5 / 9 7 5  (1% )
S t r a n d = P l u s / M i n u s
Q u e r y  15  ACTCCATC C AG A TC TG TG TC C A G A G TTTTG A A A AA TC G G A AC A TG G TC TC TA G C C G C A C C  72
i i i ! I I t  i I I i I I 1 M I I I i 1 I I I I I I I I I I  I I I  I I I I I  1 I I I I I I I I  I t I I I I  I I  I ! I I 
S b j c t  2 2  3 9  A C TC C A TC C AG A TC TG TG TC C A G A G TTTTG A A A AA TC G G A AC A TG G TC TC TA G C C G C A C C 21 8 0
Q u e r y  “ 3 AGGCAGCAAACG AAATTGTCAAAG TCG ACCG CCAGG TCGG G CTCCGAG TAGCGG G TG ATG  1 32
I i I i M M I I  I M ! I I I I I ! M I I I I I  I I I I  I I !  I I ! I I I t I I i l  I I I I  I I I I I  I I  I I I  I 
S b j c t  21  /9  AG G CAG CAAACG AAATTGTCAAAG TCG ACCG CCAGG TCGG G CTCCGAG TAGCGG G TG ATG21 2 0
Q u e r y  1 3 3  A TG AG C TC G TA C A G CTTCTTG TTG AG CTTG AAG CC TG C CG AC TCAATG G CCATCC G C ATC 1 9 2  
! : I I  I M  I I I 1 I I ! I I 1 1  I I I I I I I I I I  I I I I I I I  I I I  I I I I I I  I I I  I I I I  I I I t  I I I I I 
S b j c t  2 1 1 9  A TG A G C TC G TA C A G C TTC TTG TTG A G C TTG A AG C C TG C C G AC TC A ATG G C C A TC C G C ATC 20 6 0
Q u e r y  1 9 3  TC G TA G G C AC TC ATG C TG CCCG ACTTG TCCAG G TCAAACTTC CG G AAG ATG G ACAG G TAA 2 5 2
M  ; I i l  ! l  I I i i [ i I I ] I | ! ! ] ! i M  I I I ! I I I ! ! I I I I I I I I l i  I I I  I I I  I I I ! I | | | I 
S b i c t  2 0 5 9  TCG TAG G C AC TC A TG C TG C C C G A C TTG TC C A G G TC A AA C TTC C G G A A G ATG G A C A G G TA A 2000
Q u e r y  2 5 3  TTC C G G ATG CG G TTCCACAG G ATG TTG AACTCCACCAG G C CCAG C TTCCC ATTG CC ATC A 3 1 2  
M  M M  I I I i I I I I I I I I I I I I I I I I  I I I I I I  I I 1 I I I I I I I I I  I I I  I I I I I  I I I l i t  I 
S b j c t  1 9 9 9  TTCC G G ATG C G G TTC C A C A G G A TG TTG A AC TC C A C C A G G C C C A G C TTC C C ATTG C C ATC A194 0
Q u e r y  3 1 3  CG ATCCATG AG G TTCACCATG CTG CG G CACG ACTCTAG GCTG AAG CCCTTGG TCCGCAG G  3 7 2
■ ; H  i H  I I ! I I I H  ! I I i I I  I I I I I ! I I I  I I  I I  I | I I  I I I | I I | | |  | | | I | | | | | | | | 
S b j c t  1 9 3  9 CG A.C CA 7G A G G TTC AC C A7G C TG C G G C A C G AC TC TA G G C TG A A G C C C TTG G TC C G C A G G 1880
Q u e ry  3 "  TC TTT G 7G TTTG C TG A TG A TC C TA T TG A G G A TT G TC TG C A A C TC C TTC A C G C TG A TC TC C  4 32  
I H  I I I I I I  I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I ! I I I I I I  I I I  I I I I I I  I I I I
S b j c t  1 6 “ 9 T C T T T G TG TTTG C T G A TG A TC C TA TTG A G G A TTG TC C G C A A C TC C TT C A C G C TG A TC TC C 18 2 0
Q u e r y  , 3 3  A 7G TC C TC C C C TG C C A G C TG C C TG AA G A G G G C C TTG A A G TTC TC G TC A A TC TC C TC TTC T 4 9 2
! ! I ' H  u  I I  I I i ! I I I I  I I i l  H  I I I I ! I 1 I I I I I I  1 I i i I I I I I I I I  I I I I I I  I I I I  
S b j c t  1 6 1 9  A TG TC C TC C C C TG C C A .G C TG C C TG A AG A G G G C C TTG AA G TTC TC G TC AA TC TC C TC TTC T17 60
Q u e r y  4 53  G AG AG CACTTG CTCATCG G G G AG ATTG G C CTG G ATCTG G TCATCC AG CTC CACAG TC CCA 5 5 2
I A  H  1 I ; I I I I  I !  I i M  I i I I  I I I  I I I I I  I I I I I I  I I i I I I I I I I  I I I I I t  I I I I  I I I I 
S b j c t  1 7 5 9  G AG A G C A C TTG CTCATCG G G G AG ATTG G C CTG G ATCTG G TCATCC AG CTC CACAG TC CCA1700
Q u e r y  5 53  G CACTCITC TC IG A G AA G A AG C G C A G C A C G AA G TC G C C C TC C TTG TTG G G C TC G A AG G TG  6 12
■ : I I i : ! M  H  : i ■ ' I I I  M  i i H  i I I I !  M  I I I ! I I I I  I I I I I  I I I I  I I I  I I I I  I I I I 
S b j c t  16 99  G CACTCITC TC TG A G .AA G A AG C G C A G C A C G AA G TC G C C C TC C TTG TTG G G C TC G A AG G TG l64 0
Q u e ry  6 1 3  C-AGGGCACCACCACA7ACTCCCCGGGTGGCAGGCGGAAGCGC-GTGCTGACCTCTCGCAGG 6 7 2
; I I ! 1 I I I  I : I I i . H  I I I  I M  ! I I I I I I I I I I I I I M  I I I I I I  I I  I I I  I I I I I  I I I I 
S b j c t  1 6 3 9  GA-GGGCACCACCACA7ACTCCCCGGGTGGCAGGCGGAAGCGGGTGCTGACCTCTCGCAGG15 8 0
Q u e ry  6 c . i  c A T t A H  . u t . u T u a u u G u G tC c u A S A tG C A T  i  GGCGAcjG AAG AA o  i  C A G G c.T 7 cA A a  3 r
S b j c t  15 7 9 77G A TG AA C TG C7CTG AG C G C G C CCG AG ACG CATTG G CCAG G AAG AAG TCACG CTTCAAG 1S20
Q u e r y  ' 5 3  TG TACG GCCG GCTG GCCCACCAGCTCCGGAGGGACCTCGTAGACCGCGAAGCCAATAGTC 7 92
S b j c t  1 5 1 9  7G 7ACG G C CG G C 7G G CCC ACC AG C7CCG G AGG G ACCTCG TAG ACCG CG AAG CCAATAGTC 14 60
Q u e ry  ' 9 3  7CCATG 7CG CCGCCCG AAG CG G CG CTCG CG G CG ACG GTG CTTCTG CATAAG G -CG AGCAC 8 5 1
Q u e ry  6 5 2  G AAG CTG CAG CCTG ACTCG CG G TCCC CG TAG TCG TC CG G -TCATCCG TC7CATCCAG CCC 9 1 0
: M  I M  A  H  H  i I I  I I I I I I  M  I H  I I I I  I I I I I  I I I  I l I I I I  I I I  I I I I I I I I I I 
S b j c t  14 00  G AA G C 7G C AG C C TG AC TC G C G G TC C C C G TA G TC G TC C G G G TC A TC C G TC TC ATC C AG C C -I342
Q u e ry  9 1 1  G G A 7 C 7 7 G G A C T G A G G -T -C A C C C A G A -G -7 G T C C T G — 7AG 77CCG CCAGCCCCCCG CG  9 64
i I M  : H  : , I I I I : I I H  I ! I I I I I  I 1 I I I I I !  I I I I I I I I I I I I
S b j c t  1 3 4 1  GAT CT7G AAC7G AG G G TTCACCCAG AAG G TG G C-TG G G TAG TTTC G G CAG CCCC CCG CG 128 3
Q u e r y  9 6 5  CGGGTGCTTCCCCCG 9 7 9
S b j c t  1 2 8 1  - G — TG C T-C C C C C G  1 2 7 2
BLAST search results using sequence from calpain1-GFP retroviral plasmid sequenced with
capnl ExR1 reverse primer
275
Homo sapiens calpain 1, (mu/I) large subunit (CAPN1), mRNA 
Length=3007
Identities = 914/933 (98%), Gaps = 10/933 (1%) 
Strand=Plus/Plus
Query 68 ATGTCGGAGGAGATCATCAAGCCGAATGTACTGCACTGGGGTGTCAGCCCAAGTGCAGAA
1 1 M 1 1 M 1 1 1 1 1 1 1 1 1 1 1 1 1 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
ATGTCGGAGGAGATCATCACGCCG-GTGTACTGCACTGGGGTGTCAGCCCAAGTGCAGAA
127
Sb j ct 144 202
Query 128 GCAGCGGGCCAGGGAGCTGGGCCTGGGCCGCCATGAGAATGCCATCAAGTACCTGGGCCA 
M II 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 I I I M 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GCAGCGGGCCAGGGAGCTGGGCCTGGGCCGCCATGAGAATGCCATCAAGTACCTGGGCCA
187
Sbj ct 203 262
Query 188 GGATTATGAGCAGCTGCGGGTGCGATGCCTGCAGAGTGGGACCCTCTTCCGTGATGAGGC 
1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I I || I I | | | | | | | | | || | | I I | | || | 
GGATTATGAGCAGCTGCGGGTGCGATGCCTGCAGAGTGGGACCCTCTTCCGTGATGAGGC
247
Sbjct 263 322
Query 248 CTTCCCCCCGGTACCCCAGAGCCTGGGTTACAAGGACCTGGGTCCCAATTCCTCCAAGAC 
1 1 1 1 II II 1 1 1 1 1 1 II 1 1 1 1 1 II 1 1 1 II 1 1 1 1 II II 1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 1 II 1 I 
CTTCCCCCCGGTACCCCAGAGCCTGGGTTACAAGGACCTGGGTCCCAATTCCTCCAAGAC
307
Sbjct 323 382
Query 308 CTATGGCATCAAGTGGAAGCGTCCCACGGAACTGCTGTCAAACCCCCAGTTCATTGTGGA 
1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 II 1 1 1 1 1 1 I I 1 1 1 I I 1 1 1 1 I | I I I 
CTATGGCATCAAGTGGAAGCGTCCCACGGAACTGCTGTCAAACCCCCAGTTCATTGTGGA
367
Sbj ct 383 442
Query 368 TGGAGCTACCCGCACAGACATCTGCCAGGGAGCACTGGGGGACTGCTGGCTCTTGGCGGC 
1 II II II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 1 II 1 I 1 1 1 
TGGAGCTACCCGCACAGACATCTGCCAGGGAGCACTGGGGGACTGCTGGCTCTTGGCGGC
427
Sbj ct 443 502
Query 428 CATTGCCTCCCTCACTCTCAACGACACCCTCCTGCACCGAGTGGTTCCGCACGGCCAGAG 
1 II 1 II 1 II II 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 II 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 II 1 II II 1 1 
CATTGCCTCCCTCACTCTCAACGACACCCTCCTGCACCGAGTGGTTCCGCACGGCCAGAG
487
Sbjct 503 562
Query 488 CTTCCAGAATGGCTATGCCGGCATCTTCCATTTCCAGCTGTGGCAATTTGGGGAGTGGGT 
1 1 1 1 1 1 1 1 1 1 II 1 1 II 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 II II 1 1 II 1 II II 1 1 
CTTCCAGAATGGCTATGCCGGCATCTTCCATTTCCAGCTGTGGCAATTTGGGGAGTGGGT
547
Sbj ct 563 622
Query 
Sbj ct
548
623
GGACGTGGTCGTGGATGACCCGCTGCCCATCAAGGACGGGAAGCTAGTGTTCGTGCACTC 
1 1 1 1 II 1 1 1 1 1 1 II 1 1 II 1 1 1 1 1 1 1 II 1 1 1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 
GGACGTGGTCGTGGATGACCTGCTGCCCATCAAGGACGGGAAGCTAGTGTTCGTGCACTC
607
682
Query
Sbjct
608
683
TGCCGAAGGCAACGAGTTCTGGAGCGCCCTGCTTGAGAAGGCCTATGCCAAGGTAAATGG 
1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 II II 1 1 1 1 1 II 1 1 II 1 1 1 II 1 1 1 1 II II 1 1 1 1 1 
TGCCGAAGGCAACGAGTTCTGGAGCGCCCTGCTTGAGAAGGCCTATGCCAAGGTAAATGG
667
742
Query 6 68 CAGCTACGAGGCCCTGTCAGGGGGCAGCACCTCAGAGGGCTTTGAGGACTTCACAGGCGG 
II 1 1 II 1 II 1 II 1 1 II II 1 1 1 1 1 II 1 1 II 1 II 1 1 1 1 II II 1 II 1 II II II II 1 1 1 1 1 1 1 1 
CAGCTACGAGGCCCTGTCAGGGGGCAGCACCTCAGAGGGCTTTGAGGACTTCACAGGCGG
727
Sbj ct 743 802
Query
Sbjct
728
803
GGTTACCGAGTGGTCCGAGTTGCGCAAGGCTCCCAGTGACCTCTACCAGATCATCCTCAA 
1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 II II 1 1 1 II 1 1 1 1 1 1 
GGTTACCGAGTGGTACGAGTTGCGCAAGGCTCCCAGTGACCTCTACCAGATCATCCTCAA
787
862
Query 788 GGCGCTGGAGCGGGGCTCCCTGCTGGGCTGCTCCATAGACATCTCCAGCGTTCTAGACAT 
1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 
GGCGCTGGAGCGGGGCTCCCTGCTGGGCTGCTCCATAGACATCTCCAGCGTTCTAGACAT
847
Sbj ct 863 922
Query 848 GGAGGCCATCACTTCCCAAGAAGTTGGTGAAGG-CCATGCCTACTCTGTGACCGGG-CCA
1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 III
GGAGGCCATCACTTTC-AAGAAGTTGGTGAAGGGCCATGCCTACTCTGTGACCGGGGCCA
905
Sb j ct 923 981
Query
Sbjct
906
982
AGCAAGTGAACTACCGAGGCCAGGTGGTGAGCCTGATC-G-ATGCGGAAACCCTGGG-CG 962 
1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 II II II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II
AGCAGGTGAACTACCGAGGCCAGGTGGTGAGCCTGATCCGGATGCGGAACCCCTGGGGCG1041
Query 963 AAGGTTGGAATTGACGGGAGCCTGGGAGCGACA 9 95
1 III III 1 1 II II 1 1 1 1 II II 1 1 1 II 1 1
A-GGT-GGAGTGGACGGGAGCCTGG-AGCGACA 1071Sbi ct 1042
BLAST search results using sequence from CAPN1-GFP TOPO plasmid sequenced with
T7Foward primer
276
Homo sapiens calpain 1, (mu/I) large subunit (CAPN1) , mRNA 
Length=3007
Identities = 485/491 (99%), Gaps = 3/491 (0%) 
Strand=Plus/Plus
Query 97 GCAAATGGAACACCACACTCTACGAAGGCACCTGGTTTTGCGGGGGAGCACCGCGGGGGG 156
i i i i i i ii i i i i i i i i i i i ii i i i i i i i i i i i i i i i i i i i i i i i i i i i ii i i i i i i
Sbj ct 1234
II II 1 1 1 II II I 1 II II 1 I! I! II II II II 1 II II 1 1 1 1 1 II 1 II 1 1 1 II 1 1 1 1 1 1 
GCAAATGGAACACCACACTCTACGAAGGCACCTGG— CGGCGGGGGAGCACCGCGGGGGG12 91
Query 157 CTGCCGAAACTACCCAGCCACCTTCTGGGTGAACCCTCAGTTCAAGATCCGGCTGGATGA 216
i i i i i i i i i i i i i i i i t i i I i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 1292
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 II 1 II 1 
CTGCCGAAACTACCCAGCCACCTTCTGGGTGAACCCTCAGTTCAAGATCCGGCTGGATGA1351
Query 217 GACGGATGACCCGGACGACTACGGGGACCGCGAGTCAGGCTGCAGCTTCGTGCTCGCCCT 27 6
i i i i i i i i i i i i i i i i i i i i i I i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 1352
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GACGGATGACCCGGACGACTACGGGGACCGCGAGTCAGGCTGCAGCTTCGTGCTCGCCCT1411
Query 277 TATGCAGAAGCACCGTCGCCGCGAGCGCCGCTTCGGCCGCGACATGGAGACTATTGGCTT 336
i i i i i i i i i i i i i i i i i i i i i i i I i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 1412
1 1 1 1 1 II 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TATGCAGAAGCACCGTCGCCGCGAGCGCCGCTTCGGCCGCGACATGGAGACTATTGGCTT1471
Query 337 CGCGGTCTACGAGGTCCCTCCGGAGCTGGTGGGCCAGCCGGCCGTACACTTGAAGCGTGA 396
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 1472
1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CGCGGTCTACGAGGTCCCTCCGGAGCTGGTGGGCCAGCCGGCCGTACACTTGAAGCGTGA1531
Query 397 CTTCTTCCTGGCCAATGCGTCTCGGGCGCGCTCAGAGCAGTTCATCAACCTGCGAGAGGT 456
1 1 1 1 1 1 1 II i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 !
Sbj ct 1532
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 
CTTCTTCCTGGCCAATGCGTCTCGGGCGCGCTCAGAGCAGTTCATCAACCTGCGAGAGGT1591
Query 457 CAGCACTCGCTTCCGCCTGCCACCCGGGGAGTATGTGGTGGTGCCCTCCACCTTCGAGCC 516
i t i i i i i i i i i i i i i i i i i i i i i i i i i i t i i i i i i i i i i i i i i i i i t i i i i i i i i i i i i
Sbj ct 1592
1 II 1 1 1 1 1 II 1 1 1 1 1 1 1 II 1 II 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 
CAGCACCCGCTTCCGCCTGCCACCCGGGGAGTATGTGGTGGTGCCCTCCACCTTCGAGCC1651
Query 517 CAACAAGGAGGGCGACTTCGTGCTGCGCTTCTTCTCAGAAGAAGAGTGCTGGGACTGTGG 57 6
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 1652
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CAACAAGGAGGGCGACTTCGTGCTGCGCTTCTTCTCAGA-GAAGAGTGCTGGGACTGTGG1710
Query 577 AGC T GGAT GAC 587
i i i i i i i i i i i
Sbj ct 1711
1 1 1 1 1 1 1 1 1 1 1 
AGCTGGATGAC 1721
BLAST search results using sequence from CAPND3-GFP TOPO plasmid sequenced with 
T7Foward primer
277
calpain, small subunit 1 [Homo sapiens]
Score = 1242 bits (672), Expect = 0.0 
Identities = 672/672 (100%), Gaps = 0/672 (0%) 
Strand=Plus/Plus
Query 90 GGCGGCGGCGGTGGTGGAGGCGGCGGTGGCGGTGGAACGGCCATGCGCATCCTAGGCGGA14 9
1 1 1 1 i 1 1 i 1 1 1 1 1 i 1 1 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1
Sbj ct 290
1 II M  II II II II II II II 11 II II II 1 II II II II M  II II M  II 1 II M  II II 1 II II 
GGCGGCGGCGGTGGTGGAGGCGGCGGTGGCGGTGGAACGGCCATGCGCATCCTAGGCGGA34 9
Query 150 GTCATCAGCGCCATCAGCGAGGCGGCTGCGCAGTACAACCCGGAGCCCCCGCCCCCACGC2 09 
i i i i i i ii i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i m
Sbj ct 350
1 1 1 1 II II 1 II II 1 II 1 1 II II II II II II II 1 II 1 II II II II 1 1 II II II II II II II 
GTCATCAGCGCCATCAGCGAGGCGGCTGCGCAGTACAACCCGGAGCCCCCGCCCCCACGC4 09
Query 210 ACACATTACTCCAACATTGAGGCCAACGAGAGTGAGGAGGTCCGGCAGTTCCGGAGACTC2 69
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 410
1 1 II 1 1 II II 1 II 1 II 1 II 1 II 1 1 1 I II 1 1 1 II 1 II 1 1 II 1 1 II II II II 1 1 II 1 I! 1 II 
ACACATTACTCCAACATTGAGGCCAACGAGAGTGAGGAGGTCCGGCAGTTCCGGAGACTC4 69
Query 270 TTTGCCCAGCTGGCTGGAGATGACATGGAGGTCAGCGCCACAGAACTCATGAACATTCTC32 9
1 1 1 1 II 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Sbj ct 470
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TTTGCCCAGCTGGCTGGAGATGACATGGAGGTCAGCGCCACAGAACTCATGAACATTCTC52 9
Query 330 AATAAGGTTGTGACACGACACCCTGATCTGAAGACTGATGGTTTTGGCATTGACACATGT38 9
.... . i i i i i i i i i i . ........ i i i i i i . .............. i i i i i i i i i i i i i i i
Sbj ct 530
1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
AATAAGGTTGTGACACGACACCCTGATCTGAAGACTGATGGTTTTGGCATTGACACATGT58 9
Query 390 CGCAGCATGGTGGCCGTGATGGATAGCGACACCACAGGCAAGCTGGGCTTTGAGGAATTC4 4 9
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 590
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CGCAGCATGGTGGCCGTGATGGATAGCGACACCACAGGCAAGCTGGGCTTTGAGGAATTC 64 9
Query 450 AAGTACTTGTGGAAC AACATCAAAAGGTGGCAGGCCATATACAAACAGTTCGACACTGAC 50 9
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 650
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
AAGTACTTGTGGAACAACATCAAAAGGTGGCAGGCCATATACAAACAGTTCGACACTGAC7 0 9
Query 510 CGATCAGGGACCATTTGCAGTAGTGAACTCCCAGGTGCCTTTGAGGCAGCAGGGTTCCAC569
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct ■710
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CGATCAGGGACCATTTGCAGTAGTGAACTCCCAGGTGCCTTTGAGGCAGCAGGGTTCCAC7 69
Query 570 C T GAAT GAGCAT C T C TATAACAT GAT CAT C C GAC GC TAC T CAGAT GAAAGTGGGAACATG 62 9
i i i i i i i i i i t i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
Sbj ct 770
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CTGAATGAGCATCTCTATAACATGATCATCCGACGCTACTCAGATGAAAGTGGGAACATG82 9
Query 630 GATTTTGACAACTTCATCAGCTGCTTGGTCAGGCTGGACGCCATGTTCCGTGCCTTCAAA68 9
1 i 1 1 1 1 i 1 1 1 1 1 1 I 1 i I i 1 1 1 1 1 1 1 1 1 1 1 i 1 1 1 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1
Sbj ct 830
M  1 II It 1 1 II 1 1 1 I! ! 1 I! 1 II M  II II 1 II 1 i II II 1 II II II 1 It II II II II II II 
GATTTTGACAACTTCATCAGCTGCTTGGTCAGGCTGGACGCCATGTTCCGTGCCTTCAAA8 8 9
Query 690 TCTCTTGACAAAGATGGCACTGGACAAATCCAGGTGAACATCCAGGAGTGGCTGCAGCTG74 9 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1
Sbj ct 890
II 1 II II 1 1 II 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 M  II 1 
TCTCTTGACAAAGATGGCACTGGACAAATCCAGGTGAACATCCAGGAGTGGCTGCAGCTG94 9
Query 750 ACTATGTATTCC 761 
I I I I  I I  I I I I I I 
Sbjct 950 ACTATGTATTCC 961
BLAST search results using sequence from CAPNS1-GFP TOPO plasmid sequenced with 
T7Foward primer
278
Homo sapiens calpain 1, (mu/I) large subunit (CAPN1), mRNA Length=3007
Identities = 906/920 (99%), Gaps = 11/920 (1%)
Strand=Plus/Plus
Query 16 CGAATACGGGGA-CGCGAGTCAGGCTGCAGCTTCGTGCTCGCCCTTATGCAGAAGCACCG 74 
III I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I II II I I 
Sb j ct 13 67 CGACTACGGGGACCGCGAGTCAGGCTGCAGCTTCGTGCTCGCCCTTATGCAGAAGCACCG142 6
Query 75 TCGCCGCGAGCGCCGCTTCGGCCGCGACATGGAGACTATTGGCTTCGCGGTCTACGAGGT 134
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 1427 TCGCCGCGAGCGCCGCTTCGGCCGCGACATGGAGACTATTGGCTTCGCGGTCTACGAGGT1486
Query 135 CCCTCCGGAGCTGGTGGGCCAGCCGGCCGTACACTTGAAGCGTGACTTCTTCCTGGCCAA 194
II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 1487 CCCTCCGGAGCTGGTGGGCCAGCCGGCCGTACACTTGAAGCGTGACTTCTTCCTGGCCAA154 6
Query 195 TGCGTCTCGGGCGCGCTCAGAGCAGTTCATCAACCTGCGAGAGGTCAGCACCCGCTTCCG 2 54 
I I II I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 1547 TGCGTCTCGGGCGCGCTCAGAGCAGTTCATCAACCTGCGAGAGGTCAGCACCCGCTTCCG1606
Query 255 CCTGCCACCCGGGGAGTATGTGGTGGTGCCCTCCACCTTCGAGCCCAACAAGGAGGGCGA 314 
I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 1607 CCTGCCACCCGGGGAGTATGTGGTGGTGCCCTCCACCTTCGAGCCCAACAAGGAGGGCGA1666
Query 315 CTTCGTGCTGCGCTTCTTCTCAGAGAAGAGTGCTGGGACTGTGGAGCTGGATGACCAGAT 3 74 
I I I I I I I I I I II I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct 1667 CTTCGTGCTGCGCTTCTTCTCAGAGAAGAGTGCTGGGACTGTGGAGCTGGATGACCAGAT17 2 6
Query 37 5 CCAGGCCAATCTCCCCGATGAGCAAGTGCTCTCAGAAGAGGAGATTGACGAGAACTTCAA 4 34 
I I I I I I I II II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbjct 1727 CCAGGCCAATCTCCCCGATGAGCAAGTGCTCTCAGAAGAGGAGATTGACGAGAACTTCAA1786
Query 4 35 GGCCCTCTTCAGGCAGCTGGCAGGGGAGGACATGGAGATCAGCGTGAAGGAGTTGCGGAC 4 94 
I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct 17 87 GGCCCTCTTCAGGCAGCTGGCAGGGGAGGACATGGAGATCAGCGTGAAGGAGTTGCGGAC18 4 6
Query 4 95 AATCCTCAATAGGATCATCAGCAAACACAAAGACCTGCGGACCAAGGGCTTCAGCCTAGA 554 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I 
Sbjct 1847 AATCCTCAATAGGATCATCAGCAAACACAAAGACCTGCGGACCAAGGGCTTCAGCCTAGAl906
Query 5 55 GTCGTGCCGCAGCATGGTGAACCTCATGGATCGTGATGGCAATGGGAAGCTGGGCCTGGT 614 
I I II I I I I I I II I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I II I I I I I I I I I I I I I 
Sbjct 1907 GTCGTGCCGCAGCATGGTGAACCTCATGGATCGTGATGGCAATGGGAAGCTGGGCCTGGT1966
Query 615 GGAGTTCAACATCCTGTGGAACCGCATCCGGAATTACCTGTCCATCTTCCGGAAGTTTGA 674 
I I I I I I I I I I II I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I 
Sbjct 1967 GGAGTTCAACATCCTGTGGAACCGCATCCGGAATTACCTGTCCATCTTCCGGAAGTTTGA2026
Query 675 CCTGGACAAGTCGGGCAGCATGAGTGCCTACGAGATGCGGATGGCCATTGAGTCGGCAGG 734
I I I I I I I I I I I I I I I I I I I I I I I  I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I M  I I I I I I
Sbjct 2 027 CCTGGACAAGTCGGGCAGCATGAGTGCCTACGAGATGCGGATGGCCATTGAGTCGGCAGG2086
Query 735 CTTCAAGCTCAACAAGAAGCTGTACGAGCTCATCATCACCCGCTACTCGGAGCCCGACCT 7 94 
I II I I I I I I I I II I I I I I I I I I I I I I I I I I I II I I I II I I I I I I I I I I I I I I I I I I I I I I
Sbjct 2 087 CTTCAAGCTCAACAAGAAGCTGTACGAGCTCATCATCACCCGCTACTCGGAGCCCGACCT2146
BLAST search results using sequence from CAPN1-GFP Lenti plasmid sequenced with
CAPN1/C2F1 forward (mid seq) primer
279
Hom o s a p ie n s  c a l p a i n  1 ,  ( n u / I )  l a r g e  s u b u n i t  (C A P N 1 ) ,  mRNA L e n g t h =
r-oo
I d e n t i t i e s  =  8 7 8 / 1 0 0 2  ( 9 8 %) ,  G a p s  =  1 6 / 1 0 0 2  (1% ) 
S t r a n d = P l u s / M i n u s
Q u e r y 1 9 CGGGTGCTGACCTCTCGCAGG TTGATG -ACTG CTCTG AG CG CG CCCGAG ACG CATTGG CC 77
S b j  c t 16  00
I I I ................I I !  1 1 1 1 1 1 1 1 I I  1 1 I I  1 1 1 1 1 1 1 1 1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  1 1 1 1
CGGGTGCTGACCTCTCG CAG G TTGATG AACTG CTCTG AGCGCGCCCG AGACG CATTG G CC154 1
Q u e r y “ 8 AGGAAGAAGTCACGCTTCAAGTGTACGGCCGGCTGGCCCACCAGCTCCGGAGGGACCTCG
1 ! 1 1 1 1 1 1 1 1 1 ............ 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 ..................... ... 1 1 1 1 1 1 1 1
1 37
S b j c t 15 4 0
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
AGG AAGAAGTCACGCTTCAAGTGTACGGCCGGCTGGCCCACCAGCTCCGGAGGGACCTCG14 81
Q u e ry 1 3 8 TAGACCGCGAAGCCAATAGTCTCCATGTCGCGGCCGAAGCGGCGCTCGCGGCGACGGTGC 1 9 7
S b j c t 14 8 o
i 1 i ' i i i i : i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
TAG ACCGCGAAGCCAATAGTCTCCATGTCGCGGCCGAAGCGGCGCTCGCGGCGACGGTGC14 2 1
Q u e r y 1 9 8 TTCTG CATAAGG G CG AGCACGAAGCTGCAGCCTGACTCGCGGTCCCCGTAGTCGTCCGGG 2 5 7
S b j c t 14 2 0
1 1 1 I 1 ’ I I 1 1 1 1 i 1 : 1 I 1 I I 1 1 I 1 1 1 1 1 I 1 I I 1 1 1 1 1 1 1 I 1 I 1 1 I 1 1 1 1 1 1 1 1 1 I I 1 1 1
TTCTG CATAAGG G CG AGCACGAAG CTG CAGCCTG ACTCG CG GTCCCCG TAG TCG TCCG G G 13 6 1
Q u e ry 2 5 6 TCATCC G TC TCATCCAG CCG G ATCTTG AACTG AG GG TTCACCCAGAAGG TG G CTG G G TAG 3 1 7
S b j c t 1 3 60
i i i i i . i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i  i i i i i i i i i i i i  i i
TC ATCC G TC TCATCCAG CCG G ATC TTG AACTG AG G G TTCACC CAG AAG G TG G CTG G G TAG 13 0 1
Q u e ry 3 1 8 TTTCG G CAG CCCC CCG CGGTGCTCCCCCGCCGCCAGGTGCCTTCGTAGAGTGTGGTGTTC
! ! i 1 1 i 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  1 1 1 I I  1 1 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 t 1 1 1 1 1
3 7 7
S b j c t I3 C 0
' 1 I M i 1 1 1 I 1 1 ! l !  1 1 1 M  I I  1 1 1 I I  I I  I I  I I  1 ! M  ! 1 1 I I  1 1 1 1 I !  1 1 1 1 ! I I !  1 I I  
TTTCG G CAG CCCC CCG CG G TGCTCCCCCG CCG CCAG G TGCCTTCG TAG AG TG TG G TGTTCl 2 4 1
Q u e ry 3 7« CATTTG CG G ATGG TCCGGCTCTTGAGGGCGTCGGGTGTGAGGTTGCAGATCTCCAGGCGG 4 3 7
S b j c t 12-50
i ■ ' i 1 i i i i : i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
CATTTG CG G ATGG TCCGG CTCTTG AG G G CG TCG G GTG TG AG GTTGCAG ATCTCCAG G CG G 11 8 1
Q u e ry 4 3 8 G iG A A c T l c CG CATG AA g T g TCG ciAA TG A C A TC C A G A A g T l CC C G TC C T g CATCTTG ACC 4 9 7
S b j c t 1 1 8  0
1 : I 1 I 1 I i 1 ! 1 I ‘ i I I I i 1 1 1 I 1 1 I 1 1 I I l I 1 I 1 1 1 I 1 l I 1 I I I 1 1 1 I 1 1 1 I I I 1 1 1 1
G TG A A C 7C C C G C ATG A AG TC TC G G A A TG AC ATC C A G A A C TC C C C G TC C TC C ATC TTG AC C 1121
Q u e ry 1 98 CG G AG CTG G TCC CG TTCATATGG G TCCACG TTG TTC CAC TCTG AGG AG CTG TCG CTCCAG 5 5 7
S b y c t 1 1 2 0
1 1 1 : 1 I 1 i 1 1 i 1 - 1 1 1 1 1 1 1 1 1 1 1 I 1 1 ; 1 1 1 1 1 i 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 I 1 1 1
C G G AG CTG G TCC CG TTCATATG G G TCCACG TTG TTC CAC TCTG AG G AG CTG TCG CTCCAG 10 6 1
Q u e ry 5 5 8 GCTCCCGTCCAC7CCACCTCG CCCCAG GG G TTCCGCATCCG GATCAG G CTCACCACCTG G 6 1 7
S b j c t 10 60
■ i l i i i ; ; i i I 1 1 1 i i i 1 1 I 1 i l 1 i 1 I 1 l 1 1 1 1 1 I 1 1 1 i 1 1 1 1 I 1 1 1 1 1 1 1 1 1 l 1 l 1 1 1 I
G CTCC CG TCCACTCCACC TCG CCCC AG G G GTTCCG CATCCG G ATCAG G CTC ACC AC CTG G1001
Q u e r y 6 18 CCTCG G7AGTTCACCTG CTTG G CCCC G G TCACAG AG TAG G CATG G CC CTTCACCAACTTC
I I  1 1 : : ' . : 1 | 1 i : , ; 1 1 ] I 1 ] i 1 1 1 I 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
6 7 7
S b jC t 1 0 0 0
. . 1 I : ! ! 1 I 1 ; i I . 1 I 1 I ; . 1 I ! H  I 1 1 1 1 I I I  1 1 1 1 1 i 1 M I 1 1 1 [ 1 1 1 H  1 I 1 1 1 1
CCTCG GTAG TTCACCTG CTTGG CC CCG G TCACAG AG TAG G CATG G CCCTTCAC CAAC TTC 9 4 1
Q u e ry 67 9 77G G AAG TG ATG G CC TCCATG TCTAG AACG CTG G AGATG TCTATG G AG CAG CCCAG CAG G
! i | ’ | | i i i 1 i ; 1 I ; ' 1 | 1 | I | : 1 i | 1 j i i | | | | | | | | j | | | I j | | | | | | | | | |
7 3 7
S b j c t 3 4 0'
i ! : S  i I , 1 i ! 1 l i 1 : 1 i i 1 ! 1 i i l 1 1 ! i 1 1 i 1 ! !  M  1 1 1 1 1 I I  1 l ! I ! I I  1 I I  1 
77G AAAG TG A7G G CCTCC ATG TCTAG AAC G C TG G AG ATG TC TATG G AG CAG CC CAG C AG G 8 8 1
Q u e ry -:<« GAGCCCCGC7CCAGCGCCTTG AG GA7GATCTG G TAG AG G TCACTG G G AG CCTTGCGCAAC
. '  | I < | I 1 | ; 1 1 >, | | i : | ! | | | | | | | j  | | | 1 | | | | | | | | | | | | | | | 1 | M  1 l 1 I I  I I  1
7 9 7
S b j c t 8 80
i I 1 1 I I ; I 1 ' ' ; 1 1 1 | 1 1 I I I 1 I I  1 1 I l 1 1 I 1 1 I | 1 1 1 | 1 1 I 1 | | 11 I 1 I I  1 1 1 1 1 1
GAGCCCCG C7CCAG CG CCT7G AG G A7G ATCTG G 7AG AG G 7CACTG GG AG CCTTG CG CAAC 8 21
Q u e ry '9 9 TCG G ACCACTCG G TAACCCCG CCTG TG AAG TCCTCAAAG CCCTCTG AG G TG CTG CCCCCT
i : i 1 ' i , ! , , : ' i 1 i ■ 1 I i . 1 I 1 1 1 1 i 1 1 i 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
8 5 7
S b j c t 82 0
: 1 ! i i I ! 1 I 1 ! 1 ■ 1 1 1 1 1 1 ! 1 1 1 I 1 I ' 1 1 1 1 1 1! 1 ' 1 1 1 1 I 1 1 I I  1 1 1 1 I 1 1 I I  1 I 
TCG 7AC CAC7CGC-TAACCCCG CCTGTG AAGTCCTCAAAG CCCTCTG AGG TG CTG CCCCCT " 6 1
Q u e ry 8 5 8 G AC AG G G CCTCG TAG C7G C CATTTACCT7T G G C A T A G G C C TTC TC A -G C A G A -C G C TC C A 9 1 5
S b j c t “ 60 G AC AG G G CCTCG TAG CTG CCATTTACCTT-G G C ATAG G CCTTC TCAAG CAG G G C G C TCCA 7 0 2
Q ue r  y 9 1 6 G A -C T C G T T 7 G C C T T C C G C C A G A -7 G C A C G A -C A C T A G C T T C C -G T C C T T G A T G C -C A G C
i • i , ' t ' i l l , ;  ; i , 1 i • : i l i ; i i  l ! : ; ■  i 1 l ! I l l  1
9 7 0
S b j c t "0 1
I ; i . 1 1 ; ' i I 1 1 i I 1 1 1 1 1 1 1 1 1 1 I 1 1 i 1 1 1 I I 1 1 1 l 1 I 1 1 1 I I 1 1
C-AACTCG TT-G C CTTCG G C-AG AG TG CACG AACAC TAG CTTCCCG TCC TTG ATG G G CAG C 644
Qu e r y 9 1 -G G 7C A 7  : CACGAC  ^ o * TC C .-iA cC c r tA T C c t  AA2\A>^ i - G i  u _ i
i i i i i i 1 i i i i i i i i i :  i i i  i i i i i i  i i i i i  m i
S b j c t 64 3
1 1 i I 1 I I I I  ; I I  1 I 1 I 1 I 1 1 1 1 1 I I I  11 
A G G T C A T C C A C 'G A C C A -C G T -C C A -C C C A C T C C C C A A A -T T G  6 0 6
BLAST search results using sequence from CAPN1-GFP Lenti plasmid sequenced with
CAPN1/C2R1 reverse (mid seq) primer
280
Homo sapiens calpain 1, (mu/I) large subunit (CAPN1), mRNA Length=3007
Identities = 901/923 (98%), Gaps = 15/923 (1%) 
Strand=Plus/Plus
Query 73 ATGTCGGAGGAGAACATCACGCCGGTGTACTGCACTGGGGTGTCAGCCCAAGTGCAGAAG 
1 1 1 1 M 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 II I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I! 1 1 1 1 1 1 1 1 
ATGTCGGAGGAGATCATCACGCCGGTGTACTGCACTGGGGTGTCAGCCCAAGTGCAGAAG
132
Sbjct 144 203
Query 133 CAGCGGGCCAGGGAGCTGGGCCTGGGCCGCCATGAGAATGCCATCAAGTACCTGGGCCAG 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CAGCGGGCCAGGGAGCTGGGCCTGGGCCGCCATGAGAATGCCATCAAGTACCTGGGCCAG
192
Sbjct 204 263
Query 193 GATTATGAGCAGCTGCGGGTGCGATGCCTGCAGAGTGGGACCCTCTTCCGTGATGAGGCC 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GATTATGAGCAGCTGCGGGTGCGATGCCTGCAGAGTGGGACCCTCTTCCGTGATGAGGCC
252
Sbjct 264 323
Query 253 TTCCCCCCGGTACCCCAGAGCCTGGGTTACAAGGACCTGGGTCCCAATTCCTCCAAGACC 
1 1 II II 1 1 1 II 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TTCCCCCCGGTACCCCAGAGCCTGGGTTACAAGGACCTGGGTCCCAATTCCTCCAAGACC
312
Sbj ct 324 383
Query 313 TATGGCATCAAGTGGAAGCGTCCCACGGAACTGCTGTCAAACCCCCAGTTCATTGTGGAT 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 II 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 
TATGGCATCAAGTGGAAGCGTCCCACGGAACTGCTGTCAAACCCCCAGTTCATTGTGGAT
372
Sbjct 384 443
Query 373 GGAGCTACCCGCACAGACATCTGCCAGGGAGCACTGGGGGACTGCTGGCTCTTGGCGGCC 
1 II 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GGAGCTACCCGCACAGACATCTGCCAGGGAGCACTGGGGGACTGCTGGCTCTTGGCGGCC
432
Sbjct 444 503
Query 433 ATTGCCTCCCTCACTCTCAACGACACCCTCCTGCACCGAGTGGTTCCGCACGGCCAGAGC 
1 1 II II 1 II 1 1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
ATTGCCTCCCTCACTCTCAACGACACCCTCCTGCACCGAGTGGTTCCGCACGGCCAGAGC
492
Sbjct 504 563
Query 493 TTCCAGAATGGCTATGCCGGCATCTTCCATTTCCAGCTGTGGCAATTTGGGGAGTGGGTG 
1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TTCCAGAATGGCTATGCCGGCATCTTCCATTTCCAGCTGTGGCAATTTGGGGAGTGGGTG
552
Sbjct 564 623
Query 553 GACGTGGTCGTGGATGACCCGCTGCCCATCAAGGACGGGAAGCTAGTGTTCGTGCACTCT 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GACGTGGTCGTGGATGACCTGCTGCCCATCAAGGACGGGAAGCTAGTGTTCGTGCACTCT
612
Sbjct 624 683
Query 613 GCCGAAGGCAACGAGTTCTGGAGCGCCCTGCTTGAGAAGGCCTATGCCAAGGTAAATGGC 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 
GCCGAAGGCAACGAGTTCTGGAGCGCCCTGCTTGAGAAGGCCTATGCCAAGGTAAATGGC
672
Sbjct 684 743
Query 673 AGCTACGAGGCCCTGTCAGGGGGCAGCACCTCAGAGGGCTTTGAGGACTTCACAGGCGGG 
1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 
AGCTACGAGGCCCTGTCAGGGGGCAGCACCTCAGAGGGCTTTGAGGACTTCACAGGCGGG
732
Sbj ct 744 803
Query 733 GTTACCGAGTGGTCCGAGTTGCGCAAGGCTCCCAGTGACCTCTACCAGATCATCCTCAAG 
1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GTTACCGAGTGGTACGAGTTGCGCAAGGCTCCCAGTGACCTCTACCAGATCATCCTCAAG
792
Sbjct 804 863
Query 793 GCGCTGGAGCGGGGCTCCCTGCTGGGCTGCTCCATAGACATCTCCAGCGTTCTAGACATG 
1 1 1 1 1 II 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 
GCGCTGGAGCGGGGCTCCCTGCTGGGCTGCTCCATAGACATCTCCAGCGTTCTAGACATG
852
Sb j ct 864 923
Query 853 GAGGCCATCACTTCCAAGAAGTTGGTGAAGGGCCATGCCTACTCTGTGAC-GGG-CCA-G
1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 III III 1
GAGGCCATCACTTTCAAGAAGTTGGTGAAGGGCCATGCCTACTCTGTGACCGGGGCCAAG
909
Sbjct 924 983
Query 910 CAAGTGAACTACCGAGGCCAGTTG-TGAGCCTGATC-G-ATGCG-A-CCC-TGG— CGAA 
II 1 1 1 1 1 1 1 II 1 1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 II 1 1 II 1 1 1 III III III 
CAGGTGAACTACCGAGGCCAGGTGGTGAGCCTGATCCGGATGCGGAACCCCTGGGGCGAG]
961
Sbjct 984 L043
Query 962 GTG-A-TGGACG— AGCCTGGAG 980 
III 1 1 II 1 II 1 1 1 1 1 1 1 1 1 
GTGGAGTGGACGGGAGCCTGGAG 106 6Sbj ct 1044
BLAST search results using sequence from CAPN1-GFP Lenti plasmid sequenced with Lenti
SxW Forward primer
281
Mus musculus transgenic enhanced green fluorescent protein (EGFP)
mRNA, complete cds
Length=1151
Score = 1240 bits (671), Expect = 0.0 
Identities = 706/721 (98%), Gaps = 9/721 (1%)
Strand=Plus/Minus
Query 233 TTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAG
1 1 1 1 1 1 1 I I  1 1 1 1 1 I I  1 1 1 1 I I I 1 I I 1 1 1 I I 1 I I 1 i i I i i i i i i I i i i i i i i i I I 1 i l  1 1
292
Sbj ct 852
M  1 II 1 II II 1 I 1 1 II II II II II 1 II II II Ii I II II 1 II 1 1 1 II II 1 1 II 1 II 1 II 1 1 
TTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAG 793
Query 293 GACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTA
1 1 1 1 1 1 1 1 1 I I  1 1 1 1 1 1 1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
352
Sbj ct 792
1 M  II 1 1 1 II 1 1 II 1 II II II 1 II II II 1 II 1 1 II M  1 II II II 1 1 II 1 1 1 M  1 II 1 II 1 
GACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTA 733
Query 353 GTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTC
1 i 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 i 1 1 i 1
412
Sbj ct 732
1 M  M  1 1 II II II II 1 1 1 1 1 1 1 1 II 1 II II 1 II II II II II II 1 1 II 1 1 1 1 1 1 1 1 II 1 M  
GTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTC 673
Query 413 GGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGGTCTTGAAGTTCACCTTGATGCC
I I i i i I I I I i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
472
Sbj ct 6~>2
1 1 1 1 1 II 1 I II II 1 1 II II 1 II II 1 II I! 1 II 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGAAGTTCACCTTGATGCC 613
Query 473 GTTCTTCTGCTTGTCGGCGGTGATATAGACCTTGTGGCTGTTGTAGTTGTACTCCAGCTT
i i i i i i i i i i i t i i i i i i i i i i i i i i i i i i t i i i i i i i i i i i i i i i i i i i i i i t i i i
532
Sbj ct 612
1 1 1 1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GTTCTTCTGCTTGTCGGCCATGATATAGACGTTGTGGCTGTTGTAGTTGTACTCCAGCTT 553
Query 533 GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCAC
1 I I I  1 1 1 1 I ! 1 1 1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
592
Sbj ct 552
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCAC 493
Query 593 CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAA 
i i i i i i i i i i  i i i  i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
652
Sbj ct 492
1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAA 433
Query 653 GAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTG
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
712
Sbj ct 432
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTG 373
Query 713 CTTCATGTGGTCGGGGTAGCGGGC-GAAGCACTGCACGCCGTAG-TGAAGGTGGTCACGA 
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i  i i i i i i i
770
Sbj ct 372
1 1 1 II 1 II 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CTTCATGTGGTCGGGGTAGCGG-CTGAAGCACTGCACGCCGTAGGTCAGGGTGGTCACGA 314
Query 771 GGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGG-TCAGCTTGC
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i I I i i i I I I I I I I I I I
829
Sbj ct 313
II 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGC 254
Query 830 CGTAG-TGGCATCGCCCTCGCCCTCGCCGGGACACGCTGAACTTGTGGCCGTTTACGTCG
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i I I i i I I I I I I I l l l l I
888
Sbj ct 253
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CGTAGGTGGCATCGCCCTCGCCCTCGCCGG-ACACGCTGAACTTGTGGCCGTTTACGTCG 195
Query 889 CCGTCCAGCTCGACCAGGGATGGGCACCACCCCCGGTGAACAGCTCCTCGCC-TTGCTCA
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i I I I i I I l I I I l l I l l
947
Sbj ct 194
II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CCGTCCAGCTCGACCAGG-ATGGGCACCACCCC-GGTGAACAGCTCCTCGCCCTTGCTCA 137
Query 948 C 948
i
Sbj ct 136
1
C 136
BLAST search results using sequence from CAPN1-GFP Lenti plasmid sequenced with Lenti
SxW Reverse primer
282
Homo sapiens calpain 1, (mu/I) large subunit (CAPN1), mRNA 
Length=3007
Score = 789 bits (427), Expect = 0.0
Identities = 474/495 (96%), Gaps = 10/495 (2%)
Strand=Plus/Plus
AAATAGGAACACCACACTACTTGCGAAAAAAGAACC-GGCGGCGGGGGAGCACCGCGGGG 7 6 
I I  I I  I I I I I I I I I I I I I I I I I  I I  I I I I  I I I I I I I I I I I I I I I I I  I I I I I  I
GGCTGCCGAAACTACCCAGCCACCTTCTAGGGTGAACCCTCAGTTCAAGATCCGGCTGGA 13 6 
I I I I  I I I I I I I I I I I I I  I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I
Query 18
Sbj ct 1236
Query 77
Sbj ct 1290
Query 137
Sbj ct 1349
Query 197
Sbj ct 1409
Query 257
Sbj ct 1469
Query 317
Sbj ct 1529
Query 377
Sbj ct 1587
Query 437
Sbj ct 1647
Query 497
Sbj ct 1707
I I
  TGACTTCTTCCTGGCCAATGCGTCTCGGGCGCGCTCAGAGCAGTTTTTCTTTCTTTGCTA 37 6 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II I 
  TGACTTCTTCCTGGCCAATGCGTCTCGGGCGCGCTCAGAGCAGTTCATCAACCT— GCGA1586
GAGGTCAGCACTCGCTTCCGCCTGCCTCCCGGGGAGTATGTGGTGGTGCCCTCCACCTTC 4 3 6 
I I I I I I I I I I I I I I II I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I 
   GAGGTCAGCACCCGCTTCCGCCTGCCACCCGGGGAGTATGTGGTGGTGCCCTCCACCTTC1646
GAGCCCAACAAGGAGGGCGACTTCGTGCTGCGCTTCTTCTCAGAGAAGAGTGCTGGGACT 4 96
I I I I I I I I I II I I I I II I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
I I I I I I I I I I
BLAST search results using sequence from CAPND3-GFP Lenti plasmid sequenced with Lenti 
SxW Forward primer
283
Mus musculus transgenic enhanced green fluorescent protein (EGFP)
mRNA, complete cds
Length=l151
Score = 1177 bits (637), Expect = 0.0 
Identities = 702/729 (97%), Gaps = 21/729 (2%)
Strand=Plus/Minus
Query 237 TTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAG
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
296
Sbj ct 852
U  U  U  1 1 1 1 II I II 1 1 1 1 II 1 11 1 II 1 1 1 1 !l 1 11 II 1 1 1 1 1 1 i M  M  1 1 M  M  M  II 1 
TTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAG 793
Query 297 GACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTA
1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I
356
Sbj ct 792
I H  1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 |{ 1 1 1 1 1 1 1 1 1 ! 1 1 1 1 II 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTA 733
Query 357 GTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTC 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
416
Sbj ct 732
II 1 1 M  1 1 I M  1 II 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 I 1 II I I 1 1 I II 1 1 1 1 1 II 
GTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTC 673
Query 417 GGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGGTCTTGAAGTTCACCTTGATGCC 
i I i i i i i  I m  i I i i  i i i i i i i i  i i i i i i i i i i i > i i i i i i i i i i i i i i i i i i i i i i i i i
476
Sbj ct 672
II II 1 1 1 II II 1 II 1 1 II 1 1 I! 1 II II 1 II II II II 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 
GGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGAAGTTCACCTTGATGCC 613
Query 477 g t t c t t c t g c t t g t c g g c g g t g a t a t a g a c c t t g t g g c t g t t g t a g t t g t a c t c c a g c t t
1 1 1 1 1 1 > 1  1 I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
536
Sbj ct 612
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 II 1 1 II 1 1 
GTTCTTCTGCTTGTCGGCCATGATATAGACGTTGTGGCTGTTGTAGTTGTACTCCAGCTT 553
Query 537 GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCAC
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
596
Sbj ct 552
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 1 II 1 II 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 
GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCAC 493
Query 597 CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAA 
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i  i
656
Sbj ct 492
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 
CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAA 433
Query 657 GAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTG 
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i  i i i i i i
716
Sbj ct 432
1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 
GAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTG 373
Query 717 CTTCATGTGGTCGGGGTAGCGGGC-GAAGCACTGCACGCCGTAGGTGAAGGTGGTCACGA
......................... i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
775
Sbj ct 372
II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CTTCATGTGGTCGGGGTAGCGG-CTGAAGCACTGCACGCCGTAGGTCAGGGTGGTCACGA 314
Query 776 GGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGC 
................... ..... i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i  i i i i i i i  i i i i I i i I I I I I I I I
835
Sb j ct 313
1 II 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 
GGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGC 254
Query 836 CGTAAGGTGGCATCGCCCTCGCCCTCGCCCGGAACACGCCTGA-CTTGTGGCCCGTT-AC 
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i  i i i  I i i i i  i I i i l  l i l  l I I I  l l
893
Sbj ct 253
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 III 1 1 1 1 1 III 1 1 1 1 1 1 1 1 1 III II 
CGTA-GGTGGCATCGCCCTCGCCCTCGCC-GGA-CACGC-TGAACTTGTGGCC-GTTTAC 199
Query 894 GTTCGCCGTC-AGCTCGACCAGGGAATGGGCACCCACCCCCCGGGTGAAACAGCTTCCCT
i i  i i i i i i i i i i i i i i i i i i i i i i i i i i I i i I l i i i l  i l  I l l l  1 1 1 II l
952
Sbj ct 198
II 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 l l ll l 
GT-CGCCGTCCAGCTCGACCAGG-A-TGGGCACC-ACCCC— GG-TGAA-CAGCT-CC-T 149
Query 953 CGCCCCTTG 961
1 1 1 1 1 I I I
Sbj ct 148
I 1 M  1 IN 
CGCCC-TTG 141
BLAST search results using sequence from CAPND3-GFP Lenti plasmid sequenced with Lenti
SxW Reverse primer
284
calpain, small subunit 1 [Homo sapiens]
Score = 1225 bits (663), Expect = 0.0 
Identities = 669/672 (99%), Gaps = 0/672 (0%) 
Strand=Plus/Plus
Query 97 GGCGGCGGCGGTGGTGGAGGCGGCGGTGGCGGTGGAACGGCCATGCGCATCCTAGGCGGA
| | | I | | | | I | I I | | | | | 1 | | | I I I I | I I I I I I I | I I I I I I I I I I I I I I I 1 I I I I I I I 1 I I
156
Sbj ct 290
1 1 1 M  II II 1 II II II II 1 II II II II II II 1 II 1 1 II 1 II 1 II 1 II II 1 1 II II II 1 II 
GGCGGCGGCGGTGGTGGAGGCGGCGGTGGCGGTGGAACGGCCATGCGCATCCTAGGCGGA 349
Query 157 GTCATCAGCGCCATCAGCGAGGCGGCTGCGCAGTACAACCCGGAGCCCCCGCCCCCACGC
1 1 1 1 1 1 1 1 1 t 1 1 t 1 1 1 t t 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 t 1 1 1 1 1 1 1 i 1 1 1 1 1 1 t 1 1 1 1 1 1 1 1 1 1 1
216
Sbj ct 350
1 1 1 1 II II M  II 1 II II 1 II II 1 II II 1 1 II II 1 II II II II II II II 1 II II 1 1 II II 1 
GTCATCAGCGCCATCAGCGAGGCGGCTGCGCAGTACAACCCGGAGCCCCCGCCCCCACGC 409
Query 217 ACACATTACTCCAACATTGAGGCCAACGAGAGTGAGGAGGTCCGGCAGTTCCGGAGACTC
1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 i 1 1 1 1
276
Sbj ct 410
1 1 1  1 1  1 1  1 1  m  ii 1 1  1 1  1 1  1 1  1 1  1 1  1 ll ll lll IIllIIII II II 1 II 1 II 1 II II 1 II 1 
ACACATTACTCCAACATTGAGGCCAACGAGAGTGAGGAGGTCCGGCAGTTCCGGAGACTC 469
Query 277 TTTGCCCAGCTGGCTGGAGATGACATGGAGGTCAGCGCCACAGAACTCATGAACATTCTC
1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 !! 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
336
Sbj ct 470
II 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 II 1 1 II 1 II II II II II II II II II II 1 II II 1 II II II 1 II 
TTTGCCCAGCTGGCTGGAGATGACATGGAGGTCAGCGCCACAGAACTCATGAACATTCTC 529
Query 337 AATAAGGTTGTGACACGACACCCTGATCTGAAGACTGATGGTTTTGGCATTGACACATGT
1 1 1 1 1 1 1 II 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
396
Sbj ct 530
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
AATAAGGTTGTGACACGACACCCTGATCTGAAGACTGATGGTTTTGGCATTGACACATGT 589
Query 397 CGCAGCATGGTGGCCGTGATGGATAGCGACACCACAGGCAAGCTGGGCTTTGAGGATTTC 
1 1 1 1 1 1 1  1 1 1 1 1 1 1 1 1 1 1 1  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
456
Sbj ct 590
1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 III 
CGCAGCATGGTGGCCGTGATGGATAGCGACACCACAGGCAAGCTGGGCTTTGAGGAATTC 649
Query 457 TTGTACTTGTGGAACAACATCAAAAGGTGGCAGGCCATATACAAACAGTTCGACACTGAC 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
516
Sbj ct 650
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
AAGTACTTGTGGAACAACATCAAAAGGTGGCAGGCCATATACAAACAGTTCGACACTGAC 709
Query 517 CGATCAGGGACCATTTGCAGTAGTGAACTCCCAGGTGCCTTTGAGGCAGCAGGGTTCCAC 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
576
Sbj ct 710
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CGATCAGGGACCATTTGCAGTAGTGAACTCCCAGGTGCCTTTGAGGCAGCAGGGTTCCAC 769
Query 577 CTGAATGAGCATCTCTATAACATGATCATCCGACGCTACTCAGATGAAAGTGGGAACATG 
1 1 1 1 1 1 1 1  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  1 1 1 1 1 1 1 1 1 1 1 1 1 1
636
Sbj ct 770
1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CTGAATGAGCATCTCTATAACATGATCATCCGACGCTACTCAGATGAAAGTGGGAACATG 829
Query 637 GATTTTGACAACTTCATCAGCTGCTTGGTCAGGCTGGACGCCATGTTCCGTGCCTTCAAA 
1 1 1 1 1 1 1 1  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  1 1 1 1 1 1 1 1 1 1 1 1 1
696
Sbj ct 830
1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 
GATTTTGACAACTTCATCAGCTGCTTGGTCAGGCTGGACGCCATGTTCCGTGCCTTCAAA 889
Query 697 TCTCTTGACAAAGATGGCACTGGACAAATCCAGGTGAACATCCAGGAGTGGCTGCAGCTG 
1 1 1 i 1 1 1 1 1 1 1 1 i t 1 1 1 1 1 1 1 i 1 1 1 i i 1 1 1 i 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 il 1 1 1 1 1 1 ii 1 1 1 1
756
Sbj ct 890
II 1 II II 1 1 1 II ! II II 1 II I 1 II II if 1 1 1 II II II II II 1 II II II 1 II II 1 1 II 1 II 
TCTCTTGACAAAGATGGCACTGGACAAATCCAGGTGAACATCCAGGAGTGGCTGCAGCTG 949
Query 757 ACTATGTATTCC 7 68
I 1 I i 1 1 i i 1 1 1 1
Sbj ct 950
1 1 1 1 1 1 1 1 1 1 1 1 
ACTATGTATTCC 9 61
BLAST search results using sequence from CAPNS1-GFP Lenti plasmid sequenced with Lenti 
SxW Forward primer
285
Mus musculus transgenic enhanced green fluorescent protein (EGFP)
mRNA, complete cds
Length=l151
Score = 1218 bits (659), Expect = 0.0 
Identities = 711/733 (97%), Gaps = 15/733 (2%)
Strand=Plus/Minus
Query 237 TTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAG 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ! 1 1 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
296
Sbj ct 852
I I 1 1 1 1 1 1 1 1 1 1 M  II 1 1 il II II 1 1 II II II II 1 II 1 II 1 II II II M  II II II II 1 1 1 
TTACTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAG 793
Query 297 GACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTA
| | | | | | | | | | | | | | | | | | | | 1 1 1 | | | 1 1 1 1 1 1 | 1 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 | 1
356
Sbj ct 792
1 1 1 1 1 I M  1 II II II II II II II II II 1 1 II II II II II 1 1 1 II 1 1 II 1 II 1 1 1 II II II 
GACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTA 733
Query 357 GTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTC
| | | | | | | | | | | | | | 1 | | I | 1 | | 1 1 | | | 1 | | 1 | 1 1 1 1 I 1 I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
416
Sbj ct 732
M  II II II 1 II 1 1 II ! II I II II M  1 II II II M  II I 1 II II 1 M  M  II M  1 II M  M  II 
GTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTC 673
Query 417 GGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGGTCTTGAAGTTCACCTTGATGCC
1 1 1 t 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I 1 1 f 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 t 1 1 1 1 1 1 1 1 1 1
476
Sbj ct 672
M  II 11 II II II II 1 1 II II M  1 II II II II II II II 1 1 1 1 1 1 1 1 1 1 1 I 1 1 1 1 1 1 1 1 1 1 
GGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGAAGTTCACCTTGATGCC 613
Query 477 GTTCTTCTGCTTGTCGGCGGTGATATAGACCTTGTGGCTGTTGTAGTTGTACTCCAGCTT
i i t i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i t i i i i i i i i i i i i i i i i i i
536
Sbj ct 612
1 1 1 1 M  1 II II II 1 II II II II 1 II II 1 1 1 II 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 
GTTCTTCTGCTTGTCGGCCATGATATAGACGTTGTGGCTGTTGTAGTTGTACTCCAGCTT 553
Query 537 GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCAC 
i I i i i i ii m  i m  i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
596
Sbj ct 552
1 1 1 1 1 1 1 1 1 II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 1 I I I I I I I I I I I I I I I I I I I I I I I I I I 
GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCAC 493
Query 597 CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAA
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
656
Sbj ct 492
1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 II 1 
CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGCCGTCGTCCTTGAA 433
Query 657 GAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTG 
i i ii i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
716
Sbj ct 432
1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 II II II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
GAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTG 373
Query 717 CTTCATGTGGTCGGGGTAGCGGGC-GAAGCACTGCACGCCGTAG-TGAAGGTGGTCACGA
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
774
Sbj ct 372
1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
CTTCATGTGGTCGGGGTAGCGG-CTGAAGCACTGCACGCCGTAGGTCAGGGTGGTCACGA 314
Query 775 GGGTGGGCCAGGGCACGGGCAGCTTGCCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTG 
i i i i i i i i i i i i i ii i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
834
Sbj ct 313
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 II 1 1 1 1 1 II 1 
GGGTGGGCCAGGGCACGGGCAGCTTGCC-GGTGGTGCAGATGAACTTCAGGGTCAGCTTG 255
Query 835 CCGTAGGTGGCATCGCCCTCGCCCTCGCCCGGACACGCTGAAACTTGGTGGACCGTTTAC
i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i I i I ll ill I I I I I I l I
894
Sbj ct 254
1 1 1 1 1 1 1 1 1 1 II 1 1 II 1 1 1 II 1 1 1 II 1 II 1 1 1 1 1 1 1 1 1 1 II 1 1 II III 1 1 1 1 1 1 1 1 
CCGTAGGTGGCATCGCCCTCGCCCTCGCC-GGACACGCTGAA-CTTG-TGG-CCGTTTAC 199
Query 895 GTTCGCCCGTCCAGCTCGACCAGGATGGGGCACCAACCCCCGGTGACCAGCTCCTCGCC-
ii i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i I i i I I ll I I I I I I l l l l I l l
953
Sbj ct 198
II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 1 1 1 1 II 1 1 1 1 1 1 1 1 1 1 1 1 1 1 II 1 
GT-CGCC-GTCCAGCTCGACCAGGATGGG-CACCA-CCCC-GGTGAACAGCTCCTCGCCC 144
Query 954 TTGCCTCACCATG 966
i i i i i i i i I i i i
Sbj ct 143
1 1 1 1 1 1 1 1 1 1 1 1 
TTGC-TCACCATG 132
BLAST search results using sequence from CAPNS1-GFP Lenti plasmid sequenced with Lenti
SxW Reverse primer
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